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ABSTRACT 
Stacy Sterling: Barriers to and Facilitators of Implementation of Screening, Brief 
Intervention and Referral to Treatment for Risky Substance Use for Adolescents Pediatric 
Primary Care: A Qualitative Interview Study 
 (Under the direction of Asheley C. Skinner) 
 
 Alcohol and other drug problems can be devastating to adolescents’ health, mental 
health and well-being, and early detection and intervention are critically important.
1-3
 
Pediatric primary care, with its emphasis on health promotion is an opportune setting in 
which prevention and early intervention for substance use problems can occur.
4,5
 Screening, 
brief intervention and referral to treatment (SBIRT) for alcohol and drug use problems is a 
public health approach to early intervention for substance use problems endorsed by the 
National Institutes of Health, and the Department of Health and Human Services and the 
Substance Abuse and Mental Health Services Administration,
6-9
 and recommended by major 
medical organizations.
10-15
  SBIRT for adolescents has not been widely implemented in 
pediatric health care settings however, and there is little research on factors contributing to its 
implementation in pediatric primary care.
16,17
  
 This dissertation uses qualitative data from Key Informant interviews with Kaiser 
Permanente Northern California (KPNC) and community-based pediatric and specialty 
mental health and substance abuse treatment clinicians, policymakers and clinical staff to 
examine feasibility and factors – environmental, organizational, provider- and patient-level, 
and the nature of the intervention itself – which may inhibit or facilitate implementation of 
SBIRT in pediatric primary care.  The dissertation culminates in a Plan for Change focused 
iv 
on pragmatic steps to facilitate the implementation of adolescent SBIRT in a large integrated 
healthcare delivery system, KPNC.  The qualitative analysis and resulting implementation 
plan are informed by the findings on implementation outcomes from a cluster-randomized, 
hybrid implementation and effectiveness trial of different modalities of delivering SBIRT in 
pediatric primary care, conducted in KPNC.    
 
 
v 
“Youth is a dream, a form of chemical madness.” 
-F. Scott Fitzgerald, Tales of the Jazz Age 
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CHAPTER 1: INTRODUCTION 
Problem Statement 
Alcohol and other drug (AOD) problems can be devastating to the health, mental 
health and life trajectories of adolescents; the National Center on Addiction and Substance 
Abuse calls adolescent substance abuse “America’s #1 Public Health Problem.”18 Although 
rates of substance use have generally declined over the past forty years among youth in the 
United States (U.S.), the most recent Monitoring the Future national survey of 8
th
, 10
th
 and 
12
th
 graders found that underage drinking and drug use is still highly prevalent, and the 
continued high rates of both the use of certain substances (alcohol, marijuana and 
prescription opioids), and certain practices (e.g., binge drinking), even among young 
adolescents, are worrisome.  In 2015, 10% of 8
th
 graders, 22% of 10
th
 graders and 35% of 
12
th
 graders reported past 30-day alcohol use; 3% of 8
th
 graders, 11% of 10
th
 graders and 
21% of 12
th
 graders reported having been drunk in the past 30 days, and 7% of 8
th
 graders, 
17% of 10
th
 graders, and 21% of 12
th
 graders reported past 30-day marijuana use.
19
 Substance 
use is closely associated with the three leading causes of mortality and morbidity in this age 
group – accidents, homicide and suicide20 – as well as with medical21,22 and mental health 
comorbidities,
23,24
  and early detection and intervention can make a critical difference in 
adolescents’ health and wellbeing.1-3 Recent studies have demonstrated the significant and 
potentially irreversible damage which the use of substances, including alcohol and marijuana, 
the substances most commonly used by adolescents in the U.S., can cause to developing 
adolescent brains.
25-41
 As trusted health care professionals with regular contact with many 
 2 
adolescents, pediatric primary care providers (PCPs) are ideally placed to identify substance 
use problems before they become more serious.
4,5
  
While behavioral health problems – substance use and mental health – are among the 
most common pediatric health conditions in the U.S.,
42
 far fewer than half the children and 
adolescents in need of care ever receive services, particularly specialty substance abuse 
treatment.
43,44
  Certain population groups, including Latinos and African Americans, are 
especially unlikely to receive care.
43-46
  Many families never seek care, and many of those 
that do, because of issues of system capacity and insurance coverage, among others, have 
difficulty obtaining it.
47
  Because most families will never seek specialty care, primary care 
visits provide critical opportunities to detect substance problems,
48
 and more children in the 
U.S. with behavioral health conditions receive care for these conditions from their primary 
care provider than from any other type of provider.
49
  Studies have found that PCPs may be 
especially effective agents to provide this care,
4
 and adolescents and their parents have been 
found to be receptive to screening and intervention by pediatricians,
50
 and to have positive 
perceptions of care when their pediatrician discusses “sensitive” topics, including substance 
use, with them.
51
  Effective adolescent substance abuse prevention and early intervention 
relies on identification and intervention approaches that are effective, feasible, flexible and 
implementable in real-world clinical settings.  As yet however, standardized screening and 
intervention for adolescent substance use problems has not been widely adopted in pediatric 
primary care in the United States.  
Screening, brief intervention and referral to treatment (SBIRT) is a public health 
approach to early intervention for substance use problems endorsed by the National Institutes 
of Health, and the Department of Health and Human Services and the Substance Abuse and 
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Mental Health Services Administration.
6-9
  SBIRT may vary in how it is delivered – in 
length, type of clinician, format, etc. – but it is most commonly informed by Motivational 
Interviewing, a therapeutic approach that has been used to address a wide variety of 
behavioral health problems, but most extensively with substance use.  It is patient-centered 
and non-confrontational, and focuses on increasing readiness to change and self-efficacy, 
using empathic listening techniques, and increasing the perceived discrepancy between actual 
and ideal behavior.
52
  Interventions incorporating motivational interviewing techniques are 
thought to be particularly well-suited to the developmental stage of adolescents, due to their 
non-confrontational, non-judgmental approach,
53
 and frequent incorporation of decisional 
balance exercises,
54
 and studies have found that motivational interviewing can be effective 
for reducing substance use in adolescents,
54-56
 including those with co-occurring substance 
use and mental health conditions.
57
 While many brief interventions, particularly those 
designed to be delivered by physicians in busy medical settings, do not incorporate all the 
components of motivational interviewing, most are informed by the motivational 
interviewing approach and can be adapted to a variety of settings and interventionists.  
The efficacy, effectiveness, cost-effectiveness and feasibility of alcohol SBIRT in 
adult primary care has been well-documented,
58-62
 although the evidence on the efficacy of 
adult SBIRT for illicit drugs is mixed.
63-66
  There is a smaller but growing body of research 
suggesting that SBIRT may also be effective for adolescents,
67-73
 and a recent meta-analysis 
found that alcohol screening and brief intervention produced significant reductions in both 
alcohol use and related problems among adolescents and young adults, across diverse 
populations and modalities.
54
  Nevertheless, the efficacy and effectiveness literature is less 
robust than for adults, the cost-effectiveness of SBIRT for adolescents has yet to be 
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established,
74
 and there is little research on factors contributing to its implementation in 
pediatric primary care.
16,17
 Based upon reviews of the evidence,
75,76
 the U.S. Preventive 
Services Task Force determined that the evidence for screening and behavioral interventions 
in pediatric primary care is currently insufficient to recommend its use, for either alcohol,
77
 
or illicit and non-medical prescription drug use.
78
  
While the research literature on SBIRT for adolescents in primary care is still 
developing, intuitively and anecdotally, identifying risky health behaviors in the context of 
primary care provider visits, and pediatricians and patient discussions about avoiding risky 
behavior or minimizing risks, would certainly seem to be sound clinical practice and 
consistent with the preventative orientation of pediatric primary care.  National pediatric and 
adolescent medical organizations agree, and many have issued guidelines that specifically 
endorse regular alcohol and drug screening for adolescents.  The American Academy of 
Pediatrics (AAP) suggests that substance use be included in the health history taken at each 
visit starting at the age of 8, and their 2016 “Recommendations for Pediatric Preventive 
Health Care” recommends alcohol and drug use assessment beginning at age 11, including: 
“risk assessment to be performed with appropriate action to follow, if positive.”15  Similarly, 
the American Medical Association’s (AMA) Guidelines for Adolescent Preventive Services 
recommends that youth from 11 to 21 should have at least an annual preventive health visit, 
with screening for alcohol and drug use conducted at each visit.
10,11,79-81
     
Other forces are also driving the dissemination and adoption of SBIRT for 
adolescents, including major philanthropic investments, such as the Conrad N. Hilton 
Foundation’s $50 Million Substance Use Prevention Initiative 
https://www.hiltonfoundation.org/priorities/substance-use-prevention, which is directed 
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toward supporting multi-pronged, prevention and early intervention efforts aimed at reducing 
adolescent substance abuse. In spite of this growing momentum for the adoption of SBIRT 
for adolescents however,  most health systems – public and private – have not implemented 
routine SBIRT for adolescents, and the NIH has recently called for research on both its 
effectiveness and factors related to its implementation for adolescents.
9
 Findings from this 
dissertation add to what is known about the challenges and opportunities involved in 
implementing SBIRT in pediatric primary care. 
Topic 
A qualitative exploration of the environmental, organizational, provider and patient 
and intervention factors which inhibit or facilitate implementation of SBIRT for adolescents 
in pediatric primary care to improve early identification of and intervention for substance use 
problems among adolescents, and development of a plan for implementing SBIRT in 
pediatric primary care across a large, integrated healthcare delivery system.  
This dissertation uses qualitative Key Informant interview data from a cluster-
randomized, hybrid implementation and effectiveness trial (RCT) examining implementation 
outcomes and effectiveness and cost-effectiveness of adolescent SBIRT in an integrated 
healthcare delivery system, Kaiser Permanente Northern California (KPNC).  The RCT 
randomized Pediatric Primary Care Providers (PCPs) in a large Pediatrics clinic to one of 
three arms – a Usual Care arm and two alternative modes of delivering SBIRT: 1) by PCPs, 
and 2) by Behavioral Health Clinicians (BHCs). Pediatricians and BHCs were trained in the 
same empirically-supported SBIRT protocol, treatment fidelity was monitored, and 
performance feedback provided to both types of clinicians. The RCT used data from the 
health system’s electronic health record (EHR), collected during the course of clinical care, 
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to examine provider-level outcomes (screening, assessment, brief intervention and referral 
rates), patient outcomes (alcohol and drug use and related problems), and cost-effectiveness.  
The Parent RCT collected qualitative data, through Key Informant interviews with 
KPNC pediatricians, nurses, medical assistants, receptionists, behavioral health (Child & 
Family Psychiatry and Chemical Dependency treatment) clinicians, and Pediatrics and 
Behavioral Health leadership. It also included non-KPNC clinical leaders and policy-makers 
from public, private and governmental pediatric health care delivery systems, in order 
provide some context for the within-KPNC analysis, in terms of understanding which 
barriers and facilitators might be unique to this closed, integrated system, and which are more 
universal, and therefore generalizable, to other healthcare systems. This dissertation involves 
an analysis of these Key Informant interview data in the context of the current evidence base, 
informed by implementation findings from the parent RCT, and guided by an implementation 
research conceptual framework, concentrating on the barriers to and facilitators of 
implementing SBIRT for adolescents, and the implications for clinical practice and policy.   
Specific Aims 
Aim 1: Qualitative Analysis of Implementation Process, Feasibility. Examine the 
process of SBIRT implementation, barriers and facilitators, and intervention fidelity within 
KPNC, through semi-structured qualitative interviews with providers and staff (PCPs, BHCs, 
Nurses, Medical Assistants, Child and Family Psychiatry and Chemical Dependency 
treatment program clinicians, Receptionists, and pediatrics and Behavioral Health leaders) in 
the study.   
  
 7 
Aim 2: Examine differences and similarities in barriers and facilitators to the 
implementation of standardized SBIRT for adolescents across health care delivery systems – 
public and private – outside of KPNC.  
Aim 3: Development of a Plan for Change, informed by study findings, to guide 
implementation of adolescent SBIRT within KPNC. 
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CHAPTER 2: CONCEPTUAL MODEL 
Consolidated Framework for Implementation Research  
 The conceptual model I use for this analysis is informed most strongly by the 
Consolidated Framework for Implementation Research (CFIR), developed by Laura 
Damschroder and colleagues.
82,83
 The process of developing the CFIR involved a careful 
review of the extant implementation science literature, analysis of the key components of 
each of the models identified for conceptual and empirical strength, and a synthesis of the 
most promising constructs from each into a single flexible, overarching framework for 
organizing and guiding the implementation of health services research findings into practice 
and policy. The CFIR organizes key factors influencing implementation of an intervention 
into five major domains: the characteristics of the intervention, the outer setting, the inner 
setting, the characteristics of the individuals involved and the process of implementation. 
Within each of the five broad domains, Damschroder identifies more specific significant 
constructs which may contribute to implementation effectiveness.  A complete list with brief 
descriptions of all the CFIR constructs is included as Appendix A.  I use the CFIR model to 
guide my examination of factors related to the effective implementation of SBIRT, analysis 
of Key Informant interview data, and as pertinent and as applicable, to shape the Plan for 
Change.  
 CFIR domains. Characteristics of the Intervention. As conceptualized by 
Damschroder and colleagues, the characteristics of the intervention consist of both its 
indispensable “core components” which cannot be changed without losing its essence, as 
 9 
well as its “adaptable periphery,” i.e., elements which can be adapted to the circumstances of 
different contexts. Examples of intervention characteristics include the source of the 
intervention, the evidence of its strength and quality, its relative advantage over alternative 
approaches, its adaptability, trialability, complexity, design quality and cost. 
 In the case of this analysis, these characteristics include factors such as the SBIRT 
modality, the effectiveness of SBIRT generally and the different modalities specifically, the 
individual elements (the screening, the brief intervention, the referral to treatment process), 
pediatricians and policymakers’ perceptions of the strength of the evidence base on SBIRT, 
and the relative time required for the intervention. Mode of SBIRT delivery – whether 
pediatrician-delivered (“PCP”) or behavioral health clinician-delivered (“BHC”) – is a 
particularly salient characteristic in this study because evaluating the effectiveness of the two 
intervention modalities, against each other and compared to usual care was the focus of the 
Parent RCT.  It is not known which type of provider is best suited to effectively deliver 
SBIRT to adolescents in pediatric primary care settings.  Both PCP- and non-PCP-delivered 
SBIRT have been found effective in adult studies.
61,62,75
 Studies using non-PCPs to deliver 
screening and brief intervention for adolescents have shown promising results.
72,84-89
 
Although many adolescent SBIRT studies were conducted in schools and other non-medical 
community settings,
90-92
 a recent Portuguese study found promising results for SBIRT by 
nurses for youth in PC.
93
  Non-PCPs such as BHCs may be a cost-effective alternative to 
PCPs for providing SBIRT to adolescents in PC. Health care delivery workforce issues such 
as these are becoming increasingly important as policy-makers search for ways to decrease 
costs while increasing the quality and spread of preventive health care services such as 
 10 
SBIRT, and as health systems adopt models of primary care such as the Patient Centered 
Medical Home which rely on a team-based approach to care delivery.
94
   
 Outer setting. The outer setting includes factors such as the larger legal, political, 
regulatory and social environments which will influence the process of the adoption of the 
intervention, which in this case includes things such as the effects of Affordable Care Act 
and Medicaid expansion, and other health care reform legislation; state and federal mental 
health and addiction parity legislation; behavioral health benefit “carve-out” policies; related 
changes in public perceptions about the impact of behavioral health on overall health; and 
changing laws and regulations regarding marijuana and prescription opiates. Other salient 
outer setting factors include Health Effectiveness Data Information Set (HEDIS) alcohol and 
drug problem identification and treatment initiation and engagement performance measures), 
and recommendations from scientific and medical organizations such as the USPSTF, the 
AAP, AMA and AAFP, and the NIH and the CDC.  Factors such as reimbursement for 
SBIRT and its inclusion or exclusion as a covered benefit may also influence 
implementation, although this is less relevant in the particular context of Kaiser Permanente, 
which uses a capitated payment model, but could be an issue for non-Kaiser, fee-for-service 
organizations. 
 The CFIR also includes factors such patient needs and resources, cosmopolitanism, 
peer pressure, and other external incentives in the outer setting.  In this dissertation, patient 
factors – needs, preferences and characteristics which may influence the likelihood of being 
screened, assessed and provided with interventions or referrals to specialty care, of initiating 
specialty behavioral health treatment, including demographic characteristics, substance use 
problem severity, and medical and psychiatric conditions – are of particular interest. For 
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example, boys and older adolescents may be more likely to come to the attention of providers 
and be screened, as may those with psychiatric conditions.
95-100
 Adolescents with substance 
use problems often have more medical and psychiatric problems than other teens,
21,23
 and it 
may be that having multiple competing clinical issues reduces the likelihood of addressing 
behavioral health problems. Conversely, comorbidities may give providers an entrée for 
initiating a conversation about substance use with patients. Interviews explore how patient 
characteristics may be associated with SBIRT implementation. 
 Inner setting. The CFIR “inner setting” consists of the proximal context(s) in which 
the intervention would be adopted, such as the clinics (general pediatrics, adolescent 
medicine, family practice), and health systems (integrated health care delivery system such as 
KPNC, Federally Qualified Health Center, private pediatrics practice). Inner setting includes 
factors such as organizational and clinic/practice structure, networks and communications, 
culture, and implementation climate;  (e.g., specific things such as organizational hierarchy, 
time allotted for appointments, competing screening and other preventive care priorities, 
clinic resources and structure, staffing levels, workflow, HIT capacity and EHR tools and 
use, etc.),  
 Characteristics of individuals. The role of the characteristics of the individuals 
involved in the implementation process (in this case the pediatricians and other clinicians, 
staff and policymakers at Kaiser Permanente and the other organizations) involves factors 
such as their roles (different types of providers and staff); professional training, skills, 
expertise and orientation; attitudes toward both the intervention itself, the “problem” being 
addressed (adolescent alcohol and drug use and other risky health behaviors), and the process 
of implementation; and knowledge and feelings about the intervention and process, including 
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self-efficacy, confidence and motivation and individual stage of change. 
101-106
 Individuals’ 
identification with the organization, and other personal attributes can also potentially impact 
the implementation process. Provider demographic characteristics such as gender, age and 
years of experience may also play a role in how well providers identify substance use and 
other behavioral health problems and risk factors, and how well they intervene, and so may 
also impact implementation of SBIRT.
103,107,108
   
 Implementation process. The last major domain in the CFIR is the process of 
implementation itself, which, in order to be successful, must incorporate and respond and 
adapt to the elements of the other four domains, and which involves planning, engagement, 
execution, reflection and evaluation activities. 
Additional Implementation Science Influences  
 This dissertation is also influenced by other models from the implementation science 
literature, such as the Dynamic Adaptation Process (DAP) of the Exploration, Preparation, 
Implementation, Sustainment (EPIS) model of evidence-based practice implementation, 
developed by Gregory Aarons. The DAP and EPIS include careful consideration of the 
dynamic tension between the adaptation and fidelity of evidence-based innovations, as well 
as explicitly examining the roles of type of organization (public vs. private) and leadership 
involvement in the implementation process, factors which will be key to the development of 
this Plan for Change.
109,110
 This dissertation is also informed by Everett Rogers’ (1995) 
seminal model of diffusion, and by the Institute of Medicine’s work on moving evidence-
based drug and alcohol treatments from research to practice.
111
  It also integrates factors from 
the literature on barriers and facilitators of SBIRT, and from a model colleagues and I 
developed describing the provider, patient, and organizational characteristics that influence 
adoption of evidenced-based substance abuse treatment,
112-114
 as many of these same factors 
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will also influence adoption of SBIRT practices in pediatric primary care settings.  The role 
of the CFIR as it applies to each component of this dissertation is discussed further in 
Chapter 9. 
 
Figure 1. Adapted Consolidated Framework for Implementation Research (CFIR) 
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CHAPTER 3: SYSTEMATIC LITERATURE REVIEW 
Behavioral risk factors, including risky substance use, significantly threaten 
adolescent health and well-being, and are a compelling public health problem.
9
 The CDC has 
identified six categories of risk behaviors as contributing to the leading causes of mortality 
and morbidity among adolescents in the U.S., and alcohol and drug use is consistently ranked 
among the top of those six.
115
 Their use puts teens at risk of death or injury from motor 
vehicle and other accidents, poisoning, and interpersonal violence,
20,116
 as well as 
development of medical conditions linked to alcohol and drug use.
21,117,118
 Moreover, adult 
substance disorders, which pose a significant public health burden,
119
 frequently begin in 
adolescence,
120
 and early alcohol and drug use initiation is associated with the development 
of such problems.
121,122
  Finding interventions to identify and intervene early with teens at 
risk of developing substance use disorders is a critical public health goal.  
This review examines the extant literature on the efficacy, effectiveness and 
implementation of screening, brief intervention and referral to treatment (SBIRT) for 
adolescents in pediatric primary care settings.   
Literature Review Methods 
Sources of materials.  I considered materials from several sources, including: 1) the 
MEDLINE and other literature databases available via PubMed; 2) the CINAHL, PsychINFO 
and ERIC databases, via EBSCO; 3) United States’ governmental reports and websites: 
National Institutes of Health, Substance Abuse and Mental Health Services Administration, 
Centers for Disease Prevention and Control, and Department of Health and Human Services; 
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4) national medical organization reports and websites: American Medical Association, 
National Medical Association, American Academy of Pediatrics, American Academy of 
Family Physicians, the Society for Adolescent Medicine, the Society for Adolescent Health 
and Medicine; U.S. Preventive Services Task Force; and 5) foundation and non-profit center 
reports and websites: Center for Adolescent Substance Abuse Research (CeASAR), the 
National Center on Addiction and Substance Abuse at Columbia University 
(CASAColumbia), the Robert Wood Johnson Foundation.  
Inclusion/exclusion criteria: I focused on literature describing the efficacy, 
effectiveness and implementation of SBIRT and brief interventions in pediatric primary care 
settings for substance use problems among adolescents. Studies and reports were eligible for 
review if they examined patient outcomes (e.g., substance use (e.g., binge drinking, quantity 
and frequency of use, abstinence), substance use intentions/expectations, AOD-related 
consequences, problems and behaviors (e.g., intoxicated driving, legal problems, school 
performance, family conflict) or implementation outcomes (e.g., screening rates, brief 
intervention rates, referral to specialty treatment rates). 
Samples.  Studies and reports were eligible for review if they focused on adolescents 
or youth between the ages of 11 – 18. Studies or reports that included people 18+ were 
eligible only if they also included younger adolescents. Consistent with the focus of the 
parent trial, which studies an intervention delivered to adolescents to age 18, in a pediatric 
setting, studies which focused exclusively on college or university populations, to the 
exclusion of younger adolescents, were excluded. 
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Settings. Only those studies conducted in primary medical care settings – Pediatric, 
Family Practice and other primary care clinics serving adolescents – were included.   
Language.  English; non-English materials were included if English language 
translations were available via PubMed.   
Publication date.  Publication dates were not limited.   
Types of studies and reports. Randomized trials, quasi-experimental studies (e.g., 
trials which involve asynchronous intervention, or self-control designs), observational 
studies, longitudinal follow-ups of trials, program evaluations and descriptions, systematic 
reviews, and meeting and conference abstracts from peer-reviewed journals (print or on-line) 
or governmental, foundation or other non-profit organization sources were eligible for 
review.  
Search terms. The sources described above were searched using the search terms in 
Table 1. 
Table 1. Systematic Literature Review Search Terms 
Concept Search Terms 
Adolescents Adolescent, adolescence, teen, teenage, youth 
Screening, Brief Intervention 
and Referral to Treatment 
SBIRT, SBI, screening, “brief intervention,” 
assessment, “brief treatment,” “brief advice,” “brief 
counseling,” ”Motivational Interview(ing),” MI 
Risky substance use Alcohol, drug, substance, marijuana, “risk behavior,” 
“behavioral risk,” abuse, dependence, “hazardous use” 
Pediatric health care setting Health care, pediatrics, pediatric, “health clinic,” 
medical, “health setting,” “urgent care,” “primary 
care.” 
Study descriptors Efficacy, effectiveness, implementation, feasibility, 
review, analysis 
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In addition to searching the data sources described above, a snowball strategy was 
used, to include references (which met the established eligibility criteria) cited in the original 
articles, reports and websites. Articles designated as “similar to” or otherwise recommended 
by search engines (e.g., PubMED) based on searched articles, were also a source of 
materials. 
Assessment for second-stage review.  All materials found during the initial search 
were reviewed to determine if they merited further review.  Abstracts of journal articles, and 
reports (those for which abstracts exist), were reviewed to determine if they met eligibility 
criteria. If materials did not include an abstract, they were scanned for suitability. Full 
versions of materials which appeared to meet inclusion criteria were obtained and assessed 
further for inclusion in the review.     
Articles were organized using a MicroSoft Excel spreadsheet, which included the 
following categories: citation; type of study (e.g., randomized clinical trial, observational, 
program evaluation, etc.); intervention or program description; sample/study 
N/comparison group (if any); type of provider or interventionist delivering intervention; 
outcomes measured and data sources; evidence of efficacy; effectiveness or feasibility 
(e.g., strength of association, predictive ability if multi-variate or multi-variable models were 
used, effect size, statistical significance, etc.); overall quality of study (e.g., studies were 
assessed for types of bias, e.g., selection, attrition bias, recall bias, randomization results; for 
strength of study design, e.g., experimental vs. quasi-experimental vs. case control vs. 
observational; for validity, reliability and salience of outcomes measures; and for adequacy 
of controls, if any) ; and any other important limitations. 
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Literature Review Results 
One hundred and sixty-six papers were identified through searches as potentially 
eligible for inclusion in the review.  Following abstract review, 107 merited further review, 
and full versions of those articles and reports were assessed for inclusion in final review. 
Fourteen studies were found: five trials,
68,123-126
 a randomized pilot,
69
 a quasi-experimental, 
asynchronous, self-controlled trial conducted in two countries,
67
, a secondary analysis of data 
from that trial,
127
  an observational study,
128
 and two systematic reviews, 
75,76
 and three non-
trial implementation studies.
105,129
  The venues for the studies in the review included primary 
care clinics, either Pediatric or Family Medicine.  See Table 1 for detailed information on 
studies in pediatric primary care settings. 
Evidence of the effectiveness of SBIRT and SBI for adolescents in primary care 
settings. Unlike the extensive literature on SBIRT in adult primary care, there have been 
relatively few studies of SBI or SBIRT in pediatric primary care in the U.S., and recent 
systematic reviews of behavioral interventions in primary care for alcohol misuse and for 
illicit drug use and non-medical prescription drug use, conducted for the U.S. Preventive 
Services Taskforce, both found insufficient evidence to recommend their use for 
adolescents.
75,76
  An early randomized trial of SBI in pediatric primary care by Boekeloo 
found significantly higher rates of alcohol use and related outcomes in the intervention arm 
compared to usual care, which the authors attributed to intervention participants’ increased 
willingness to disclose risk behaviors as the result of receiving the intervention.
123
 Findings 
from a randomized pilot of SBI in a pediatrics clinic by D’Amico which compared usual care 
to a 15-20 minute MI delivered in a primary care clinic, and also examined the effect of a 
booster phone call. They measures peer influence (including perception of % of students in 
school who drank or used marijuana, how often they spent time around people who drank or 
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used marijuana, friends’ consumption of AOD), intentions to use alcohol or marijuana in 
next 6 months, quantity and frequency of alcohol and marijuana consumption (days per 
month, number of times used per day, quantity of drinks per day, and number of binge 
drinking days), use-related consequences, and social desirability. The authors found that 
those in the intervention group were less likely to report intention to use marijuana in the 
next 6 months, reported a lower perceived prevalence of marijuana use at school, reported 
fewer friends who used marijuana, and reported using marijuana fewer times on the days 
they used, compared to the usual care group (all p<.05). However, this pilot was limited by a 
very small sample size.
69
 Elizabeth Ozer and colleagues examined the effects of primary 
care-based screening and brief intervention in a large, integrated health care delivery system. 
The two-part intervention included screening, brief advice and referral on a variety of risk 
behaviors by pediatrician, followed by a same-day reinforcement session by a health 
educator on the same topics, aimed at increasing the teen’s self-efficacy about reducing 
behavioral risk.  
Fourteen year-old primary care patients who were due for or had scheduled a well-
visit in one of the three clinics were contacted for recruitment.  A comparison group 
consisted of California Health Interview Study (CHIS) adolescent participants, (711-14 year 
olds and 699-15 year olds). Substance use measures included “ever used alcohol” and “ever 
used drugs.” The authors found no evidence of an effect of the intervention on self-reported 
alcohol or drug use, compared to the comparison group, but the questionable comparability 
of the control group makes it difficult to draw conclusions about their findings.
128
   
More recent studies, with stronger methodologies, have shown promising results. In 
2012, Harris et al. conducted a study in 19 primary care clinics in the U.S. and the Czech 
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Republic, using a quasi-experimental design, in which sites served as their own historical 
controls (UC), to examine the effects of computer-facilitated substance use screening, 
pediatrician-delivered brief advice. The intervention involved patients (12 – 18 years old) 
completing a substance abuse screening instrument prior to their appointment, which 
assessed level of use and related consequences; receiving their substance use screening score; 
and reviewing information on the computer about the health risks of substance use. 
Pediatricians were given a report with the patient’s screening results, risk score and a guide 
to talking points for their conversation with the patient.
67
 They examined past 90 day 
quantity and frequency of alcohol, cannabis, hard drug consumption, perceived alcohol and 
drug use by peers, siblings and parents, rates of substance use, substance use initiation among 
those reporting no use in the past year, and cessation in those reporting use in past year.  
In the U.S., intervention condition participants reported lower rates of any substance 
use at both 3- and 12-month follow-up (p<.05).  At 3 months, intervention participants 
reported lower past 90 day alcohol use, and higher alcohol cessation rates at 3-month follow-
up, compared to TAU. At 12 months, intervention teens reported lower past-12-month 
drinking rates and alcohol initiation rates (p<.05).  
In the Czech Republic, there were no main effects.  At the 3-month follow-up, 
intervention teens reported lower cannabis initiation rates than those in the TAU condition 
(p<.05).  At 12-month follow-up, intervention teens reported lower past 12 month cannabis 
use rates, as well as lower cannabis initiation and higher cannabis cessation rates, compared 
to TAU (all p<.05).  
Significantly, in contrast to other studies, in both ED and primary care settings, which 
suggest that BIs may be more effective for those who have already initiated substance use, 
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Harris et al. found that the intervention was effective at both increasing cessation in those 
already using, and at decreasing initiation among those who had not yet begun to use, a 
particularly important role in the pediatric primary care setting.  
An RCT of therapist versus computer-delivered BIs, conducted with cannabis-naïve 
adolescents recruited from several Federally Qualified Health Centers (FQHC), focused on 
cannabis use prevention rather than reductions in use, examining cannabis use along with 
self-efficacy in refusing cannabis use, intention to use, and perceived risk of use, as well as 
alcohol and other drug use and delinquent behaviors. Controlling for demographics, among 
those who received the computer-delivered BI there was a significantly lower cumulative 
prevalence of any cannabis use over 12 months, (RR = 0.70, p<.05), and significantly less 
cannabis use at 3 and 6 months (IRR=0.53 and 0.61, respectively, p<.05), and less other drug 
use at 3 months (IRR=0.52, p<0.01), and those receiving the therapist-delivered BI had lower 
delinquent behavior at 3 months (IRR 0.53, p<0.01), and lower alcohol use severity at 6 
months (IRR 0.57, p<0.05), compared to controls.
124
 A similar RCT, focused on reducing 
cannabis use and related problems among adolescent FQHC patients already using cannabis, 
found no differences between groups in cannabis or alcohol use over time, but found 
significantly less other drug use at 3 months (p<0.05) and 6 months (p<0.01) among those 
receiving the computer-delivered BI. They also found significantly lower rates of cannabis-
related consequences at 3 months among those who received the computer BI (p<0.05), and 
significantly lower frequency of cannabis-related driving under the influence at 3 months, 
among those who received the therapist-delivered BI (p<0.01): critical outcomes for youth 
and linked to the significant mortality and morbidity associated with teen substance use.
125
 
Although these findings are promising, there is clearly still much research needed on 
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SBI/SBIRT in primary care, to broaden the evidence base on its efficacy and effectiveness 
among adolescents. Moreover, because many pediatric medical organizations are 
recommending implementation of SBIRT or at least regular screening for and counseling 
about substance use for adolescents, and many initiatives are planned or are underway to 
implement SBIRT, it is critically important to examine how implementation can be 
successfully and effectively accomplished.   
 Adolescent SBI/SBIRT implementation. There are only a few rigorous SBIRT 
implementation trials, even in the adult literature, and none to my knowledge, other than the 
parent RCT of this dissertation, which have been set in pediatric primary care settings. A 
recent cluster randomized implementation trial comparing models of SBIRT implementation 
in adult primary care found that training primary care providers to deliver SBIRT resulted in 
significantly higher rates of screening and of brief intervention/referral than in usual care 
(44.4% vs. 2.6%, p<0.01), but significantly lower rates of screening than a model using non-
physicians to perform SBIRT (9.23% vs. 50.9%, p<0.01).
130
 A Dutch study of a tailored, 
multi-faceted improvement program directed at reducing hazardous alcohol use in adult 
primary care found no significant change in screening and intervention behavior among 
providers.
131
  
 Few studies have simultaneously examined the factors at patient, provider, 
intervention and system levels that impact implementation. To date, there have been very few 
studies of any kind in the U.S. on factors contributing to the implementation of SBIRT in 
pediatric health care settings, including provider type.
16,17
 A recent Swiss pilot study which 
trained PCPs to deliver brief interventions (BI) for substance use to youth, and compared 
them to PCPs not trained in BI, found no effects on patient outcomes.
126
  Lustig et al. found 
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that training pediatric PCPs on the delivery of clinical preventive services, including alcohol 
use screening and counseling, increased the alcohol screening rate from 59% to 76% 
(p<0.01) and the tobacco screening rate from 64% to 76%, p<0.05), but had no significant 
effect on the rates of alcohol or tobacco counseling delivered by the providers in the study.
129
 
Based on the same sample, Ozer et al. examined the impact of providing training and 
resources on increasing the delivery of preventive services, through patient reports of 
screening, pre-(T1), during (T2) and post-implementation (T3) and found significant 
increases in the teens’ reports that they had been screened: from T1 to T2, patient-reported 
screening increased for and alcohol use (59% to 96%) and tobacco (61% to 95%), (both 
p<.000). From T1 to T3 alcohol screening increased from 59% to 90%, and tobacco 
screening from 61% to 90% (both p<0.001). Counseling rates increased significantly from T1 
to T2 (alcohol, 46% to 91%;  tobacco, 55% to 96%), and from T1 to T3 (alcohol 46% to 
91%; tobacco, 55% to 96%) (all, p<0.001). However the study did not examine the provider, 
patient, and system factors associated with successful implementation.
105
 A recent study of 
school-based health center providers found that self-efficacy, confidence and attitudes toward 
role responsibility for the delivery of SBIRT were associated with SBIRT practices.
132
 A 
2012 survey of KPNC’s pediatric PCPs’ alcohol and drug screening practices found that 
many providers cited time constraints, lack of training and information about alcohol and 
drug screening techniques, treatment resources and effectiveness, and discomfort discussing 
alcohol and drug use as barriers to screening and intervention with their adolescent patients, 
and the majority suggested that having another clinician on the team to conduct screening 
would make it more likely to happen.
133
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Non-physicians could be a cost-effective alternative to physicians and other PCPs, but 
while both physician and non-physician-delivered SBIRT have been found to be effective in 
adult primary care,
61,62
 it is not known which is best for adolescents. A few studies using 
non-physicians to deliver screening and brief intervention for adolescents have shown 
promising results.
72,84-89
 Although most were conducted in schools and other community 
settings, a non-experimental, pre-post Portuguese study found reductions in alcohol use at 6 
months following delivery of SBIRT by clinical nurse specialists to youth in primary care.
93
  
Two studies of ED-based adolescent SBIRT implementation were primarily 
descriptive, discussing the process of implementation,
134,135
 but they did not systematically 
examine factors which affected implementation, and such factors may at any rate differ in the 
ED compared to primary care settings.  
A recent review of the current evidence for alcohol screening and brief intervention 
for adolescents noted the dearth of studies of adolescent BIs in pediatric primary care 
settings, and that few studies included younger adolescents, and the authors concluded that 
more research was needed into the kind of contextual factors such as setting and screening 
tools, as are studies which include younger adolescent and consider their particular 
developmental needs.
136
 Recent commentaries by national scientific leaders in the field of 
substance use have highlighted the need for research on SBIRT implementation,
9
 particularly 
in the context of electronic health records.
137
  
Other Literature  
Adolescent SBI/SBIRT in other settings. Because of the paucity of studies on 
SBI/SBIRT in pediatric primary care, research from other settings can help inform this 
dissertation and consideration of SBI/SBIRT for implementation, and is important to 
mention. Evidence of the effectiveness of SBIRT for adolescents in other settings can also 
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inform the discourse around SBIRT for adolescents and increase the likelihood of its 
adoption in pediatric primary care settings, especially as primary care practices increasingly 
incorporate non-physicians such as behavioral health clinicians into patient care roles.  
Health systems may look to the evidence base on adolescent SBIRT effectiveness and 
feasibility delivered by non-PCPs, much of which comes from studies conducted outside of 
primary care.  Health system policy-makers and clinical leaders will also inevitably draw on 
the adult and college primary care and adolescent emergency department SBIRT literatures 
to inform decisions about the implementation of SBIRT for adolescent primary care, and in 
fact, have already begun to do so, for example, the Center for Health Care Strategies 
(CHCS), in partnership with the Association of Community Affiliated Plans (ACAP) The 
Center for Health Care Strategies (CHCS), in partnership with the Association of Community 
Affiliated Plans (ACAP), is developing strategies for the dissemination of SBIRT for 
adolescents and training of pediatric primary care providers in safety net health plans in the 
Mid-Atlantic region, as part of the Conrad N. Hilton Foundation’s aforementioned adolescent 
substance use prevention and early intervention efforts.  
Adolescent SBI/SBIRT in emergency departments. While the literature on SBI and 
SBIRT for adolescents in pediatric primary care is limited, there have been considerably 
more studies conducted in other settings where adolescents frequently receive care and 
services, including emergency departments (ED), schools and other community settings.  In 
fact, the majority of adolescent SBI and SBIRT studies conducted in medical settings have 
taken place in the ED (n=14).
73,138-150
  There is evidence to suggest that BIs in the ED to 
reduce alcohol and drug use may affect not only substance use, but other important outcomes 
as well.  In several cases, while alcohol or drug consumption itself was not reduced as a 
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result of the intervention, other related risk behaviors were, or else participants reported 
approaching substance use in a more careful, risk-averse manner.  Cunningham and Walton 
et al. found that alcohol or drug use did not decline, but that teens who received the 
interventions reported less violent behavior, a critically important alcohol and drug use-
related outcome that is more directly related to adolescent morbidity and mortality than 
substance use itself.
20
  Studies also found reductions in drinking and driving
138
 and dangerous 
binge drinking behavior,
145
 two major causes of adolescent injury and death.  While Tait 
found no reductions in drinking, participants were more likely to initiate substance abuse 
treatment, and those who did, experienced better substance use and emotional outcomes than 
those who did not.
141
 Other studies found that participants who received interventions were 
more likely to reporting efforts to quit or limit their use.
150
  Most of the interventions focused 
on alcohol use, but Bernstein et al. found significantly lower marijuana use in those who 
received a BI, a year after the intervention.
149
 The findings from that study are important in 
terms of both the apparent sustainability of the intervention effects and the fact that it focused 
on marijuana, a substance of particular interest because its use among teens continues to 
increase, recent surveys find that they perceive the risks involved in its use to be low,
151
 and 
we are seeing a changing landscape with regard to marijuana legislation and policy. 
Several of the studies suggest that those with pre-existing or higher severity problems 
benefitted more from interventions than those without, or with lower severity problems.  For 
example, in a trial of brief MI, Spirito et al. found no main effects among the sample as a 
whole, but that those with higher alcohol problem severity at baseline, who received a BI, 
reported lower frequency of drinking and binge drinking at follow-up, compared to standard 
care.
73
 Maio et al. also found no main effects in an RCT of a computerized BI compared to 
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usual care, but found significant reductions in binge drinking and alcohol related 
consequences among those who received and Bi and who had reported binge drinking and 
drinking and driving at baseline.
145
  Similarly, Becker et al. found that those with depressed 
mood showed a better response to the intervention,
144
 which could have important 
implications in the primary care setting, where depressed mood and substance use are 
common and frequently comorbid.
152
  Comprehensive or “broad brush” adolescent risk 
reduction interventions which took a primary rather than secondary risk prevention approach, 
seemed to be less effective, at least in addressing alcohol and drug use; the study which 
examined a broad brush BI found no effects on alcohol or drug use or problems.
140
 The one 
study which examined the cost-effectiveness of ED-delivered SBI found that it was more 
cost efficient than usual care, and produced a more favorable cost-effectiveness ratio than 
counseling on the use of seat belts.
139
 
Adolescent SBI/SBIRT in non-medical settings. There is a more robust literature on 
its effectiveness in other settings; the majority of the extant adolescent SBI/SBIRT research 
has been conducted in non-medical settings. Although the evidence on its effectiveness is 
mixed,
153
  several studies in non-medical community settings such as schools have shown 
promising results.
53,84-86,153,154
  A trial by Winters et al. comparing adolescents with substance 
use problems assigned to receive one of two therapist-delivered brief interventions or a 
control condition, found that the adolescents receiving an intervention had better 6-month 
outcomes (fewer days of alcohol use, binge drinking, and illicit drug use, and fewer negative 
consequences) than the controls.
72
 A 2012 study by Mitchell et al. also found significant 
reductions in drug use and frequency of drinking to intoxication at 6 months among 
adolescents who received SBIRT compared to those who did not.
90
 McCambridge et al. 
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found that brief motivational interviewing delivered by non-physicians reduced alcohol, 
marijuana, and tobacco use at 3 months among 16- to 20-year olds,
89
 although results were 
not sustained at 12 months.
155
  A small Thai study which examined BI for high-school 
students with methamphetamine disorders found short-term decreases in quantity and 
frequency of use in the BI group compared to the control condition.
88
 A study of homeless 
teens found that counselor-delivered BI produced short-term reductions in drug use among 
the intervention group compared to controls.
156
  
Broad-brush versus targeted SBI. While it is tempting to assume that 
comprehensive or combined SBI (i.e., a screening that includes a variety of health risks and 
behaviors, including substance use, but also sexual behavior, nutrition, exercise, sleep 
hygiene, seatbelt use, etc.) will be as effective as (and more efficient than) single-focus BIs, 
the findings from this review and other studies
157
 suggest that this may not necessarily be the 
case.  It may be that screening combined with preventive broad brush BI is not effective, 
whereas combined BIs which target existing co-occurring disorders are, which would be 
consistent with the findings from this review on the relative effectiveness of alcohol and drug 
use BIs for those teens with depression,
144
 as well as findings showing improvement in 
emotional well-being from alcohol and drug use-focused interventions.
141
  Combining 
preventive BIs for multiple risk behaviors may dilute the effects on some or all of the risk 
behaviors, or some risks may be more or less salient to some teens, depending on a variety of 
factors, including presence of problems and developmental level, whereas BIs focused on a 
small number of risk behaviors, delivered to teens who have endorsed those behaviors, may 
be more compelling to them, and ultimately more effective. Given the high prevalence of co-
occurring substance use and mood and anxiety disorders among adolescents, there is a 
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tension between effectively meeting the treatment needs of these teens with the realities of 
today’s clinical environment and limited time and resources. Who should get SBI, and how, 
are questions deserving considerably more study. 
Provider characteristics. Another important question not well-examined, especially 
in the adolescent literature, is that of who will deliver SBIRT if it is determined to be 
effective.  In most of the studies, the interventions were delivered by people trained and 
supplied by the research study. In none of the ED studies did indigenous clinicians or staff 
members deliver the interventions.  In three of the primary care-based studies, physicians 
provided the interventions, and in two of those, the intervention showed either no effects or 
increased substance use in the intervention arms. In only one of the studies in either setting 
(Harris et al.) in which indigenous medical personnel provided the intervention did the 
authors find a reduction in either alcohol or drug use or related risk behaviors.  The 
competing priorities and diminishing visit times faced by primary care providers, including 
pediatricians, are well-documented in the literature,
48,158
 and time pressures are frequently the 
number one barrier to alcohol and drug SBI cited by primary care providers.
159,160
 Further 
research is needed into how SBI/SBIRT can fit into current clinical workflows, and whether 
and how existing medical clinicians (physicians, nurses) can be trained to effectively and 
efficiently deliver SBI/SBIRT, or whether this intervention is better provided by others, who 
will need to be hired (and paid for) by health systems.   
Studies are needed which examine these sort of factors, including workforce issues 
and how SBI/SBIRT can be integrated with the use of electronic health records, as well as 
considering not only the effectiveness of different and innovative ways of delivering SBI – 
through computer or video applications, by physicians versus non-physicians, etc. – but also 
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how those differences impact the likelihood that such innovations will be adopted. There are 
many interventions whose efficacy and effectiveness have been demonstrated many times 
over but which have never been adopted. Until recently, this has been the case with adult 
alcohol SBIRT; in spite of decades of evidence on its efficacy and cost-effectiveness, 
systematic implementation remained elusive. Even now, it has only been successfully 
implemented in highly-developed, integrated health care systems like Kaiser Permanente and 
the Veteran’s Administration, and only through considerable effort.161,162 
The literature on adolescent SBI/SBIRT
163
 suggests that while the evidence of its 
effectiveness has not been unequivocally established, it may hold promise as an intervention 
for addressing adolescent substance use and related problems, which are major public health 
concerns. Few studies have been published about SBI/SBIRT in pediatric primary care, and 
most of those have had small sample sizes and/or problematic methodologies. The evidence 
base is more fully developed for SBI for adolescents in the ED: clinician, peer-counselor and 
computer-facilitated BIs have all been found to effectively reduce substance use, or related 
problems and risk behaviors, or both. While more studies are clearly needed to fully establish 
its effectiveness, the best-designed primary care study, several pilots, and studies of SBIRT 
in primary care for other age groups, and of SBI/SBIRT for teens in other settings, all suggest 
that it may work well in primary care for adolescents too, and many national policy-makers 
recommend regular screening for adolescents.
4,5,71,81,164
 More research is needed into the 
comparative effectiveness, and cost-effectiveness of various modalities of SBIRT, including 
the appropriate clinicians and the most feasible formats, and many questions also remain with 
regard to the challenges of implementation and the barriers to and facilitators of adoption.  
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CHAPTER 4: ENVIRONMENTAL CONTEXT 
A wide range of external factors could influence the reception that SBIRT will face in 
a health care system like Kaiser Permanente, and the likelihood of its ultimate 
implementation.  These factors include political, policy, and social trends, and technological 
developments in the general environment, as well as some which are unique to the health 
care milieu, and many of which are germane to both.  These factors may have a direct 
bearing on the potential for SBIRT implementation in KPNC and other settings, or may have 
a more indirect impact by contributing to changing societal perceptions of substance abuse 
and its identification and treatment.  The following section examines some of the 
environmental factors relevant to pediatric SBIRT implementation. An assessment of the 
environment is a critical part of the foundation for a leadership plan. The following 
assessment is not derived from the Key Informant interviews, but is based on observation and 
experience in the KPNC system and the larger field of adolescent behavioral health, and 
provides the needed context for a plan for change. This assessment provides context for 
interpreting the results of the interviews and using those results to inform the Plan for 
Change. 
General Environmental 
 Political/policy. Several significant pieces of health care reform and mental 
health/addictions parity legislation, and associated regulatory changes and funding initiatives, 
pave the way for integration of behavioral into primary care settings.  
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  The Mental Health Parity and Addiction Equity Act of 2008 was a groundbreaking 
piece of federal legislation that, for the first time, stipulated that insurers and health plans 
serving employers with more than 50 employees cannot impose treatment restrictions such as 
limitations on the number of visits, or financial requirements such as co-insurance, co-pays 
or deductibles on mental health or substance abuse treatment that are different than those for 
medical or surgical services.
165-169
 Many states, California included, also independently 
enacted parity legislation, and in fact, California’s parity law preceded the federal 
legislation.
170
  California’s parity legislation was more limited than the ultimate federal law, 
and applied only to care for a limited number of the most serious mental health and substance 
use problems, so called “parity diagnoses.” Beyond increasing access to behavioral health 
care services by removing practical and financial barriers, these laws sent a powerful 
message to insurers, providers and patients alike: that behavioral health problems and their 
treatment are as “legitimate” and deserving of care as other kinds of health concerns.  A 
limitation of both federal and state legislation was that it only applied to health insurance 
plans that offered behavioral health services: in other words, it did not require that health 
plans cover such services, but if they did, they had to be provided at parity with medical and 
surgical services.  Nevertheless, it can be argued that these laws represented a critical step in 
changing coverage for behavioral health problems, and both reflect, and have helped to 
shape, the general public’s and the health care system’s slowly changing attitudes toward 
substance abuse and mental health problems and treatment. 
 Building on the progress made by federal and state parity legislation, the Patient 
Protection and Affordable Care Act, commonly called the Affordable Care Act or ACA, has 
had an even more profound effect on the coverage and delivery of mental health and 
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substance abuse treatment services in the U.S. by requiring many insurers and health plans to 
cover behavioral health services. Under the ACA, beginning in 2014, mental health and 
substance abuse treatment became part of the package of services which must be covered 
under individual and small group health plans, including all plans offered through the federal 
insurance marketplace.
171
 Especially relevant to this dissertation, the required services also 
include preventive services, including alcohol and drug use assessment for adolescents, at no 
added cost to beneficiaries.
172
 For the many people without any previous coverage for 
behavioral health services, its full implementation in 2014 represented the first time they had 
access to mental health and substance abuse treatment. Many health systems, including 
Kaiser, continue to grapple with understanding and meeting the behavioral health needs of 
the influx of new members coming in through health insurance exchanges and Medicaid 
expansion.  Kaiser Permanente Northern California’s share of the Medicaid population in the 
region has grown from 7.6% to 10.4% in the past 3 years, and from 28.8% to 32.1% of the 
total population in the region, much of that through the health insurance exchanges.
173
 
 There are other critical changes resulting from health care reform efforts which may 
have bearing on the potential for SBIRT implementation.  Several initiatives in the ACA 
incentivize the integration of behavioral health care into primary health care setting in the 
U.S., in both public and private settings. Funding to Federally Qualified Health Centers 
(FQHCs) has stimulated this integration,
174
 and new federal grant programs support 
integration of primary and behavioral care services. Behavioral health workers are a high 
priority in the ACA’s National Workforce Strategy section and behavioral health providers 
are eligible for community health-team grants.
175,176
 Moreover, several new federal education 
and training grants and loan repayment programs are targeted to substance use treatment 
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providers (particularly child/adolescent specialists) and to the development of educational 
programs for primary care providers and behavioral health providers focused on the 
integration of mental and physical health.
171,176
  
 Another model which continues gain traction in current health care delivery system 
redesign efforts, and which supports the inclusion of behavioral health services in medical 
settings, is the “patient centered medical home.” Consistent with other current health care 
reform efforts that stress less fragmentation in service delivery, 
177
 advocates of patient-
centered medical homes, which originated in pediatric settings for caring with children with 
multiple chronic conditions, have called for including behavioral health services in a fully 
integrated model for delivering primary care, substance abuse and mental health services.
178
 
A broad coalition of health care stakeholders, including many specialty societies (e.g., the 
American College of Physicians, the American Academy of Pediatrics, the American 
Academy of Family Physicians, etc.), have endorsed the model, and it is being extensively 
evaluated in a number of public and private health plans.
177,179,180
 
 Insurance. Health care benefit design changes may effect SBIRT implementation by 
limiting covered behavioral health services for vulnerable children and adolescents. 
Payment mechanisms and insurance status could also effect the implementation of 
SBIRT for adolescents.  While Kaiser Permanente is a capitated system, receiving a per-
member-per-month payments for each member, and in which behavioral health benefits are 
“carved-in” or provided within the health plan as a covered benefit for the large majority of 
members, for one group of members, Medi-Cal (as Medicaid is called in California) 
beneficiaries, specialty mental health and substance use services are “carved-out” of their 
managed care health plan, to be provided by county mental health and alcohol and drug 
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treatment programs, as a result of successful lobbying by county mental health and alcohol 
and drug treatment systems to retain the “right of first refusal” for providing these services.  
Although originally all mental health services were carved out to the counties, with full 
implementation of the ACA in January 2014, and consistent with the behavioral health 
integration goals of the ACA, some mental health services, for mild-to-moderate mental 
health problems, were transferred back to Medicaid MCOs to cover for their members who 
are Medi-Cal beneficiaries.  Specialty substance use services remain carved out for Medi-Cal 
managed care beneficiaries. The Medi-Cal population is one which is particularly vulnerable 
to a variety of social stressors, and may need screening and early intervention services even 
more than other populations.  The behavioral health carve out could act as a barrier to SBIRT 
implementation, if providers feel that screening for substance use is pointless without 
adequate intervention services. Conversely, providers might view screening and brief 
intervention as a way to provide early intervention services “in house,” in the absence of 
available services for small but significant populations of patients, thus providing an impetus 
for SBIRT implementation. 
 Marijuana use legislation and public acceptance. Changing social mores and 
attitudes toward marijuana use and changing marijuana use laws may affect teens’, parents’ 
and clinicians’ attitudes towards its use by adolescents and interventions aimed at curtailing 
use.  
This is a period of rapid change in cultural attitudes and official policies regarding the 
use of marijuana. California has long been tolerant toward marijuana use, and was the first 
state to legalize its use for medical purposes.  Since 1996, medical marijuana has been legal 
in the state, and since 2011, the penalty for possession of less than one ounce of marijuana 
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has been an infraction, or comparable to a minor traffic violation.
181
 Full legalization of 
recreational marijuana is very likely to be on the statewide ballot in 2016, and is widely 
expected to pass, based on current public opinion polls. Several nearby states (Washington, 
Oregon, Colorado) have fully legalized marijuana for recreational use, contributing to 
regionally lenient attitudes. The city of Oakland, the setting for this study, is also considered 
a center of “cannabis culture” in the Bay Area, and is home to a number of medical 
marijuana dispensaries.  For many Californians, particularly in the socially and politically 
liberal Bay Area, casual and even regular marijuana use has become normalized, and is 
widely tolerated and viewed as relatively harmless, akin to moderate alcohol use, and 
qualitatively different from the use of other illicit drugs. Marijuana is also the illicit 
substance most commonly used by adolescents.  Cultural attitudes and governmental policies 
regarding marijuana use may influence how patients, parents and providers alike weigh the 
potential risks of use and may affect providers’ likelihood of adopting drug screening and 
intervention practices like SBIRT.
182,183
 
 Cultural attitudes toward substance abuse and mental health problems. Stigma 
about substance abuse and mental health conditions remains a powerful barrier to treatment-
seeking, although attitudes are gradually evolving, and frank discussion of these problems is 
becoming more normalized. 
  Cultural attitudes towards behavioral health conditions generally, and alcohol and 
drug problems specifically, may also play a key role in determining the implementability of 
SBIRT for adolescents.  Historically, both mental health and substance abuse have been 
deeply stigmatized health conditions.
184-187
 Substance abuse in particular has often suffered 
from being seen, and treated, as a moral failure rather than a legitimate health condition, and 
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many people struggling with alcohol and drug use problems speak of the shame involved.  
This stigmatization has had a number of effects, and has been cited extensively in the 
literature as a barrier to treatment seeking and engagement.
188
  It may also contribute to the 
reinforcement of existing disciplinary hierarchies in health care, in which psychiatry is 
sometimes perceived as less prestigious than physical medicine but more than chemical 
dependency treatment.   
While it continues to exerts a powerful influence, particularly among certain 
populations for whom discussing behavioral health problems is still taboo,
45,46,189-192
 the past 
two decades has also seen a slight lessening in the stigma surrounding behavioral health, 
particularly for certain conditions, such as depression and anxiety, and a very gradual 
normalization of mental health treatment.  So too has there been slight normalization in 
American culture of substance use problems and help-seeking, mostly due to a number of 
highly publicized stints of addiction treatment for celebrities.  These cultural attitudes – both 
the lingering stigma and the simultaneous softening towards behavioral health – may 
influence providers’, patients’ and families’ feelings about alcohol and drug screening and 
intervention practices. 
 Confidentiality. Confidential Adolescent Services. Confidentiality is an essential 
cornerstone of Adolescent Medicine which can nonetheless act as a barrier to integrating 
behavioral health into primary care. 
Confidentiality is a critical component of all patient-provider health care interactions, 
but never more so than those between adolescents and their doctors.  The assurance of 
confidentialty has been determined to be a key element of quality adolescent health care,
193
 
and all the major medical organizations which focus on adolescent care strongly endorse  its 
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provision. A guarantee of confidentiality combined with a strong clinician-patient rapport is 
widely believed to be essential to eliciting frank discussions of sensitive (and potentially 
risky) health behaviors such as sexuality and alcohol and drug use, and pediatricians are 
typically very conscientious about carefully guarding patient information from disclosure, 
including to parents.  Because of this, they may struggle with how to guide patients who 
endorse risky substance use toward open discussions with their parents about their use and 
potential  interventions. While parent participation is not technically required for mental 
health or substance abuse treatment in California (all adolescents 12 and over can consent to 
chemical dependency or mental health treatment without parental permission), in reality, few 
teens are likely to seek and engage in treatment, especially for substance use, without the 
encouragement and participation of their families.  So the necessary restrictions placed on 
pediatrician sharing of pateint information could inadvertently pose a barrier to coordination 
of care and integrated processes such as SBIRT. 
 Confidentiality and Substance Abuse Treatment. Stringent confidentiality laws 
protecting substance abuse treatment records may inhibit optimal communication between 
providers across departments and disciplines. 
Related to the issue of stigma discussed above, there are particularly strong 
safeguards around patient information related to substance abuse treatment.  Under Federal 
law (42 CFR), the sharing of substance abuse treatment data is strictly prohibited, in many 
cases, even among different departments, e.g., Pediatrics, Psychiatry and Chemical 
Dependency, within a health system such as Kaiser. So when providers refer patients to 
specialty treatment for substance abuse, they may never find out the outcome of the referral, 
unless the patient or family report back to them or the treatment program goes through the 
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steps of obtaining permission to disclose treatment information and contacts the primary care 
provider to report on the disposition of the referral.  This kind of logistical complexity, 
resulting from well-intentioned policies designed to protect confidential health care of 
particularly vulnerable populations – adolescents and people with stigmatizing conditions - 
could impact how or whether SBIRT is implemented. 
 Performance measurement. Quality and performance measures, particularly those 
mandated by accrediting organizations, provide powerful incentives for the adoption of new 
health care practices such as substance abuse screening. 
Performance measures can be a powerful driver of organizational and provider 
behavior, particularly when tied, directly or indirectly, to financial incentives or penalties. 
The increasing use of performance measurement in the behavioral health sphere is 
increasingly being used to spur interest in and movement toward the implementation of a 
variety of behavioral health care services. Quality performance measures used by 
accreditation organizations such as the National Committee for Quality Assurance (NCQA) 
and their Health care Effectiveness Data and Information Set (HEDIS), are now used to 
determine whether health systems meet their Medicare STARS quality goals, and there are 
significant financial implications involved in gaining (or losing) a Medicare STAR.  Potential 
financial penalties will be what pushes leadership to actively embrace performance 
measurement and implementation of best practices in this area of care delivery. The adoption 
of the drug and alcohol problem identification and treatment initiation measures for HEDIS, 
the development of Current Procedural Technology (CPT) codes which allow for Medi-Care 
reimbursement for brief treatments in medical settings, the issuance of the National Institute 
on Alcohol Abuse and Alcoholism’ Clinicians Guide for adult patients with alcohol problems 
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and the evidence-based screening questions which accompany it, all contribute to raising 
awareness of the need to deliver quality health care services for behavioral health problems 
and create an atmosphere where providers and health systems are now aware that quality and 
performance is as likely to be measured for behavioral health as for other medical conditions. 
While there are not, as yet, any national performance measures for adolescent substance use 
screening, there are for adolescent depression screening, suggesting that accreditors and 
regulators may in the future consider adolescent substance use screening performance 
measures. 
 Health information technology/electronic health records. Electronic Health 
Records have the potential to facilitate the use of evidence-based health assessment 
instruments and clinical decision-support tools, such as intervention and referral algorithms 
and patient scripts, but their dissemination and adoption are complex and multi-factorial. 
  Health information technology (HIT), in its many manifestations, has become a key 
factor shaping health care delivery. Expansion of the use of HIT in many forms, but EHRs in 
particular, is a cornerstone of the ACA,
194
 and its use makes possible many things that were 
heretofore simply not feasible.  The widespread adoption of EHRs has been touted as a 
critical ingredient in efforts to increase health care quality while “bending the cost curve” in 
health care, i.e., slowing the growth of health care spending. Through its “Meaningful Use” 
provisions, the ACA has involved a combination of carrots and sticks – incentives and 
penalties – to encourage the adoption and implementation of EHRs by providers and health 
systems.
195
 Kaiser was an early implementer of EHRs, and as such, now has a mature and 
robust EHR which providers and staff use constantly. It is not only private health systems 
like Kaiser that are implementing EHRs however; recent federal funding provided over $2 
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Billion, or $60,000 per eligible FQHC provider, for EHR implementation. Nevertheless, even 
in a system like Kaiser, the potential of the EHR to simplify and streamline clinical 
workflows while improving the quality of care, is only just beginning to be realized.  
      The impact of EHRs in driving care delivery is obviously more complicated than 
simply installing the system, of course, and involves numerous factors, including provider 
and staff willingness to use EHR-embedded screening and assessment instruments and 
clinical decision-support tools. 
196
 Data, people and procedures, and data functions (input, 
control, processing, storage and output) determine how EHR systems and data are used for 
health care quality measurement and improvement.
197
. Context is important to consider, in 
terms of providers’ and systems’ capacities and populations, but also the areas of medicine 
and health care involved, and there are disparities in the use of EHRs across health 
conditions. Not surprisingly, the advances in quality and performance measurement resulting 
from EHR adoption have become almost commonplace in many systems in the delivery of 
care for common chronic medical conditions such as hypertension and diabetes. In other 
areas of health care such as behavioral health, historically perceived by the medical 
establishment as more…peripheral…  optimal use of the EHR and other HIT tools is only 
beginning to gain traction.  Nevertheless, EHRs are being touted by NIH as key elements 
which will help to make systematic substance use screening, assessment and treatment a 
reality across health systems.
137,198
    
Organizational Environment 
In addition to the broader environmental factors outlined above which could influence 
the effectiveness and feasibility of SBIRT implementation, there are a number of 
organizational-level factors which may also be salient.   
 42 
 Resources. Resources – time, space, staff, materials – are critical factors shaping the 
ability and willingness of health care organizations to implement new interventions. 
The issue of resources, however measured, is a perennial concern when considering 
the implementation of any new health care process, and there are myriad ways in which 
resources, or lack thereof, can impact the implementation of new services.  The competition 
in health care delivery is fierce, and revenue margins increasingly tight.  Most health care 
organizations, Kaiser included, currently operate in an atmosphere where maximizing 
efficiency is a top priority, and cost-cutting measures may make the implementation of new 
services considered “non-essential” challenging, if not impossible. In many instances, new 
innovations have to have been proven cost-effective in order to be considered for adoption, 
unless they are otherwise mandated by quality performance standards.  Efforts to save health 
care dollars are manifested in many ways.  Physician appointment times are shorter than 
ever, and physician schedules tightly packed.  Physicians are faced with numerous competing 
priorities, and primary care physicians in particular are faced with a seemingly infinite list of 
preventive activities they are expected to accomplish during the course of patient visits.
199
  
Non-physician staffing also clearly impacts the capacity of health care teams to implement 
new practices, particularly if they involve the use of multiple staff, in a team approach to 
care.  Other workforce factors, such as training costs (both the direct costs of the training and 
the costs of staff time to participate), may also influence the willingness of an organization to 
implement an intervention.  Exam rooms and office space are also scare resources for many 
health care organizations and their availability can impact services. 
Organizational priorities also determine the openness of organizations to the adoption 
of new services and tend to direct the flow of resources. Health care systems tend to focus on 
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initiation of only a limited number of new initiatives at any given time: diabetes prevention, 
for example, or hypertension reduction, or increasing breastfeeding or Latino health.  This 
organizational attention and will, and investment of resources, can be driven by any number 
of factors, some of which have been described above, such as quality measurement, new 
evidence on effectiveness or cost, etc.  Leadership support is crucial for the successful 
implementation of new initiatives in any new organization.  However, in very large 
organizations like Kaiser Permanente, the implementation of significant new initiatives 
almost always require “executive sponsorship,” i.e., the tacit (and hopefully enthusiastic) 
support of top leaders for the initiative.  Without it, successful large-scale implementation is 
unlikely to occur. 
 Behavioral health in Kaiser Permanente. Fraught labor-management relationships 
among KPNC’s behavioral health departments may impede SBIRT implementation.        
Kaiser Permanente Northern California is currently experiencing significant turmoil 
across their behavioral health programs.  Two issues are causing considerable disruption 
across the regions, and could impact SBIRT implementation, either directly, or indirectly 
through their effect on the clinical atmosphere.  While two separate issues, both relate to 
access to care.  The first issue is that the organization is just emerging from a protracted and 
bitter labor dispute between the union representing the non-psychiatrist behavioral health 
workers – the clinical psychologists, licensed clinical social workers, marriage and family 
therapists – that make up the bulk of its behavioral health workforce, and regional 
management.  The union position has been that low staffing levels have stressed therapists 
and compromised patient care.  Discussions between the union and management were highly 
contentious, and accusations and counter-accusations spilled over into the media and 
 44 
advertising.  While the immediate conflict has been settled for the time being, the issues 
underlying the dispute continue to simmer, and bruised feelings between the parties persist.   
The second and related issue is a large fine levied in 2014 against Kaiser by the State 
Department of Managed Health Care as a result of violations related to patient access to 
mental health appointments, especially overly long wait times for appointments and favoring 
group over individual therapy appointments.  In the time since the report and fine and 
resulting negative publicity, Kaiser has scrambled to remediate the situation through a variety 
of means.  It has increased the therapist workforce by something like 40%, has contracted out 
to behavioral health care providers to deal with patient overflow, and has reorganized many 
aspects of its delivery model.  Nevertheless, the organization continues to struggle to meet 
the demand for services with its current capacity. 
 Both of these issues, the tense atmosphere which has resulted from them and the 
general sensitivity about behavioral health care access, could impact the organization’s 
interest in an integrated behavioral health intervention like SBIRT, either by further 
weakening linkages between departments, or by creating interest in behavioral health 
alternatives which improve access while circumventing specialty care entirely by taking 
place under the auspices of pediatric primary care. 
 Departmental/disciplinary tensions. Historic divisions across discliplines – 
medical, mental health and substance abuse treatment – are present across KPNC’s 
Pediatrics, Child & Family Psychiatry and Chemical Dependency Treatment departments, 
and make weaken linkages and communication, and create barriers to SBIRT 
implementation. 
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 A factor which has been cited in the literature as contributing to the lack of 
integration of behavioral health has been the historical separation between Medicine, 
Psychiatry and substance abuse treatment providers.  The reasons for this historical 
separation are many: differences in disciplinary philosophies, training and perceptions of 
problems (e.g., how Pediatrics perceives substance abuse and its impact on health and 
wellbeing compared to Psychiatry compared to Chemical Dependency treatment).   
 These lingering divisions between the clinicians and systems treating medical, mental 
health and substance abuse problems which can pose barriers to coordination of care have 
their roots in the organization of these systems of care which occurred in the 20
th
 century.  
Although today it occurs mainly in separate systems, historically substance abuse treatment 
was located within the larger mental health treatment system. Until well into the 20
th
 century, 
patients with substance use problems, when provided treatment at all, received care from 
institutions and organizations charged with mental health care, such as asylums and sanitoria. 
(More often problems were addressed within the criminal justice and, to a lesser extent, the 
social welfare systems). The latter part of the twentieth century saw the alcohol and drug 
treatment field begin to separate from the mental health system in a variety of ways: 
programs were designed to specifically treat substance use disorders, “disease model” of 
addictions and the attendant proliferation of the 12-step and self-help movements became 
more prominent, and research institutions dedicated to the formal study of substance misuse 
were established. The two separate public systems of care became largely funded by the 
federal government via separate block grants, which also reinforced the separation of 
services.  The medical system was funded through yet other payment mechanisms.  
Unfortunately, the separation also created an environment in which most programs and 
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providers often do not have the resources, training or inclination to collaborate on patient 
care, and reinforced differences in provider attitudes toward specific types of disorders and in 
overall treatment philosophy. Differences between the medical, mental health and substance 
abuse treatment fields in clinician beliefs, training, behavior, and ideology exacerbate loose 
linkages between organizations, and even departments within the same health system, such as 
Kaiser, posing significant barriers to the effective identification and treatment of substance 
use problems.  For example, on the mental health side it is often argued that substance use 
problems are simply symptoms of deeper psychological distress, and that when those other 
disorders are properly treated, the substance use will lessen or subside. This perspective 
reinforces the disciplinary hierarchy discussed above in which substance use problems and 
their treatment are seen as less legitimate and therefore less deserving of attention and 
resources. At the same time, the alcohol and drug treatment field has been particularly 
ideologically driven, and its disagreements with the mental health field on appropriate 
diagnosis and treatment have often been contentious.  Substance abuse treatment and general 
medical services have been even less integrated than substance abuse treatment and 
psychiatry. Medical (including Pediatrics), mental health and substance use services continue 
to operate separately, in spite of the growing evidence in both the adult and pediatric 
literature suggesting that integration would contribute to better outcomes.
200-204
 
 The fields of alcohol and drug treatment, mental health, and medicine also have 
widely different provider education and training.  Providers in medicine are generally 
physicians or advanced practice nurses, and mental health clinicians typically hold doctoral 
or master’s level degrees; education and training among addiction treatment providers is 
more varied, and may include individuals with training ranging from medical or doctoral 
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degrees to non-degreed peer counselors.  Physicians and other medical clinicians typically 
receive very little training on the identification and treatment of substance use problems,
205-
207
 in spite of their high prevalence across patient populations. 
      Because of these complex organizational factors, patients are forced to navigate 
separate systems of care, often both public and private, contacting different agencies, or 
departments within large organizations (e.g., a health system like Kaiser), and seeing 
multiple providers. Too often patients or their families are made responsible for coordinating 
their own care because appropriate linkages between providers, department and organizations 
are lacking. Many patients “fall through the cracks” in these fragmented systems of care, 
contributing to the notoriously low treatment initiation, engagement and retention rates 
among patients with substance use problems.
208
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CHAPTER 5: STAKEHOLDERS 
 This section examines stakeholder circumstances and perspectives which may impact 
the implementation of SBIRT for adolescents in KPNC pediatric primary care. The 
stakeholders discussed here represent an attempt to include all groups directly relevant to 
adolescent SBIRT implementation within KPNC.  Other stakeholders will almost certainly 
have indirect impacts on, or be impacted by, SBIRT implementation within KPNC.  
Moreover, in other settings, other stakeholders will be relevant to implementation (e.g., 
payers in fee-for-service delivery settings). Examination of these stakeholders merits further 
examination, but is beyond the scope of this dissertation.
  
4
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Table 2. Stakeholders 
Stakeholders 
 
 
 
 
Issues/Concerns 
 
 
Potential 
Impact on Teen 
SBIRT 
Implementation 
Facilitator (+) 
Barrier (-) 
Unclear (~) 
Patients 
 Many youth are in distress, have co-occurring mental health, substance  and/or 
medical problems, are under pressure, and may face multiple stressors (family, school, 
social, cultural, sometimes legal).  
 
+ 
 Teens often do not want to reveal substance use or other risk behaviors to parents and 
are ambivalent about both substance use and the need for intervention, and may prefer 
that screening and assessment not occur at all.  
 
- 
 
 Many teens are fearful or uncertain about specialty behavioral health care, especially 
chemical dependency treatment, and may feel more comfortable having these issues 
addressed in the relatively familiar and non-stigmatized milieu of Pediatric primary 
care.  
 
+ 
 Adolescent-pediatrician rapport and trust about confidentiality of patient-provider 
conversations is a (some would say the) key element of effective adolescent health 
care,
80,193,209,210
 and implementation efforts must take special care to preserve 
confidentiality and faith in confidentiality on the part of teen patients. Concerns about 
confidentiality could facilitate implementation by supporting need for additional 
resources for substance abuse for PCPs in Pediatrics, and/or could act as a barrier, as 
pediatricians prefer not to identify/address problems at all. 
 
 
~ 
  
5
0
 
 
Parents/ 
Families 
 Parents are deeply concerned about their children and worried about their emotional 
distress, stress and risky behaviors and the impact of all of these on their children’s 
health.  
 
+ 
 
 Some parents are in denial of children’s use or ambivalent about knowing about kids’ 
problems and may not welcome increased attention to behavioral health problems.   
 
- 
 Similarly, many may use substances themselves, either socially or problematically 
(especially alcohol and marijuana), and may have ambivalence (and potentially, guilt) 
about their children’s use and need for intervention.   
 
- 
 Parents may also be wary of specialty treatment, especially chemical dependency 
treatment, which they may see as the place where “bad” or delinquent kids go.  
 
- 
 Taboos about revealing personal/family information about mental health/substance 
abuse problems and/or mistrust of behavioral health treatment systems may be 
especially strong among certain ethnic groups, including African-Americans and 
Latinos.
190,192,211
 
 
- 
 Conversely, parents from groups wary of specialty mental health or chemical 
dependency treatment may welcome resources for behavioral health within Pediatrics, 
and associated with a trusted medical professional.
212-215
 
 
+ 
  
5
1
 
 For some subsets of Kaiser parents, opportunities for behavioral health treatment 
integrated into pediatric primary care may be welcome because such a delivery 
mechanism could effectively circumvent specific systemic barriers.  These include 
parents whose insurance coverage imposes cost sharing mechanisms (co-pays, co-
insurance, deductibles) which may function as barriers to specialty treatment, and 
parents of children who are Medicaid Managed Care beneficiaries and for whom 
specialty mental health and substance abuse treatment services must be obtained 
outside of the health system, through county systems.
216
   
 
+ 
 Many parents of adolescents are also concerned about the confidentiality protections 
afforded adolescent patients and many would prefer to be more involved in all health 
care discussions involving their adolescent children; some of these parents may object 
to confidential behavioral health screening, assessment and intervention.
217-221
 
 
- 
Pediatric 
Primary 
Care 
Providers 
(PCPs) 
 Pediatric primary care providers are extremely stressed in the current health care 
environment, both within and outside of integrated systems like Kaiser.  They want to 
provide best care to adolescent patients, while coping with time pressures
199
 (across 
the organization, with a few exceptions, pediatric PCPs generally have 15 minutes for 
Adolescent Well Visits), competing priorities (multiple, simultaneous initiatives 
occurring simultaneously, e.g., childhood obesity, asthma control, HPV vaccination, 
teen dating violence, ADHD treatment, etc.) and multiple, simultaneous leadership 
directives. This could inhibit implementation of physician-delivered SBIRT because 
of lack of time. 
 
 
- 
 
 
 
 
 
 
 
 Conversely, such pressure could make PCPs more amenable to an embedded 
behavioral health clinician model which could free up their time for other preventive 
activities. 
 
+ 
  
5
2
 
 Many generalist pediatricians report discomfort with alcohol and drug use and mental 
health issues, have had little training in behavioral health assessment and 
intervention,
133
 and low self-efficacy about handling behavioral health problems (e.g., 
screening, identification, assessment and intervention). 
 
- 
 Relationships with, and knowledge of the services provided by, specialty behavioral 
health providers are less than optimal.
222,223
 
 
~ 
Adolescent 
Medicine 
Specialists 
 Adolescent Medicine Specialists are advocates for optimal adolescent health policies 
and practices.  They are typically more sensitized to and knowledgeable about the 
main adolescent health threats and their management, including substance abuse, than 
are their generalist pediatrician colleagues.  They often have more time allotted for 
teen well visits than generalists. Very sensitive to confidentiality concerns of 
adolescents, particularly with regard to sexual health and contraception, but in terms 
of behavioral health as well.  Typically very adept at structuring workflows in a way 
that preserves confidentiality. They help to shape teen preventive services policy, but 
have may encounter difficulty getting generalist pediatrician colleagues to change 
practices.  They are likely to be advocates of more integrated models of adolescent 
behavioral health care. 
 
 
 
+ 
Other 
Pediatrics 
Department 
Staff: 
Medical 
Assistants, 
 If pediatricians cannot deliver behavioral health services for logistical reasons, non-
physician clinicians or staff may be tapped to deliver components of SBIRT. This 
could open up opportunities for non-physician staff to work “at the top of their job 
scope.” 
 
 
+ 
 
 
 Conversely, non-physician staff may feel put-upon by new demands, may be stressed 
by additional duties. 
 
- 
  
5
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Nurses, 
Clinical 
Health 
Educators 
 In a few locations within the KPNC system, there are already embedded behavioral 
health clinicians, although their hours are usually limited and they deal with 
behavioral problems across the age spectrum. These “pioneers” could help to lay the 
groundwork for regional SBIRT implementation. 
 
+ 
Child & 
Family 
Psychiatry 
(Psych) 
clinicians and 
Adolescent 
Chemical 
Dependency 
(CD) 
clinicians 
 Committed to adolescent behavioral health.  Significant expertise in adolescent 
behavioral health care. 
 
+ 
 
 Concerns about out-stationing into Pediatrics, losing ground with current models of 
siloed specialty care, losing “specialist” roles, losing resources.  May be threatened by 
models of care which move focus to non-specialty care settings (e.g., Pediatrics).  
May be wary of pediatric health staff involvement in behavioral health care provision. 
 
- 
 Behavioral Health clinicians currently have a relatively tense, contentious relationship 
with management, regional leadership. 
 
- 
Regional 
Pediatrics 
Leaders 
 Have established priorities, pressure from health system leadership to meet 
performance measures (e.g. % asthma control, adolescent depression screening), 
increase efficiencies.   
 
~ 
 
 Committed to improving quality of care.   
+ 
 New leadership may be interested in more integrated models of care, in response to 
environmental changes. 
+ 
Regional 
Mental 
Health 
Leaders 
 Concerned about adolescent behavioral health care quality. 
+ 
 Under pressure for access, quality of adult care, teens may be a lower priority. 
- 
 Organizing to meet HEDIS adolescent depression screening performance measures. 
This effort could lead to focus on inclusion of substance abuse screening measures. 
 
+ 
  
5
4
 
 Conversely, the focus on response to HEDIS adolescent depression screening 
performance measures and development of workflows which focus solely on 
depression screening while ignoring significant co-occurrence of depression and 
substance use, may inhibit SBIRT implementation. 
 
- 
 Regional leaders’ commitment to home-grown, un-validated instruments and 
protocols, outcomes monitoring agendas, may impede evidence-based SBIRT 
implementation. 
 
- 
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CHAPTER 6: METHODS 
 This dissertation examines the feasibility and factors which may facilitate or impede 
implementation of SBIRT for adolescents in pediatric primary care. I conducted qualitative 
Key Informant interviews with KPNC Pediatrics providers, staff and administrators, Child & 
Family Psychiatry and Chemical Dependency program clinicians, and with clinical leaders 
and policy-makers from outside of Kaiser Permanente to understand SBIRT feasibility and 
the barriers and facilitators to its implementation.  
Setting 
 Kaiser Permanente Northern California is a large, non-profit, integrated healthcare 
delivery system in Northern California. It provides insurance coverage and comprehensive 
healthcare services for about 3.8 million members in 13 Northern California counties, 
including approximately 500,000 members aged 11-18 years old.  The KPNC Oakland 
Medical Center Pediatrics Department where the study took place has a racially and socio-
economically diverse patient population representative of its catchment area; half of families 
earn less than $50,000 annually.
224
 Pediatric primary care in Oakland is delivered by 
physicians and resident physicians certified in Pediatrics or Family Medicine. Fifty-nine 
percent of the PCPs are female; 49% are non-white and many use languages other than 
English (e.g., Spanish, Mandarin, Cantonese and Vietnamese).  
 Adolescents are seen for well-teen visits without their parents present in the exam 
room for at least part of the appointment, in order to encourage frank discussions of sensitive 
topics and disclosure of risky health behaviors.
193
 Under California law, patients aged 12 and 
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older can receive confidential services related to substance use problem assessment and 
treatment without parental permission or notification.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
Table 3. Parent RCT Procedures and Implementation Outcomes 
PARENT RCT PROCEDURES 
The RCT study compared SBIRT implementation in pediatric primary care 
provided by pediatricians trained in SBIRT (PCP), by pediatricians working in 
coordination with embedded behavioral clinicians (BC), and usual care (UC). The study 
was a non-blinded, cluster randomized, hybrid implementation and effectiveness trial 
examining SBIRT implementation outcomes across 2 intervention and UC implemented 
over a two year period (November 1, 2011, through October 31, 2013). 
The parent RCT randomly assigned the 52 pediatric PCPs in the Oakland, CA 
Medical Center to one of the three study arms. Preliminary analyses showed no differences 
in screening rates by PCP provider type (e.g., Physicians vs. Residents). Therefore we did 
not need to stratify by provider type prior to matching. Providers were not matched on 
other characteristics (e.g., gender, years of experience) because we were able to adjust for 
these statistically in analyses, and matching on these characteristics would have prevented 
us from examining their effects (as proposed in the conceptual model). During the study 
period, 9,032 adolescents had “well-teen” visits.  
Population-based approach. The parent RCT used a population-based approach to 
examine data collected during outpatient clinical visits. All patients at the clinic for a well-
teen visit are asked to complete a Teen Well Check Questionnaire, which becomes part of 
their EHR. We worked with Pediatrics leaders to incorporate evidence-based substance use 
screening questions, including the CRAFFT, a well-validated 6-item substance use 
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screening instrument for adolescents,
225,226
 into the Teen Well Check Questionnaire in the 
EHR, along with 30-day and 6-month AOD quantity and frequency questions, and AOD-
related problem questions, as a clinical assessment tool, and for baseline and 12-month 
outcomes measurement for this study. No direct research contact (recruitment, consent) 
with KP patients was made. This approach has several advantages. In addition to large cost 
savings, many more patients can be studied using this type of approach; it includes the 
population base of patients. Recruiting patients would have biased the representativeness 
and naturalistic character of the study and decreased the ability to implement the study and 
its generalizability; there would be interference with the care flow. Both the EHR and 
KPNC policy enable this approach; HIPAA privacy policies, as communicated to all 
members at enrollment and available on the KPNC website, explicitly acknowledge that 
clinical data may be used for research under Institutional Review Board (IRB) oversight. 
The University of North Carolina, Chapel Hill, the KPNC and the University of California 
San Francisco (UCSF) IRBs approved this study methodology.  
Training. Trainings were conducted by Dr. Derek Satre, a Clinical Psychologist at 
UCSF and an expert in Motivational Interviewing (MI), following strategies used 
successfully to train and implement SBIRT.
227,228
 Along with core MI principles,
229-231
 the 
trainings included information on the prevalence of substance use and other behavioral 
health problems, norm setting and providing educational resources and advice about AOD 
use, and processes for referral to specialty behavioral health treatment. Physicians in the 
PCP arm received 3 - 60-minute, on-site, lunchtime training, those in the BHC arm 
received 2 - 60-minute trainings, for which they received lunch and Continuing Medical 
Education units. This is consistent with how other new practice guidelines are implemented 
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in KPNC.
232,233
 Providers in all three arms were reminded via email from their Site Chief 
about the substance use screening and assessment tools in the EHR and the regional 
requirement of documenting any activities performed during the course of a patient 
encounter. This was equal across arms and consistent with ongoing regional quality 
improvement efforts to reinforce the importance of documentation in the EHR, and 
reinforced by HEDIS performance measures. 
Follow-up patient data at 12 and 24 months. In the two intervention arms, we 
asked PCPs to schedule all patients determined to be at possible risk for AOD or mental 
health problems (“yes” to AOD use or Mood symptoms in past 12 months and “yes” to ≥ 2 
CRAFFT questions) for a follow-up visit at 12 months (by the PCP or BHC).  Because not 
all patients will return for follow-up visits during the first 12 months, we will continue to 
examine patient outcome data through 24 months post-intervention. The 24-month patient 
outcomes will not be available until after this dissertation is complete, thus will not inform 
its analysis or discussion. 
SBIRT Intervention Protocol 
Step 1: 
AOD 
Screening 
Teen Well Check Questionnaire “trigger” questions: 
 
During the past 12 months, did you: 
 
1. Drink any alcohol (more than a few sips)? 
2. Smoke any marijuana or hashish? 
3. Use anything else to get high? 
(“Anything else” includes illegal drugs, over the counter and prescription drugs, and 
things that you sniff or “huff”.) 
 
OR 
 
4. During the past few weeks, have you OFTEN felt sad, down or hopeless? 
5. Have you seriously thought about killing yourself, made a plan, or tried to kill yourself? 
 
OR 
 
In PCP’s clinical judgment, teen has risk for AOD or other behavioral health problems. 
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PCP reviews patient’s answers and enters them into EHR.  Endorsement or presence of any 
of the above items “triggers” further assessment. 
 PCP ARM BHC ARM USUAL CARE 
 Evidence of Behavioral Health 
Risk? 
 
 
Evidence of Behavioral Health 
Risk? 
PCPs may decide 
to further assess 
or intervene. 
They have the 
same access to 
the CRAFFT and 
BH referral 
resources as the 
intervention 
arms. Usual Care 
is that PCPs may 
counsel patients 
with Behavioral 
Health risks. 
When they do, 
clinical policy 
requires them to 
record these 
activities in the 
EHR. However, 
PCPs in this arm 
do not receive 
the SBIRT 
training or have 
access to a BHC. 
Step 2: 
CRAFFT 
and AOD 
Frequency 
Questions 
 
NO: No further 
action. 
 
YES: PCP 
further assesses 
AOD problems 
using CRAFFT 
and AOD 
frequency 
questions. 
NO: No further 
action. 
 
YES: PCP 
refers 
patient to 
BHC for 
further 
assessment. 
 
BHC further assesses AOD 
problems using CRAFFT and 
AOD frequency questions. 
 
 
 
Step 3: 
Brief 
Intervention 
or 
Referral 
CRAFFT score 
<2 and no 
severe AOD 
problems: 
 
PCP conducts 
Brief 
Intervention 
CRAFFT score 
≥ 2:   
 
 
Referral to 
specialty 
treatment by 
PCP for 
additional 
assessment and 
treatment. 
CRAFFT score 
<2 and no 
severe AOD 
problems: 
 
BHC conducts 
Brief 
Intervention 
CRAFFT 
score ≥ 2:   
 
 
Referral to 
specialty 
treatment by 
BHC for 
additional 
assessment 
and 
treatment. 
 
As discussed above, findings from the parent study serve as critical preliminary 
work informing this dissertation’s core data collection, analysis, discussion and Plan for 
Change. Data on the implementation outcomes have been published and are summarized 
below. Both the implementation and (preliminary) patient outcome results laid the 
groundwork for the analysis and interpretation of the qualitative data, and have influenced 
the development of the Plan for Change, which considers the effectiveness, feasibility and 
inherent challenges of each model and make recommendations about their adoption and 
integration based on those characteristics.   
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IMPLEMENTATION OUTCOMES FROM PARENT RCT 
Implementation outcomes findings from the parent RCT have added to the extant 
adolescent SBI/SBIRT implementation literature and were published in a November 2015 
paper in JAMA Pediatrics.
152
  Fifty-two pediatricians were randomized to 1 of 3 SBIRT 
implementation arms; patients aged 12 to 18 years were eligible. Implementation of SBIRT 
included screening, assessments, brief interventions, and referrals to specialty substance 
use and mental health treatment. The final sample included 1871 eligible patients among 
47 pediatricians; health care professional characteristics did not differ across study arms. 
Patients in the PCP (adjusted odds ratio [AOR], 10.37; 95%CI, 5.45-19.74; P < .001) and 
the embedded BHC (AOR, 18.09; 95%CI, 9.69-33.77; P < .001) arms had higher odds of 
receiving brief interventions compared with patients in the UC arm. Patients in the 
embedded-BHC arm were more likely to receive brief interventions compared with those 
in the PCP arm (AOR, 1.74; 95%CI, 1.31-2.31; P < .001). The embedded-BHC arm 
patients had lower odds of receiving a referral compared with the pediatrician-only (AOR, 
0.58; 95%CI, 0.43-0.78; P < .001) and UC (AOR, 0.65; 95%CI, 0.48-0.89; P = .006) arms; 
odds of referrals did not differ between the pediatrician-only and UC arms.  
Both intervention arms had better screening, assessment and BI rates than those in 
usual care. Although referral rates to specialty treatment were low across all three arms, 
patients in the PCP and UC arms were more likely to be referred to specialty treatment than 
those in the embedded-BHC arm. More of the PCP assessments were in response to 
endorsement of AOD use alone, and more of the BC assessments responded to MH 
symptoms alone. The content delivered in the BIs, documented by the PCPs and clinicians, 
differed in similar ways: more of the BIs in the PCP arm contained only AOD-related 
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content, and more of the BIs in the embedded-BHC arm contained only MH-related 
content, or any MH content at all.  
 
Dissertation Data Sources and Measures 
 I conducted semi-structured, in-person (n=18) or telephone (n=2) Key Informant 
interviews with KPNC Oakland (the site for the parent RCT) PCPs, a clinic receptionist, the 
BHC, as well as the Chief of Pediatrics, Child & Family Psychiatry and Chemical 
Dependency treatment program clinicians, and Behavioral Health leaders in the KPNC health 
system (N~15). The sample size (n=20) was determined because it included representation of 
different disciplines and functional roles, and different organizations, and within KPNC, 
pediatricians from the different RCT arms and levels of performance. KPNC pediatricians 
from the two intervention arms were divided into “high” and “low” performers based on the 
number of assessments and brief interventions delivered, in the case of those in the 
pediatrician-only arm, and the number of referrals to the BHC in the BHC arm.  Two 
pediatricians from each tier – high and low – in each intervention arm, were assigned to be 
invited to be interviewed. I was unable to schedule two of the low performers, one from each 
intervention arm, even following multiple phone, email and in-person attempts to make 
contact. I also included three pediatricians from the usual care arm, and one of the clinic’s 
receptionists. I interviewed the single Adolescent Chemical Dependency program clinician in 
Oakland, and three Child & Family Psychiatry clinicians who were willing to be interviewed. 
The KPNC policymakers were chosen because they were high-level leaders in behavioral 
health within the organization and I felt they could provide both a “big-picture” perspective 
of KPNC organizational change processes within the context of the changing behavioral 
healthcare environment.  Participants outside of KPNC were recommended to me as being 
 62 
familiar with either the processes involved in SBIRT implementation, or the adolescent 
behavioral healthcare landscape, or both.  The 20-50 minute interviews explored perceived 
barriers to and facilitators of SBIRT implementation, and the feasibility of integrating 
adolescent behavioral health services into pediatric primary care, with special consideration 
given to the provider, patient, intervention and organizational characteristics contained in the 
various domains of the conceptual model. In order to gain a balanced perspective, I spoke 
with pediatricians from all three arms of the parent RCT. 
  To gain a sense of the similarities and differences in barriers and facilitators of 
integrated adolescent behavioral health in other types of health systems, I also conducted a 
number of Key Informant interviews (n=6) with clinical leaders and policy-makers from a 
variety of public and private, not-for-profit health care delivery settings. 
 Measures. The interview guides (see Appendix B)  covered a comprehensive series 
of topics related to the domains of the overarching conceptual model (informed by the CFIR) 
while remaining flexible and open-ended so participants could share their experiences freely, 
as if participating in a conversation rather than a formal interview. The interviews were 
intended to elicit the perspectives on the different modalities of SBIRT for adolescents in 
particular, and on integrated adolescent behavioral health care more generally, and to 
understand and convey the context for their decisions and practices. Interviews discussed 
current practices, the role of patient confidentiality policies and laws in clinical practice, the 
importance of evidence in clinical decision-making, how new practices are disseminated and 
adopted within organizations, communications and relationships between different 
departments and professional disciplines, the impact of external environmental factors such 
as healthcare reform and drug policy, and patient, family and cultural factors, such as stigma, 
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comorbidity, and financial constraints.  Active listening, interpretive questioning, and 
reflexive objectivity principles informed the interview depth and direction.
234
   
Analytic Methods 
 Qualitative analysis. While content was shaped by the guiding conceptual model and 
interview guide, the analysis used an inductive approach to build an understanding of the 
complexities involved in implementation of SBIRT in pediatric primary care. Audiotapes of 
the provider interviews were transcribed by a professional transcriptionist.  Analysis was 
conducted using NVivo, a software application designed to facilitate the organization and 
analysis of unstructured data.
235
 Each transcript was read thoroughly at least once prior to 
coding, to provide a general overview and impression.  Transcripts in MS Word document 
format were imported into NVivo to be organized. Interviews were independently coded by 
me and Dr. Ashley Jones, a Clinical Psychologist with experience in SBIRT and trained in 
qualitative text coding, and the each coder was blind to the other’s codes during the initial 
coding.  Dr. Andrea Altschuler, a researcher at the Division of Research with extensive 
experience in qualitative interviewing and coding techniques, consulted on the analytical 
approach. Using NVivo, “nodes” (thematic categories) were created based on the broad 
domains of the CFIR model: outer setting, inner setting, characteristics of the intervention, 
characteristics of the individuals involved, and process of implementation. Within those 
overarching nodes, thematic sub-categories (“sub-nodes”) reflecting greater nuance within 
themes were developed by the coders, based on participant responses and informed by the 
extant literature, including some (but not all) of the more detailed constructs described in the 
CFIR. Coders met to discuss their understanding of nodes, and differences were reconciled 
by consensus.  Unused nodes were discarded after discussion between coders, and some sub-
nodes deemed to be virtually identical were collapsed into larger nodes. Inter-rater reliability 
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was calculated, and both percentage coder agreement and a Kappa Coefficient calculated to 
measure inter-rater agreement by interview, node, and across the sample. The coding and 
analytical group discussed interpretations as nodes were developed and applied, and to 
reconcile discrepancies, and team discussed issues which came to light which may have been 
salient but were not necessarily included as a domain within the coding system. Node, sub-
node and source frequency analyses were also conducted. Inherent in qualitative methods 
such as key informant interviews is bias – both participant recall bias and researcher bias, in 
the development of interview guides and coding and analysis of interview data. I attempted 
to minimize the latter through independent, dual coding of the interview transcripts, and 
frequent consultation and discussion of participants’ intent. 
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CHAPTER 7: RESULTS 
 The tables immediately below summarize the sample participants by their functional 
roles, provide a descriptive overview of the themes and sub-themes discussed by participants, 
and present the results of the inter-rater reliability analyses. Consistent with inductive 
qualitative analytical methodology, I have not conducted hypothesis testing across categories 
of personnel or organizations. The narrative findings which follow the tables illustrate some 
of the most compelling responses from key informants, across many of the themes. 
Table 4. Sample Participants, by Functional Role 
 (n-20) 
Kaiser Primary Care Pediatrician 7 
FQHC Primary Care Pediatrician 1 
FQHC Medical Director 1 
Kaiser Specialty Child & Family Psychiatry Clinician 3 
FQHC Behavioral Health Clinician 1 
FQHC Psychiatrist 1 
Kaiser Adolescent Chemical Dependency Treatment Clinician 1 
Director of County Adolescent Substance Abuse Treatment 
Programs 
1 
Kaiser Behavioral Health Kaiser Behavioral Health Policymaker 2 
Administrator, FQHC Collaborative 1 
Kaiser Receptionist 1 
 
Table 8 summarizes the themes and sub-themes identified in the analysis of interview 
data.  Using NVivo, a priori, over-arching “nodes” (thematic categories) were created based 
on the broad domains of the CFIR model: outer setting, inner setting, characteristics of the 
intervention, characteristics of the individuals involved, and process of implementation. 
Some (but not all) of the more detailed constructs described in the CFIR were also included 
as a priori “sub-nodes” and are indicated in bolded red font.  Additional emergent sub-
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nodes, informed by the CFIR themes and sub-themes and the extant literature, and reflecting 
the nuances of the interviews, were created by the coding team.  
Table 5. Summary of Themes and Nodes 
Nodes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     # of 
sources 
citing 
# of
references 
OUTER SETTING                                                                 
Total 
 260 
External Policies and Incentives 2 5 
Confidentiality 11 46 
Cultural Attitudes and Mores about Substance Use 10 28 
Growing Awareness of the Role of Behavioral Health 8 20 
Stigma 7 17 
Marijuana Policy & Legislation 7 17 
Performance Measures 5 13 
Insurance coverage, co-pays, co-insurance 5 12 
Billing/Financing 2 5 
   
Patient and Family Needs 3 4 
Comorbidity 11 23 
Parental Attitudes 8 23 
Linguistic 7 17 
Patient Behavior 9 16 
Family Behavior 4 11 
Clinical Acuity 4 8 
Logistics/Distance 4 7 
SES 1 3 
Gender 1 2 
Health Care Reform, ACA 1 1 
   
INNER SETTING  381 
Structural Characteristics 3 12 
Time, Appointment Length 15 49 
Screening, Assessment Instruments 15 40 
Competing Priorities 13 31 
HER 11 31 
Workflow 8 23 
Workforce 7 18 
Protocols 6 18 
Warm Handoff 4 12 
   
Networks and Communications 5 9 
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Nodes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     # of 
sources 
citing 
# of
references 
Referral Process 15 35 
Linkages between Departments 13 35 
Information back to Pediatricians about resolution of 
referral 
4 8 
Consultation with Colleagues 5 5 
Infrastructure 4 4 
   
Community Resources 5 13 
Implementation Climate 8 28 
Leadership Engagement 4 10 
   
CHARACTERISTICS OF THE INTERVENTION                     
Total 
 126 
Relative Advantage of BHC Model 15 69 
Evidence Strength and Quality 10 29 
Information Technology 3 11 
Cost 3 7 
Relative Advantage of PCP Model 5 6 
Impact of Trial 2 4 
   
CHARACTERTISTICS OF THE INDIVIDUALS 
INVOLVED   Total  
 90 
Provider Knowledge and Skills 13 44 
Provider Attitudes Toward Substance Use 8 16 
Provider Self-Efficacy 5 13 
Provider Perception of Role vis a vis Behavioral Health 7 11 
Medical Training 3 6 
   
IMPLEMENTATION PROCESS                                             
Total 
 93 
Planning 13 35 
Executing 6 24 
Training 9 22 
Engaging 5 8 
Reflecting 1 3 
Evaluating 1 1 
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Table 6. Inter-rater Reliability 
 Kappa 
Coefficient 
% Agreement between 
coders 
Overall 0.7837 98.85 
Outer Setting 0.8309 99.21 
Inner Setting 0.7833 98.31 
Characteristics of Intervention 0.8514 99.18 
Characteristics of Individuals 
Involved 
0.7913 98.95 
Implementation Process 0.7969 98.89 
 
Outer Setting 
      Factors in the Outer Setting domain were identified quite often by participants during 
the course of the interviews as influencing the possible implementation of SBIRT for 
adolescents, and behavioral health integration in pediatric primary care.  Outer Setting factors 
were second only to Inner Setting ones in the frequency at which they were discussed.  It was 
clear from the interviews that even in the highly structured, somewhat insulated environment 
of the Kaiser health system, providers and policymakers there are not immune to external 
influences on their patients and clinical practices. National and state policies and legislation, 
shifting cultural attitudes about substance use and behavioral health problems, and patient 
characteristics were all noted as particularly salient to the issue of integrated behavioral 
health practices in pediatric primary care.      
 Comorbidity. Comorbidity – in particular, co-occurring substance use and mental 
health problems – was mentioned by several participants, across profession disciplines and 
settings, as a factor which was quite common among their patient populations. 
Kaiser Primary Care Pediatrician:  
 I think that they probably don’t have one problem. I think they have drug and alcohol 
 and behavioral issues… 
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Kaiser CD Clinician:  
…there’s a good percentage of teens that I see tend to have some anxiety or 
depression, and I think that’s been clearer since we’ve done the outcomes study…. A 
lot of families will come in with more that the mental health disorder is creating the 
other problem, and the teen is self-medicating…. 
 
 
Kaiser Child & Family Psychiatry Clinician:   
And, of course, we know that depression and anxiety is also a big factor for kids self-
medicating. If you’re anxious you drink, and when you drink you’re less anxious 
when you go to parties. 
 
 Linguistic. Linguistic needs of patients and families, and the barriers they posed to 
accessing treatment and quality of care, were mentioned several times by participants, both 
within and outside of Kaiser.  Participants noted the lack of linguistic capacity of programs 
and systems to provide linguistically appropriate services needed for increasingly diverse 
patient populations. 
Child & Family Psychiatry Clinician:   
The massive barrier in this system, even with the improvements Kaiser has made, is 
language. We do not have a Spanish-speaking receptionist. We need one. It really 
continues to be a huge barrier if you don’t speak English. We get a huge patient 
population are Spanish-speaking.  
 
FQHC Clinic Consortium Behavioral Health Integration Manager:  
 Resources in the County are sparse, and language ability (has) become an issue,  
 because we have all kinds of immigrant populations here or other languages. Asian 
 Health Services, for example, have no one to refer people to. So the client is still left 
 stuck and may end up circling back to the primary care setting for the help that they 
 need. 
 
 Marijuana policy & legislation. The significant and growing impact of liberalizing 
marijuana legislation was mentioned by several participants, particularly the pediatricians, as 
complicating their ability to influence patients’ use of marijuana. Participants reported that 
changing marijuana policies served to support many patients’ and parents’ perception that 
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marijuana was less risky to adolescents than other substances, more “natural,” and therefore 
less of a concern.    
Kaiser Primary Care Pediatrician:   
 
 Of course, if it was other drugs or alcohol, then I’d probably be more pushed. But  the 
 feeling about marijuana is so… it’s so hard to convince anybody that’s it’s a 
 problem, but the kids I know – the ADHD kids and all those kids – are self-
 medicating and they feel better and – but I also know that if I try to get them help for 
 their anxiety or depression, I wouldn’t be able to get anywhere until they quit, I hate 
 that it’s getting so laissez-faire.  It’s just going to make our job harder. 
 
Kaiser Primary Care Pediatrician:  
 
 I think there's a lot of confused message with the legalization of marijuana, and 
 medical marijuana. Even billboards – there's a billboard about improving your 
 mental health – I just saw it yesterday, for medical cannabis! I mean, these 
 kids are driving down the freeway, seeing that, and they got depression and anxiety, 
 and when they smoke they can sleep better and feel better, and they know Aunt Sally 
 is high every day because she's got cerebral depression. I don't know how to deal 
 with that. I think that there probably could easily be some mixed messages. 
 
Child & Family Psychiatry Clinician:  
I definitely see a lot more of a tolerance or minimizing the behavior if it is involving 
marijuana.  I think that marijuana use is looked at differently than other, you know, 
drugs or alcohol. 
 
Child & Family Psychiatry Clinician:  
It shouldn’t if we talk about it the way we should talk about it. Alcohol is legal for 
people are over 21, but not for people under 21. Marijuana could be legal for people 
over 21, but not under. It goes in the same place. So, the way I talk to the kids, I say, 
‘It’s illegal,’ you know? And I talk to the parents. ‘It’s illegal.’ 
 
Kaiser Policymaker:   
 
I think legalization of marijuana is a really interesting one, especially when you think 
about adolescents in particular, because anytime I muddy a message, it becomes more 
difficult for the adolescents to understand it.   
 
I was reading something recently about how parents who drink alcohol at home, their 
kids have a higher incidence of alcohol dependence. The idea behind that is that 
we’ve normalized a behavior that’s perfectly legal. They’re not drinking a lot, but 
we’ve removed a barrier that potentially the adolescent sees: Wait, my parents are 
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drinking. They’re drinking an appropriate amount, but the adolescent doesn’t know 
what an appropriate amount is. They just see their parents are drinking, so it 
normalizes the behavior. They’re not going to get that. They’re just going to see, Oh, 
my parents are using, so it’s fine for me to do it as well.  
 
 Confidentiality. Patient confidentiality was among the most frequently mentioned 
topics by participants, reflecting the ambiguity of its role in the conversation about integrated 
behavioral health for teens.  It is an (or perhaps the) essential element in adolescent 
healthcare, but poses challenges to integrating interventions like SBIRT, which address 
potentially sensitive or taboo behaviors, into the interaction between providers, patients and 
their families. Several pediatricians described struggling with how to deal with information 
about substance use while protecting adolescents’ confidentiality, and how this can inhibit 
their ability to get teens the intervention they may need. They varied in their understanding of 
the extent of healthcare providers’ ability to maneuver under the law: some interpreted the 
law more conservatively, understanding breaches of confidentiality as allowable only in case 
of threatened suicide or homicide, while others interpreted the law more liberally and felt that 
significant substance use could constitute sufficient risk to allow them to bring parents into 
the conversation. Pediatricians described methods they had developed for talking with teens 
about risky behaviors, and for facilitating discussions with patients and parents, about risks, 
behaviors, intervention and possible referral to specialty care. 
Kaiser Primary Care Pediatrician:  
 
 Well, the barrier is having this teen that says they use marijuana every day. They 
 don’t see the problem, and their mother doesn’t know. So how am I supposed to do 
 that without the mother knowing; and, if I call someone to come up and talk to them 
 for 15 extra minutes, what’s the parents sitting in the waiting room going to think? 
 And, because we tell them we’re keeping it confidential, but that can’t stay 
 confidential. I mean, at a certain point, it can’t be confidential. So then, how do I 
 decide that it should break confidence? 
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Kaiser Primary Care Pediatrician:   
 
What I tell kids before – as soon as I throw the parents out of the room, I say to them, 
‘What we talk about now is confidential. If you think you’re going to hurt yourself, 
hurt somebody else, somebody’s hurting you.’ So, if they, you know, disclose 
something that I think is dangerous, then I might say, you know, ‘This is – this is a 
concern. This is dangerous, and I really need to talk with your parents and  get you 
help for this.’ 
 
Q:   So… you just kind of do the calculus in your head, like, I think this level –  
A:   If they said they’re going to hurt themselves, you know. 
Q:   Well, but I mean, like, level of alcohol use; say if someone says, you know, ‘I’m 
using such and such.’ It’s very different if some 17-year-old says, ‘Oh, yeah, well, I 
drank a couple of beers or a beer at a party’ – versus a 13-year-old who’s, like, ‘Oh, 
yeah, I’m drinking three times a week.’ 
 
A:   Yes. 
Q:   So, do you ever, you know, give that information to parents if the – break 
 confidentiality. 
 
A:   Yeah, yeah, yeah, yeah. If it’s bad enough I will.  It’s got to be pretty bad,  though. 
Kaiser Primary Care Pediatrician:   
 
Well, the law's very clear. I mean, unless they're homicidal or suicidal, then – and I 
don't – I don't – and I can't. I might still really try to convince the kid, like, ‘Hey, this 
is – I think you need help and how you gonna hide this?’ or whatever… But – and if 
they're high as a kite in the room, and the parent's still sitting there, I'm, like, ‘Did you 
smoke something today?’ You know, I’ll call them on it in front (of their parents) 
because that's not breaking confidentiality.  
 
Kaiser Primary Care Pediatrician:   
 
But I will also offer the teen: ‘Do you want to tell your parent? Do you want me to 
tell your parent? Do you want to tell your parent with me in the room? Do you want 
to wait until you go home? Do you feel safe at home?’ Kind of giving them help in 
talking about it.  I think the only time I have brought it to the parents, because of my 
legal issue, is if the parents brought it to me first and then talked about it. And I 
would send the parent out and I would get the kids permission to talk about it to the 
parents.  
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 Stigma. The stigma surrounding behavioral health problems – mental health, and 
substance abuse in particular – was mentioned by several participants as an important factor 
shaping their interactions with patients and families.  Clinicians from both Pediatrics and 
Psychiatry cited stigma as a barrier to patients’ and families’ willingness to consider 
engaging in specialty behavioral health treatment, or even to discuss behavioral health 
problems.  A Child Psychiatry clinician saw stigma as inhibiting pediatricians’ willingness to 
ask patients about behavioral health problems. However, an FQHC-based pediatrician 
described parents’ hesitation lessening after finally speaking to a behavioral health clinician, 
suggesting that obstacles posed by stigma have the potential to be ameliorated through 
communication with a trusted healthcare provider. 
Kaiser Primary Care Pediatrician:   
Now, CD they’re always scared about, but I explain to them, you know, the – you 
know, why I think it’s important, and I say, ‘Nobody ever wants to go, but the teens I 
know who have done it have found it extremely helpful.’ The stigma of it, they don’t 
think that the problem is that bad. It’s just the stigma of rehab. 
 
Child Psychiatry clinician:  
I think  chemical dependency, it’s kind of like how psychiatric conditions were a few 
years ago, you know , that it’s still a huge stigma, that people are not recognizing it, 
people are not seeing it. I think they’re reluctant to ask about it. 
 
FQHC Primary Care Pediatrician:  
Occasionally, parents, because of the stigma around mental health are resistant at 
first, but usually it doesn’t even take five minutes to convince the parent to not and 
most of the time they’re really, really open to it and really thankful, especially once 
they meet the particular people. 
 
 Cultural attitudes and mores about substance use. Related to the stigma around 
behavioral health problems, patient, family and provider attitudes about substance use were 
mentioned as a factor which could affect discussions about use, risk and intervention. 
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Kaiser Policymaker:   
 
Two things that occur to me, which is that there’s a value judgment that is placed on 
this. Even though we would like for that not to be the case, we are still human beings, 
as physicians. If I’m seeing a colleague’s child, I may just automatically assume, hey, 
wait, you know, they can’t be using substances, because my colleague is the best and 
brightest physician that I know, and they can’t possibly have kids that have any 
problems. It affects everyone. It really affects everyone at all SES levels, all types of 
education. All types of ‘good people’ have these issues, and good kids have these 
issues. And I think you have to normalize that for physicians, because otherwise you 
place value judgments on some of the responses. I think also you do have a fair 
number of physicians who have personal experience with substance use disorders, 
either in their family or themselves. And they’re going to have particular thoughts 
about whether they should ask it and how aggressively to pursue it. 
 
 Growing awareness of the role of behavioral health. There were several mentions, 
particularly from community-based providers, of the growing recognition among medical 
professionals of the critical role behavioral health plays in the overall health and well-being 
of patients, and of the high prevalence of behavioral health concerns among their patient 
populations.     
FQHC Clinic Consortium Behavioral Health Integration Manager:  
We recognize that 50 percent of our population, if not more, has co-occurring 
behavioral health conditions, and that is holding people back from being able to 
address the chronic care issues that are happening to them…. I think the world in 
general is moving toward integration. 
 
FQHC Primary Care Pediatrician:  
 I mean, the bulk of our physicals are really – are mainly psychosocial visits. 
FQHC Medical Director:  
 
 I think a common conversation that people have these days is that they can’t even 
 imagine what it was like before we’ve had a lot of these resources, that it just feels so 
 essential to treating our patient population and probably any patient population to  just 
 kind of have some of these resources here in clinic, that it makes such a big 
 difference.  
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 Insurance. One Kaiser clinician mentioned that, as Kaiser has increased its insurance 
product offerings beyond its traditional all-inclusive, minimal co-pay plans, to include higher 
deductible and higher co-pay and co-insurance products, financial concerns have become 
more of a barrier to specialty behavioral health services for patients. The issue of 
affordability and co-pays and co-insurance, while less relevant to most teens in the public 
and Medicaid systems, could certainly be salient to those with private insurance coverage 
where “skinny plans” and other high cost-sharing plans are more common.  While most 
Kaiser members still have relatively small cost-sharing burdens, these types of plans have 
become more common, not only in for-profit plans, but in not-for-profit health systems such 
as Kaiser. Interventions provided under the auspices of the Pediatrics Department could offer 
a lower-cost alternative to specialty behavioral health services. 
Child Psychiatry clinician:  
 
 I’ve had parents tell me they can’t afford to come here. And if you have more than 
 one child and you’re just picking between a medical doctor and psychiatry, and your 
 child has a high fever, well, most parents are going to go in that direction. So, 
 unfortunately, the financial thing is a big barrier. 
 
 Healthcare reform/ACA. While none of the Kaiser clinicians discussed the effects 
of the ACA or healthcare reform on SBIRT implementation specifically, or adolescent 
substance use screening more generally, a community-based mental health provider 
mentioned the ACA as a facilitator of SBIRT implementation.  
FQHC Psychiatrist:   
 
 Providers were for a long time just clamoring for more mental health integration into 
 the primary care clinics. There’s always been the county mental health clinics for the 
 patients with more severe schizophrenia or bipolar that are kind of unstable or 
 unstable depression where they’re suicidal or something like that. But for all the 
 other patients, it was very difficult to get people counseling. Recently with the ACA, 
 the county and all the health clinics are mandated to provide mental health. Medi-Cal 
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 SBIRT is mandated to provide mental health counseling resources and pay for them 
 in the community. 
 
 Performance measures. Externally developed and disseminated performance 
measures, such as those in the HEDIS of the National Committee of Quality Assurance 
(NCQA), were discussed as an environmental factor that frequently drive internal guidelines 
and by turn, providers’ individual clinical practices. 
Kaiser Primary Care Pediatrician:   
 Yeah, if we’re forced to do it, and there’s a HEDIS thing, and we’re measured on it, 
 we’re going to do it. 
 
Child & Family Psychiatry Clinician:   
Because the initiatives they have to do are the HEDIS. We do a lot of energy behind 
the measuring all these different guidelines, and that’s the only one they have to do.  
 
Inner Setting 
      Inner Setting factors were the most frequently discussed during the interviews, as 
either barriers or facilitators to SBIRT and behavioral health integration. Issues such as 
current clinical workflows, the structure and time allotted for adolescent well visits, the 
pressures experienced by providers faced with multiple competing priorities, and the 
relationships with other departments, organizations and colleagues from other clinical 
disciplines were all repeatedly mentioned as impacting providers’ ability to deliver 
interventions such as SBIRT. 
 EHR. The potential value of, and the challenges of effectively using, electronic 
health records in SBIRT implementation were discussed by participants in both Kaiser, with 
its mature and robust EHR, and in community settings still adapting to EHRs. One 
pediatrician discussed her frustration with the time and effort involved in documenting care 
practices, including alcohol and drug screening, in the EHR, and her tendency to forgo using 
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standardized, evidence-based screening questionnaires embedded in the EHR in lieu of 
documenting use in clinical notes.  Another acknowledged that if screening instruments are 
embedded in the EHR, and patients’ answers clearly visible as part of their record, that it 
became harder for providers to ignore that information.  Similarly, a mental health provider 
pointed out that what is in the EHR gets asked, and that if alcohol and drug screening was in 
the EHR the way that smoking is, that it would be more likely to be attended to. Someone 
charged with overseeing the integration of behavioral health into the county’s FQHCs 
described the challenges involved in designing, building and implementing systems for 
electronic documentation of behavioral healthcare services. 
FQHC Clinic Consortium Behavioral Health Integration Manager:   
 
 Some clinics are doing the paper version and scanning into the medical records, and 
 then, others are actually using the screenings that are in the EHR.  
 
 They have a specific person on their IT staff who's been helping to think through this 
 process and then really to interface with the EHR system. They really want to be 
 documenting everything directly into the EHR.  
 
Kaiser Primary Care Pediatrician:  
 
…not everybody uses those questionnaires all the way. Because if you see how they 
work, they’re so cumbersome and unwieldy.  I usually do a note instead and then I 
disregard the questionnaire. I try to address whatever was positive but I don’t 
necessarily go back in and change the answer. That will be probably six more clicks. 
It opens up a new window so it totally ruins your flow of thought – you know? 
 
Kaiser Primary Care Pediatrician:   
Once the information's glaringly right there, if you're going to ask very specific 
questions about how many drinks and all that stuff, we're probably going to pick up a 
few more. 
 
Child & Family Psychiatry Clinician:  
I mean, cigarette smoking is in our template. You have to mark it before you close it. 
But the other one, not really, you know? Nobody said, ‘Did you counsel them about 
substance use,’ right? 
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 Screening & assessment instruments. The instruments and methods used to screen 
and assess adolescents were a major topic of the interviews. Several providers discussed the 
pros and cons of the instrument used during the trial – the CRAFFT – with many saying it 
was easy to use, although it was clear that they did not use it systematically. It was clear that 
there were no standard, uniform screening practices used across the providers, and that many 
did not use evidence-based substance use screening instruments on patients unless they 
suspected that a patient was at risk. A Kaiser pediatrician described following up on initial 
substance pre-screening by performing further assessment without using a standardized tool. 
Similarly, in the community-based FQHC adolescent clinic, the Behavioral Health Clinician 
described screening, but in an informal way, without the use of an evidence-based 
instrument. A Kaiser mental health clinical described a relatively minimal substance use 
assessment, not using a standardized, evidence-based instrument.  Interestingly, both the 
Kaiser CD clinician and Policymaker endorsed the use of a broad-brush assessment tool, that 
embeds alcohol and drug use items into a comprehensive series of risk and health behavior 
questions, as a way of lessening potential stigma and increasing patients’ frank disclosure of 
use. 
Kaiser Primary Care Pediatrician:  
…having that CRAFFT was handy. So it made it easy to ask the questions so that if 
they were all normal, then I would feel more relieved, but it is totally a time thing. 
 
Kaiser Primary Care Pediatrician:  
 
Doing CRAFFT questionnaire is pretty helpful. Because it takes more time, but 
you’re going more specific then and I’ve tried to make sure they’re not drinking and 
driving or being in the same car with somebody who’s kind of under the influence. At 
least they’re not doing dangerous behaviors like that.   
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Kaiser Primary Care Pediatrician:  
 
Most of the teens I see don’t ever use alcohol or rarely use alcohol or have tried 
marijuana but don’t do it regularly. And I have done the CRAFFT. I don’t think I’ve 
done it in a few months. I mean, having that CRAFFT was handy. It made it easy  to 
ask the questions so that if they were all normal, then I would feel more relieved,  but 
it is totally a time thing. 
 
Kaiser Primary Care Pediatrician:  
 
 Certainly, I always ask about the drinking and driving and smoking and driving – 
 ‘Do you ever put yourself in a bad situation?’ ‘Have you ever drunk so much that, 
 you know, you got sick or, you know, felt like you needed to drink because you were 
 hung over?’ I think they're kind of the CAGE questions. 
 
Child & Family Psychiatry Clinician:  
We don’t use an instrument like CDRP (specialty substance abuse treatment program) 
does. The parents or the legal guardian, they fill out a form, and then for kids 12 and 
up, they’re filling out forms. And in that form it’s asking do they use and what do 
they use, and the frequency of use. 
 
FQHC Primary Care Pediatrician:  
Anybody coming in for a physical, we actually have a form that our medical and 
social workers give the patient before we even go in to see them, and they fill it out. 
We go over it with them. Within the HEADSS Assessment, we ask about, mental 
health – anxiety, depression, abuse, safety at home, drug use, all of those things. 
 
FQHC BHC:    
 
So my approach to alcohol and drugs is we do a screen. If I’m with someone I’ll first 
try and see, ‘How much risk behavior is this patient doing.’ If I feel like there’s risk, 
the first would be conflict with family. If there’s any stress that comes out. If there’s 
no stress, I normally won’t ask about drugs or alcohol, if they report none.  If they say 
‘I’m really stressed out, life is really stressful. I feel A, B, C, D,’ then I will almost 
always ask about drugs and alcohol after a little bit of time. I’ll say ‘On a Saturday, 
how many drinks of alcohol will you drink?’  From that answer I’ll ask how much. 
Some will say ‘Oh, my God.  I never drink.’   And someone else will say ‘I don’t 
know. We’ll finish like three boxes – three handles between four friends.’ And (from 
their answer) I’ll do a different line of assessment. 
 
Q:   It sounds like you don’t use a standardize screen or on paper? 
A:   No. This one has one question, and that’s like my start, ‘How often do you use 
alcohol or drugs to relax, feel better, or fit in?’ 
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CD Clinician: 
 
Q:   So, do you think it’s better to just focus on a single thing like substance abuse alone 
or do you think it’s better to integrate that into a screener for sort of behavioral health 
more broadly. 
 
A:  I kind of like the idea of bigger and a part of a bigger piece. I mean, just to integrate it 
because I think – I think teens will be honest about their answers. Yeah. I think if it’s 
just part of it, they’re going to answer. If it’s too specific, then it kinds of stands out a 
little more. 
 
Kaiser Policymaker:  
 
 I think, for teens in particular, incorporating as many of these screening questions 
 into a single instrument is useful because it kind of destigmatizes, you know, how you 
 answer it. For example, if you give a teen a PHQ-A, for example, that automatically 
 says, okay, we’re looking for depression, and there’s a little bit of, perhaps, some 
 stigma around that, or they want to hide that information from their parents, 
 depending on how it’s administered. Or there may just be a concern about what’s 
 going to happen with those results. 
 
 You embed two or three questions into a full-on teen well-check questionnaire, and 
 you’re asking about seatbelt use while you’re also asking about drug and alcohol use. 
  
 Time, appointment length. As in the adult SBIRT implementation literature, time 
(or the lack thereof) was the most frequently discussed factor impacting participants. Kaiser 
pediatricians spoke with great frustration about the time pressures they experience due to the 
short (15 minute) adolescent well visit appointments. They described the challenges of caring 
for their patients and how these time pressures their ability to adequately screen and address 
adolescents’ substance use and/or mental health problems within the timeframe of a typical 
well check. One physician expressed skepticism about providers’ ability to provide 
comprehensive, quality care to their adolescent patients under the system as it is currently 
structured. An FQHC psychiatrist also discussed the time constraints that primary care 
providers operate under in the clinics where she works. 
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Kaiser Primary Care Pediatrician:  
 
 In Pediatrics, dealing with so many things, I wish I had time to spend more time on 
 the conversation. Usually I think I probably don’t spend that much time. Just because 
 of the time constraints because if it’s a baby or teen with multiple problems, it’s still 
 only 15 minutes. Usually, I’m running late and probably there for more than 15 
 minutes, then I’m late for the next patient. I wish I had talked more. I would talk 
 about addiction and effects on their health and their achievement and if they’re going 
 to be playing sports or something, how it’s going to affect maybe their taking part in 
 sports. So, unfortunately, I don’t have very long conversations. 
 
Kaiser Primary Care Pediatrician:   
 
 We have 15 minutes for every patient, and as you can imagine, with any teenager, 
 you have to do the regular physical stuff, plus how’s school, socializing, any bullying, 
 any substance abuse, any sexual activity. You need to talk to them confidentially. 
 Eating  habits – there’s just a million things. 
 
 Fifteen minutes for a very healthy, self-motivated teen is easy enough to do, but most 
 teens have other things. And trying to get their confidence in 15 minutes to have them 
 – you know, you ask them to take off all their clothes, and, you know, they’re already 
 – a lot of teens are already feeling awkward and vulnerable. And then you have to 
 talk about a million different things. 
 
 So whenever I have a patient that has anything outside of being 100 percent 
 normal, it’s a little discomfiting, because I just don’t feel like I’m going to have the 
 appropriate amount of time to take care of them, or to be able to address or answer 
 their questions in a timely fashion in a way that serves them and serves all of the 
 patients after them, because I will stay with them as long as they need, but then it will 
 put me behind with everyone else. 
 
 I really have a hard time being able to speak for other doctors. I can tell you that 
 we’re all – the 15 minutes, most of us feel it’s not appropriate – not that it’s not 
 appropriate; it’s not sufficient. It’s not sufficient.  ….I just don’t know that our 
 system is set up to help our teens in 15-minutes visits. 
 
 Competing priorities. Closely related to the time pressures described by participants 
are the competing priorities faced by today’s primary care providers. Pediatricians described 
the multiple recommended preventive services and activities they are expected to perform 
during the course of a typical adolescent well visit: physical examination components, 
various screening activities (e.g., smoking, nutrition, exercise, school performance, sexually 
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transmitted infections, bullying, etc.), immunizations, school/sports forms, etc. Many 
reported feeling overwhelmed at the sheer volume of activities, and made clear that visits 
were clearly a zero-sum game; it was impossible to complete all the required preventive 
activities, as well as addressing concerns specific to the patient, and they were constantly 
forced to choose the services they felt were most important and appropriate for particular 
patients. They are forced to make judgements about patients highest priority conditions, 
which means that “invisible” problems like substance use and other risky behaviors may go 
overlooked. 
Kaiser Primary Care Pediatrician:  
 
 Well, the good thing is that if it’s patients that we know, you just pick the things 
 you’re going to spend time on. You know, so if it’s my teen who is stable from an 
 eating disorder, I’m going to spend time on that. If it’s, you know, a kid with ADHD, 
 then I’m going to spend time on ADHD and their medicines and whatever. So maybe 
 not on the other stuff because I know that stuff is okay.  
 
Kaiser Primary Care Pediatrician:   
 
Well, teenagers –  I spend more time because, not only do we need to do the physical 
and, usually, do a school form and talk them about immunizations and make sure that 
they’re ready for sports and everything, but we have to also research their home life 
and their emotional selves. There’s so much change happening for them and if I know 
the teen and we already have sort of established a relationship and they’re pretty easy 
to talk to, then they will tell you anything honestly.  
 
 But if you don’t know the teen, then also takes some extra time to sort of make sure 
 that they feel comfortable talking to you and opening up and telling you – 
 
You’ve probably seen the number of things that we have. We have asthma control 
tests, we have three questionnaires for the teen. We have the Obesity Get Healthy 
Action Plan game, we have their school forms and then you have to do Asthma 
Action Plans if they need them for school and, you could spend the whole time just 
doing clerical work. 
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FQHC Clinic Consortium Behavioral Health Integration Manager: 
 
  Providers are overwhelmed with the enormous amount of mental health conditions 
that are – that they see in their practices. But quite honestly, this is not what they went 
into medicine for. 
 
 Workforce. While not discussed by providers, several of the managers and 
policymakers had clearly thought about whom among their workforce might best be used to 
deliver components of SBIRT and other integrated behavioral health intervention in their 
settings. They talked about the benefits of using various different, non-physician personnel, 
for screening and intervention, and some of the challenges involved in tapping those staff for 
SBIRT. 
FQHC Clinic Consortium Behavioral Health Integration Manager:   
 
So, [Clinic A] has their medical assistant do the initial screening, flags to do the 
larger level screening. They then do a warm handoff to a behavioral health clinician, 
and then, the behavioral health clinician will take on the larger screening and assess 
for sort of where a person's at, and then, do the brief intervention. 
 
Now they're actually trying to train a higher level of community health worker. 
There's a lot that those mid-level kind of professionals – you know, unlicensed or 
working towards their license – can be doing. 
 
How you think through the functions of your team, including your non-licensed 
professionals, and, you know, so that it alleviates the burden on just the licensed 
folks.  
 
 Workflow & warm handoff. Quite a few participants discussed their clinical 
workflows with regard to handling teens’ behavioral health risks. Those with access to 
embedded behavioral health clinicians specifically discussed how a “warm handoff” – where 
a primary care provider personally introduces the patient to a behavioral health clinician 
during the course of the patient’s visit – fits into their clinic workflows, and its importance in 
facilitating patient engagement in behavioral health interventions.    
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Kaiser Primary Care Pediatrician:  
 
Oftentimes I would already know that there was an issue, whether it was the private 
questions or, even if they weren’t the private questions, grades are dropping or they 
admit to having a real problem sleeping, ‘I’ve lost my appetite’ – anything that would 
make me think that they weren’t – that they might use some help just talking about it, 
to even just tease it out to see if there is an issue. 
 
I would let them know: ‘I’m really fortunate at this time. I’ve partnered up with Dr. 
XYZ, who does the mental health kind of check-in with teenagers. So I’ll do the 
physical, and then I’ll give her a call. And if she’s available, she’ll come in right 
away and talk to you. If not, she might just come and say hello and then follow up 
with you. But if she’s not there, she will give you a call to follow up.’ 
 
I’ve never had her come down and be in and out in two minutes and be like, Oh, they 
didn’t want to talk to me. Like, it’s a minimum of 20 minutes, more like 30 minutes, 
and oftentimes 45 to an hour. Kids would talk to her, would open up. They would talk 
and really discuss what’s going on with them. And she always has – she was able to 
get out of them a lot more than I could in, you know, 10 minutes. 
 
I never had a patient say, No, I don’t want to meet with her. I never had a parent say, 
Why do they need to meet with a therapist? I think everyone’s kind of aware: 
Teenagers are hard. I think kids who are having challenges, parents are seeing it at 
home. It’s not a big surprise.  
 
And sometimes parents will say ‘I want my kid to see someone. And I’ll say, ‘Well, 
we have someone who can meet with them right now.’ And they, like, you know, 
want to kiss the ground I walk on, because they’re just – because there’s nothing like 
the immediacy. Sometimes they have a hard time getting their teen in here to begin 
with to discuss an issue which they feel is not an issue. 
 
FQHC Primary Care Pediatrician:  
 
If it’s something like headaches and I really think that it’s about anxiety or 
something, I’ll say, ‘Now that we’ve talked I really don’t think that there is a purely 
medical explanation for what’s going on and it sounds like a lot about what you were 
telling me about – about the stress at home and the violence is really contributing – 
and we have people here that can help you with that.  
 
I could give you tons and tons of pills, but I don’t actually think this is going to go 
away with just pills. I really want to introduce you to our social workers because I 
think they’re going to be able to help.’  Most kids at that point are like, “Yes. Please. 
Yes.” They’re open to talking to anyone.  And I’ll say, ‘I’m really worried about you, 
and I actually don’t feel comfortable letting you leave until you at least talk to them. 
You don’t have to make a follow-up. You don’t have to commit to anything. But I 
just want you to meet them face-to-face.’ And, if the person who’s on call isn’t the 
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one that’s down here, I’ll say, ‘Okay. Well, they’re seeing patients right now. Let me 
call them and see if they’re available. If they’re available, I’ll have them come to you. 
If not, we’re going to get you an appointment as soon as possible.’ 
  
And then, if it looks like it’s going to be a really long conversation that the social 
worker and the patient are going to need to have, then I’ll ask the social worker to 
bring them up to their office, up here, so that we can free up the room and keep the 
flow of clinic going. 
 
It didn’t used to happen. We didn’t have anyone down here so we used to have to call 
and see if they were in-between patients or could come down. And so we decided that 
it’s much easier to have somebody who has no scheduled patients just be sitting there.  
 
FQHC Medical Director:  
 
I think most people agree that the best way to get patients to actually follow up with 
their health coaches was if there was a warm handoff, and they actually met the 
person, rather than someone calling them up later. Doing the counseling on behavior 
change, motivational interviewing, and even assessing the situation fully takes a lot 
more time than the 15 minutes or so that we have in our typical visits. 
 
 Linkages between departments. Throughout the interviews, participants across 
disciplines and organizations discussed the personal, professional and departmental 
relationships which impact the provision of behavioral health services for adolescents on a 
regular basis.  It was clear from the interviews that linkages between departments and 
organizations often depend on the relationships between and efforts of individual staff 
people, rather than intentionally established, systematized connections intentionally created 
to link departments or organizations, creating “systems of care.” When personnel changed, or 
if successful personal-professional relationships were never established, linkages were often 
weak, potentially compromising optimally integrated care for adolescents with co-occurring 
health and behavioral health concerns.   
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CD Provider:  More of my work is with child and family psychiatry than the Pediatrics 
department. I probably have had interaction with Pediatrics through of my interaction with 
child and family, but that’s the only time I’ve had any interaction with pediatrics. With Child 
& Family, going to a monthly liaison meeting.” 
Q:  So it sounds like you don’t get a lot of direct referrals from the pediatricians? 
A:  Pretty rare. I do. 
Q:  And when you do, are those the more severe kids would you say or – 
A:  I would say it tends to be more severe. I’m trying to think because there’s so few. 
Child & Family Psychiatry Clinician:  
 
I personally saw it on both sides of general psychiatry and chemical dependency 
recovery program, what Kaiser was trying to get us to do, end up no wrong door, 
because we know we lose people when we’re referring over. 
 
There are certain providers that just seem to catch things more. I think it depends on 
the provider. For me, it’s not been an issue of a close relationship. I just knew the 
other doctors more. And as they’ve retired, you know, we haven’t done it in a while, 
but we’ve done different things over time. We used to do once a month case 
conferences where they’d come down here, we’d go down there. I don't know why 
that hasn’t happened again. But, you know, it was a select few. It was those doctors 
who were more psychologically inclined. At least that was a nice opportunity. Many I 
don’t even know, they wouldn’t even know I worked for Kaiser. 
 
      It was clear that the weak linkages between pediatric primary care and behavioral 
health departments described by front-line clinicians were not well understood by 
policymakers at leadership levels:  
Kaiser Policymaker:  
 
And one of the things that I think about pediatrics, though, that’s different than with 
adults, is that pediatricians tend to stay much more involved with their patients. So 
there’s a lot more communication and crosstalk between the pediatrician and the child 
psychiatrist or the therapist. So I think actually that makes them better informed, and 
so they’re better able to understand what’s going on, even if they’re not treating the 
patient. 
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Referral process. Several participants described the referral process to specialty 
behavioral health services – either to Child & Family Psychiatry or to the Chemical 
Dependency program, in the case of Kaiser, or to outside behavioral health services, in the 
case of community-based primary care providers – once a teen was identified as needing 
more intensive services than could be provided in the context of primary care.  Kaiser 
pediatricians described some of the barriers inherent in the referral process, including 
unwilling patients and families or inflexible program rules which exclude patients with co-
occurring mental health and substance use problems. Community-based pediatricians also 
described patients unwilling to follow through on referrals to specialty care, preferring 
instead to continue to receive care in a familiar setting, with trusted providers. Community-
based program administrators also discussed some of the service capacity limitations across 
community programs, and the impact the lack of resources have on the specialty treatment 
referral process. 
Kaiser Primary Care Pediatrician:  
 
Sometimes, I would refer the child to Psychiatry but, as you probably know, there’s 
not always a great follow-up with that. Or the parent really wants to have follow-up 
with that because they feel sort of at a loss to deal with their kid and I don’t think we 
have excellent parenting resources. It’s pretty hard. And to try to get the kid to agree 
but a lot of times, the teen won’t agree to come. So you’re sort of at a stuck position. 
Sometimes the teen really does want to go and will agree to referral and may actually 
go for the intake but doesn’t often follow-up. 
 
Kaiser Primary Care Pediatrician:  
 
Our behavioral medicine here, just a referral down to there to let them sort it all out, 
even if the parents are on-board and want to do it, and it seems like they have 
underlying reasons why they're using substances, I've found Child and Family Psych 
will not see them if they continue to use substances, so that's just out – you're stuck. 
There's no one then to advocate. 
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Kaiser Primary Care Pediatrician:   
 
If there’s a drug issue, then behavioral medicine won’t see them until they deal with 
that. But I don’t know that I’ve had any patients that –  maybe one or something – 
that’s followed through and mostly because there was other things going on. But, I 
guess, it seems like it’s such a huge, huge program, huge commitment that – for a 
normal, average, busy family that someone’s using marijuana, you know, I’m not sure 
they’re ever going to follow through. 
 
FQHC Primary Care Pediatrician:  
 
Our patients that are really having a lot of other more complicated issues, we can 
refer out, but it’s very, very limited who we can get in there. It’s like very, very high 
risk and, you know, they have to have some sort of ongoing abuse or, you know, 
something like really, really acute.  
 
And, especially with teenagers, it’s actually really hard when we refer patients out. So 
many times, they won’t go. It’s like, ‘This is their clinic. This is where they’re going 
to come for everything,’ and particularly if they’ve already made a connection to one 
of those social workers, even if they are like, ‘Your depression is really bad. I want 
you to start seeing a psychiatrist or a psychologist every week,’ the amount of times 
that they actually follow through with that is so rare. 
 
FQHC Clinic Consortium Behavioral Health Integration Manager:  
The other challenge is the referral part of it. I would say that our County system is 
trying to figure that out, trying to be as supportive as possible and create more 
resources, but it's not happening fast enough. 
 
 Information flow back to pediatricians about resolution of referral. In discussing 
the referral process, pediatricians often expressed frustration about not hearing back from 
specialty behavioral health colleagues about the outcome of a referral.  While understanding 
about the specific confidentiality protections afforded mental health and especially substance 
abuse treatment (under 42 CFR), they longed for more information about the fate of their 
patients referred for care. A CD clinician confirmed that there is typically little follow-up 
contact with pediatricians following a referral for treatment, but also described the program’s 
standard “consent-to-release-information” form signed by virtually all patients, thus pointing 
to a potential facilitator of better communication with Pediatrics. 
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Kaiser Primary Care Pediatrician:  
 
Q:  So, do you usually – what’s it like when you refer people to behavioral health or to 
the CDRP? Do you get feedback from the programs about the disposition of the case? 
 
A:  More than I used to. CDRP I don’t get anything back from, ever.  Child and Family 
Psych – thank you very much – we usually at least get a note saying that they’ve been 
seen. And some people are better than others about sending us more information on 
what’s happening. 
 
Kaiser Primary Care Pediatrician:  
 
So, once we put in a referral, we can’t see it anymore and a lot of the providers, when 
they do the intake, there’s no physical notes at all. Some providers really don’t give 
us that much back. The thing with behavioral medicine is because of that 
confidentiality, you can’t see – you can just see have they had any visits but you don’t 
necessarily get… More information for me is always better – from everybody. 
 
CD Provider:  
 
Q:  Do you get permission to talk to their primary care provider? 
A:  You know, it’s rare that we contact pediatrics in terms of whether a teen has been in 
the program, unless there was that already there, that communication. 
 
Q:  Is that something that you would consider? I mean, do you think that would help sort 
 of integrate – if the family was willing. 
 
A:  We do ask them to sign a release within Kaiser so we can talk. It’s rare that we have 
 that refused or declined, so it’s kind of up there when the intake is done. 
 
 Infrastructure and resources. Several participants, particularly in the community-
based settings, decried the lack of programmatic funding for adolescent specialty treatment 
services, and its impact on infrastructure and resources for services. 
FQHC Psychiatrist:  
 
So, you know, in a dream world, then everybody would get staffed up and we would 
all use this kind of collaborative model and the county would develop some kind of 
dashboard that connected everybody in terms of the county resources and the 
individual clinics would have caseload, you know, some type of AHRP flow that you 
could just update and there would be time allocated for us. 
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County Adolescent Alcohol and Drug Treatment Services Administrator:  
Everyone loves to complain about money, you know, and how there's not enough. 
But really, for adolescent treatment services, we are painfully underfunded. And I 
think our capacity to really meet the need that I think is out there isn't quite there. 
 
Characteristics of the Intervention 
      All of the interviews included questions about SBIRT. Participants were asked about 
the importance of the evidence base in determining their adoption of new interventions and 
the role of cost-effectiveness in influencing implementation.  Providers who had participated 
in the SBIRT trial were specifically asked to reflect on the merits of the different modalities 
of delivering SBIRT. 
 Cost. Quite a few participants discussed the role of cost as it influences the 
implementation of new interventions like SBIRT. While acknowledging that a new 
technology’s cost and cost effectiveness was clearly an important factor in determining its 
ultimate adoption, they also allowed as how the demonstration of cost savings alone were not 
enough to insure implementation, and that factors such as quality and usefulness must be 
combined with cost effectiveness in order to encourage adoption. A community-based 
pediatrician felt that the use of an embedded behavioral health clinician increased her clinic’s 
pediatricians’ productivity, and that having such a resource allowed her to see a greater 
number of patients.    
Kaiser Child & Family Psychiatry Clinician:  
 
How do you make the case to leadership that this is an investment we’re going to 
make now? We may not see the benefit right away, but this is the right thing to do in 
terms of quality, in terms of care for our – our patient – our members, and, you know, 
a lot of these people are going to stay Kaiser members. And, so, we are planning the 
seeds of good health and well-being now. I mean, how do you do that? 
 
If you look at hospital rates among teens, the ones that are in and the ones that are 
repeated are the ones with dual diagnoses.  
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I think that is very expensive for the organization.  One time we ran the numbers – 
like 60 percent of the patients that are repeated, that go in or stay longer, all have dual 
diagnoses. 
 
So, they have some kind of chemical dependency problem, they also have psychiatric 
problems. And if you have the two together, they’re much more dysfunctional, and 
they more dangerous, more high risk, and more likely to be in the hospital. So, we 
actually can say what we already have, you know? Focus on the short-term cost 
benefit. 
 
Can we can decrease hospitalization rates, can we avoid them, can we have shorter 
stays if we have an actually integrated system in place from detection to intensive 
intervention? So, you can talk about a progression of treatments, right? So, you can 
have education, you have primary prevention, and then you have intervention, and 
you have intensive treatment. 
 
FQHC Primary Care Pediatrician:  
 
Because, it may increase our productivity. If I didn’t have the social worker and the 
health educator downstairs, there’s no possible way that I could through all my 
patients, because I would be doing it all myself. And, there again, it’s not possible, 
because almost every person that comes into the clinic, has a mental health issue and 
a birth control need. Or diabetes or something. You know, like, it would health 
education needs and a mental health issue, regardless of what their visit is. 
 
 Evidence strength and quality. Many participants discussed the importance of 
evidence in determining whether they would adopt new intervention into their clinical 
practice.  While they talked about evidence as an important element in determining clinical 
practice, and something the pediatricians aspired to have as a major factor in their own 
individual practices (several described evidence-based practice as “doing the right thing”), 
they described a nuanced situation in which the scientific evidence, quality and performance 
measures and leadership directives all played a role in determining clinical guidelines and by 
turn, individual clinicians’ practices. Some also described the continued use of practices for 
which there was no evidence of usefulness, but which persisted out of habit.  Interestingly, 
one policymaker began by discussing the importance of evidence, but made it clear that 
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evidence alone was insufficient to change practice in a large health system, and suggested 
that anecdote can be as compelling to policymakers decision-making as the evidence base.  
Kaiser Primary Care Pediatrician:  
 
I think evidence is huge. Our medicine has significantly gone towards evidence-based 
management. I think everyone feels better knowing that someone’s done some level 
of research and that you can hang your hat on it just for your own peace of mind, but 
also in explaining it to parents and to families and trying to get their buying in to what 
you’re doing. 
 
Kaiser Primary Care Pediatrician:  
I think we all are more prone to do what is required of us. I mean, we all want to try 
to do the right thing, right? Then, next, it’s the little dashboard things where we kind 
of forced to do that stuff and then we’re going to – I think evidence-based is probably 
driving the dashboard but… 
 
Kaiser Primary Care Pediatrician:   
 
 I think if people know the evidence, if people understand – we’re all providers. I 
think everybody here wants to do the right thing. And I think evidence is really, really 
important. I think that’s why education for me is really important. Conferences are 
really important because even if they hear it, it sorts of stays somewhere, you know? 
And maybe 30 percent of your Pediatricians will read it, but following a conference, 
occasionally an article gets sent to them, and they will click on it. And many read 
journals as well to just keep the practice going. 
 
Kaiser Primary Care Pediatrician:   
I think so much of what we do in pediatrics is not evidence-based. Think about all the 
medications we use that were never approved in kids, but we still use them. And – 
some of these metrics that have nothing to do with patient care. 
 
Kaiser Policymaker:  
 
The evidence base is crucial, but it’s not sufficient. I think you can never take a model 
out to anyone and sell it without there being at least some very strong evidence that it 
works and in the way that it works as well.  
 
If the issue is that we’re not identifying enough substance use disorder and these kids 
are ending up 20 years from now in a really severe end-stage, substance use disorder 
of some sort, I need to have some data that supports that assumption to make the case 
and to paint the story for why we need to do it. But that’s not going to be enough. I 
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need to also prove that it can be implemented in a cost-effective fashion and is really 
the best use of those resources. 
 
So, if I’m going to take out a model that says you need to increase the length of the 
pediatrics visits to 20 minutes so they can address these issues when they arise, I need 
to have some very, very clear reasons why spending that extra money or, you know, 
creating those additional appointments in pediatric schedules, why that’s going to be 
useful and how it’s going to be helpful. 
 
And I think that the way you actually do that is you come back to the patient and the 
experience of what is going to happen to that teen 20 years down the road based on 
what our evidence shows. Or even personal anecdotes can be very powerful in this 
regard as well. We know a lot of things about what happens to teens who are using 
substances. We need to bring those in and say, ‘This potentially could be where this 
kid is headed, and we want to implement programs that will support this teen in 
making some better choices.’ 
 
 Relative advantages of BHC conducting SBIRT. By far the most discussed topic, 
and one raised by ¾ of the participants, was the relative advantage provided by the embedded 
Behavioral Health Clinician model.  Kaiser pediatricians who had access to the embedded 
BHC during the trial, and community-based pediatricians whose organizations used the 
model, all described how it supported their practices, supplemented their work and allowed 
them to more fully address (or address at all) the behavioral health needs of their adolescent 
patients. Some discussed some of the workflow and logistical problems resulting from the 
using the embedded BHC, including exam room availability and the clinician not always 
being available to respond to a new case if she was already with another patient. Pediatricians 
who had not had access to the BHC also talked about the benefits of such a model, as 
offering a way to extend care services available to patients, in the context of the limited visit 
times and competing priorities discussed above. A community-based pediatrician said very 
explicitly that she could not do her job if she was not able to work in collaboration with an 
embedded behavioral health clinician, because of the high prevalence of behavioral health 
problems among her patients.  Specialty treatment clinicians also talked about the benefits of 
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this model, describing the important referral facilitation role the BHC played, for those teens 
whose problems were severe enough to warrant a referral for specialty care.  For one such 
clinician, the BHC was able to “prime” patients and families for engagement in specialty 
care.  Another discussed the convenience of the “one-stop-shopping” offered by the BHC 
model as having potential to increase access to behavioral healthcare for busy families who 
might be unlikely to find time for multiple visits to specialty behavioral health. The Medical 
Director of a public health clinic described the initial, but ultimately unfounded fears among 
clinic staff about disruptions to clinic flow, and how ultimately, embracing the model has 
made his clinic more productive and less stressful.  Kaiser policymakers acknowledged the 
important role behavioral health could play in pediatric primary care, but were less convinced 
of the value of the embedded BHC model, and spoke of the need for caution and careful 
consideration before implementing such a model. 
Kaiser Primary Care Pediatrician: 
 
Q:   And how did it change for you having that embedded person? 
 
A:   Hugely, and I was very successful in having my patients meet with X, mostly because 
I actually did not offer it as an option. And, in my opinion, it’s an injustice offering it 
as an option, because I kind of feel like, if the child has asthma, he needs albuterol. If 
the kid has diabetes, he needs insulin. If a kid has a significant social issue, they need 
to talk to someone about it. 
 
I don’t think it makes sense to have pediatricians doing more in-depth evaluation or 
counseling. Even if you kind of trained us, our system is not set up to allow for it, and 
it’s not our expertise. I mean, there’s a reason why people go to school for many 
years. Teenagers are hard when you’re perfectly healthy, just kind of with the ups and 
downs of hormonal stuff, let alone, you know… 
 
I think if Pediatricians were aware that it would really kind of shorten their visit. For 
some of them, that won’t resonate, because they’re not asking to begin with, and so 
there’s nothing really to shorten. But I do think that the teens do need it. 
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Kaiser Primary Care Pediatrician:  
 
I think having somebody available when you think there’s a kid with a significant 
either depression or – or, you know, family issue or drug and alcohol issue, it would 
be great to have somebody around, because otherwise the chances of getting 
downstairs are iffy at best. 
 
The big thing is: I get frustrated pretty easily and, you know, there’s been a few times 
where I’ve called the number and either nobody has answered or they weren’t 
available, and we have time pressure, we have room pressures, you know, and it’s just 
hard. I’d love it if I could pick up the phone and call and say, ‘This kid’s got this 
problem. Deal with this.’ We don’t have the time to sit and wait and talk, and it’s just 
not there. 
 
FQHC Primary Care Pediatrician:  
 
There’s no possible way we could work here without it. Especially because our 
population, there is so much trauma and so much violence. I can’t think of one patient 
that I haven’t screened positive for something. It may not be current, but the amount 
of abuse and neglect and parents using drugs and physical violence and emotional and 
drugs use and sexual activity young. You know, in our ideal world, what we’re really 
wanting to get to is a one-to-one ratio of behavioral health people.  
 
It may increase our productivity. If I didn’t have the social worker and the health 
educator downstairs, there’s no possible way that I could through all my patients, 
because I would be doing it all myself. And it’s not possible. 
 
Kaiser Child & Family Psychiatry Clinician:   
 
I think that there were more referrals and more awareness from Pediatrics. And I 
think having that early intervention was really helpful, because I think in some cases 
it helped for the family to get immediately connected with somebody, and it 
facilitated the process of them being oriented to our department and to therapy in 
general. And it was kind of more of a warm hand-off, as opposed to just having a 
referral through e-consult or something like that. 
 
Kaiser Child & Family Psychiatry Clinician:   
 
You know, Kaiser has struggled about behavioral health; having someone there 
makes sense because they could grab a person right then and there, and some triage 
function, sort of very lower level kind of secondary prevention, early intervention, 
and they’re already there, but I’m sure the parent and/or kid would be thrilled, 
particularly the parent. And then if it actually need to be referred here, that works 
well. So, I’m not sure why as an organization they’ve struggled to take on that model 
because they talked about it in the past.  
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Kaiser Primary Care Pediatrician:  
Ideally having someone who's just sitting right there to say, ‘Alright, you need to 
come and meet with this teen right now’ to get them hooked into whatever they need 
so I can go off and see another patient. But – but yeah, I think that would be an ideal 
world. You'd have someone sitting right there. 
 
Kaiser Policymaker:   
 
For CD specifically, I think those individuals can be particularly useful in 
differentiating what is kind of adolescent behavior around substances versus a 
budding substance-use disorder or a full-blown substance-use disorder that requires 
intervention. I’m not sure to what degree pediatricians can make those 
determinations. 
 
Even if you don’t hand off the patient to those individuals, having that person present 
and available, either in person or by phone, is really essential, because questions will 
arise, and different physicians are going to handle those questions in different ways. 
Some will be overly conservative and say, You know what? I think you’ve got a 
chemical dependency problem. You need to go to CDRP, when maybe they don’t. Or 
you have others that actually are going to be more liberal and just not even pay 
attention to those questions. 
 
So I think having those behavioral health providers in Pediatrics or at least 
immediately available is very helpful for answering questions, but then also to serve 
as a resource to train the rest of the staff. If I go in my department as the chief of 
psychiatry to train pediatrics, I’m going to be received differently than a psychologist 
who’s working day to day with these same individuals and they’ve developed a 
relationship and a certain level of trust with that individual. And that, in my mind, is 
better for education and making things more consistent across the board.  
 
Well, I think actually most anyone would want somebody just to hand over a patient 
to when they need to, because it’s easy – it’s easier, I should say. But that isn’t 
necessarily the best for the patient. So, you know, if my kid is 14 or 15 and has been 
seeing the same pediatrician for the last 14 or 15 years, they know that person. They 
feel comfortable with that person, and they’re likely to hear that person differently 
than if their pediatrician hands them over to someone who’s completely new. 
 
And so I think the use of a psychologist in primary care has to be very, very carefully 
orchestrated with the workflows of a pediatrician but, I think, has to really exist 
embedded along with the pediatrician, not as kind of a separate, ‘I’m handing over a 
patient to you,’ but more, you know, ‘Let me consult with a colleague, and then, you 
know, I’ll let you know what I think are the next steps.’ That, to me, is more 
effective. It can be incredibly time-consuming, not to mention one of these 
psychologists is probably working with, you know, eight or 10 pediatricians and may 
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not be available. So those are some of the issues with that approach, but I think it 
works better. 
 
FQHC Medical Director:  
 
You know, I think we were more worried it was going to change the flow of clinic, 
but it hasn’t really been a big problem. I think everyone’s been happy. They’re 
finding things out that they hadn’t found out and normalizing the screening process. I 
don’t think it will ever go back the other direction. Hopefully not, because I think it’s 
made a huge difference, made clinic just more effective and less stressful. 
 
 Relative Advantage of pediatrician conducting SBIRT. Some pediatricians also 
talked about the benefits of a model of behavioral health integration in which the pediatrician 
provides behavioral health care interventions such as SBIRT.  They discussed the power of 
the rapport between physicians and their patients, the strength of the relationship they had 
established with their patients, and the unique potency that physician guidance around risk 
behaviors seems to have for patients.  
Kaiser Primary Care Pediatrician:  
To me, my patients, they’re girls and most of them have been seeing me for a few 
years. They are comfortable. That’s why they come to me. 
 
Kaiser Primary Care Pediatrician:  
There’s so much change happening for them and if I know the teen and we already 
have sort of established a relationship and they’re pretty easy to talk to, then they will 
tell you anything honestly. 
 
Kaiser Primary Care Pediatrician:  
 
A lot of teens don't want to switch, don't want to see someone – they just want to see 
me. Especially the boys. A lot of them just want to stick with me. So, I'll sit them in a 
room, walk next door, talk through everything with her, turn around, come back in the 
room, talk it all out. And if I feel comfortable with the way I've explained it, and the 
family's good with it, then, we just do it that way, almost, like, you know, ‘I'm just 
giving you an expert's opinion, with my opinion.’ Run it that way. 
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Characteristics of the Individuals Involved 
      Fewer participant responses related to individual provider characteristics as either 
barriers or facilitators of SBIRT implementation. Individual provider attitudes, self-efficacy 
and knowledge and skills with regard to screening and intervention for substance use 
problems were among the individual provider characteristics which were discussed. 
 Provider self-efficacy. Participants were mixed in their assessment of pediatrician 
self-efficacy with providing behavioral health interventions like SBIRT. While some felt 
very comfortable discussing sensitive topics and risk behaviors with patients, to the extent 
that they felt the SBIRT training had not really increased their skills in this area because they 
were already quite competent in this area, most others were less confident in either their 
behavioral healthcare skills, or their ability to change behavior, or both. 
Kaiser Primary Care Pediatrician:   
 
Because it makes me think, ‘Well, how should my practice try to change,’ right? You 
have to decide if someone comes in whose got psychosocial problems or issues or 
risky behavior, and also, has medical problems, what are you going to do? The fact 
that an obese teen has a 75 percent chance of being an obese adult, that’s not really, 
honestly, something I’m going to be able to change, which is really hard to say. So, 
then you’re, like, ‘Well, maybe I can change some behaviors.’ But it would be hard. 
 
Kaiser Primary Care Pediatrician:   
 
I appreciated the training. I understood the point of the training. But part of it was sort 
of, like, well, I feel like I'm kind of already doing this to some extent. I didn't have a 
problem talking about it with teens and trying to get their feel – their take on it. I 
didn't feel any more effective, you know. I felt like I'm doing this because I was told I 
need to do it, but I've kind of being doing this. I think I’m effective. I think it was just 
how comfortable people are with teens, talking with teens.  And I am comfortable 
with teens and I don't mind talking about these things. 
 
Kaiser Primary Care Pediatrician:  
Everybody knows that telling someone that they’re overweight and they need to make 
some healthy choices and walk in and ‘Yeah, let’s do this questionnaire and can you 
pick two goals?’ and then having a phone follow-up later. That’s not going to actually 
do anything – 
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 Provider knowledge and skills. Closely related to provider self-efficacy are their 
skills in and knowledge of behavioral health. Both clinicians and policymakers 
acknowledged that behavioral health is frequently not a strength of most generalist 
pediatricians, and several of the doctors readily admitted that they lacked skills in this area 
and were happy to have specialists trained in behavioral health interventions handle these 
issues. A community-based behavioral health clinician discussed the tendency of 
pediatricians in her organization to both over- and under-identify significant behavioral 
health risks in teens. A Kaiser policymaker agreed that many doctors are uncomfortable 
handling screening and intervention for substance use problems, but felt that physician 
training in SBIRT had the potential to provide a lot of benefit, for relatively little effort. 
Kaiser Primary Care Pediatrician:   
 
I think bringing the data to the Pediatricians also gives them some skills, but it also 
helps them – and honestly, I don’t think anyone doesn’t do it because they don’t 
believe that it’s helpful.  
But, you know, there are – a lot of these things, substance abuse, promiscuity or 
unprotected sex, and obesity, they’re just – they’re behavioral – changing behavior is 
still hard. You can talk about it ad nauseam, and I can see people being like, Yeah, 
I’ve already mentioned it 10 million times, and it’s the same issue. It’s kind of hard to 
– so having more skills. 
 
Kaiser Primary Care Pediatrician:    
 
I feel like I know when to access the BHC and I know I don’t really have the skills to 
do a lot. I can read the card about motivational stages of change, and where are you in 
the thing. My teens really like me, but I think they also really like the BHC, so I’m 
very happy to have someone who has way more skills. I mean, she’s the sub-
specialist – take that on and lead the way. 
 
Kaiser Policymaker:   
 
SBIRT, you’re talking about screening and training providers in pre-intervention, 
right? So the bar, in terms of the effect you get, is not that high, because it’s not that 
intensive to do that. And my sense is that pediatricians will readily acknowledge that 
it’s their responsibility to be looking out for those things but also readily say that 
they’re uncomfortable dealing with it. They don’t know what to say or what to do. 
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FQHC Behavioral Health Clinician:  
 
I would say the problems with behavioral health here are the lack of behavioral health 
knowledge of medical providers and nursing staff. I think that that’s like a personal 
issue for me. I feel like there’s a lot of over pathologizing. I think that hurts patients. I 
think that that hurts people when we over pathologize them. And providers will say, 
‘This patient in room 4 is like so depressed,’ and then I’ll do an assessment. And I 
don’t find any depression symptoms. I think that has to have some effect on the care.  
 
And then, probably providers also missing symptoms, if they’re not referring to me. 
So if there’s a patient that’s really suffering. I’ve done screens on people, the 
provider’s like ‘Oh, yeah. Yeah. They’re great. Just going to college.’  And she’s 
suffering from psychotic symptoms. And in the back of my mind, I think, ‘Thank 
God for behavioral health, because if I didn’t catch her...’ 
 
 Medical training. Unless they had specifically sought out adolescent medicine 
during their medical education, most pediatricians reported receiving little training on 
substance abuse, and indicated that further training was both needed and welcome.   
Kaiser Primary Care Pediatrician:   
Yeah. I think it’ll be good to have more training. Because I think when I did my 
residency, they didn’t have a whole lot of training. I think if you don’t have training 
then it kind of makes it a little uncomfortable. So having more training, definitely is a 
good thing.  
 
Kaiser Primary Care Pediatrician:   
When I was in medical school for pediatrics, I chose to do a lot more pedi stuff, like, 
at Juvenile Hall and the Violence Intervention Program and stuff, so that was one 
thing. Then I was at UCSF, and they have a pretty good adolescent medicine. So I 
feel like I got a good education there. 
 
Kaiser Policymaker:  
  
Well, you know, now a lot of residency programs are requiring some substance use 
disorder training as part of their transition for, like, primary care and even psychiatry. 
We only had one month of chemical dependency training even in my psych 
residency; now I think it’s up to, like, two or three. I think those are opportunities that 
are really important. But those are long-term fixes. 
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Implementation Process 
       A number of interview participants discussed the steps and processes involved in 
implementing new clinical activities or programs.  They described their experiences with 
how new organizational initiatives and innovative practices had been implemented in the past 
in their organizations, and in some cases explicitly suggested strategies and tactics for 
adolescent SBIRT implementation. 
 Planning. Several participants from community-based organizations described the 
planning processes that they had gone through as they attempted to implement SBIRT. They 
discussed the need to consider issues such as workflow, workforce and cultivating 
relationships with other community resources as they begin to plan out implementation.  
Others offered or reflected on creative approaches for integrating behavioral health and 
SBIRT into Pediatrics which could be incorporated into future SBIRT implementation 
planning efforts. 
FQHC Clinic Consortium Behavioral Health Integration Manager:   
 
A component of it also is the implementation and administrative kind of thinking 
about how you actually do this – so, one is a skill-level based, and then the other 
portion of it is, you know, kind of a work flow processes. And then I work with our 
behavioral health directors on what you would call implementation of it at the clinic 
level.  
 
Another layer of this that concerns SBIRT is that in the last couple months five of our 
eight health centers got a HRSA grant to do SBIRT and depression-focused initiative. 
That's the thrust of where we're at right now. People are trying to figure out, ‘How do 
you do universal depression and alcohol screening in our clinics’ 
 
FQHC Behavioral Health Clinician:   
 
I think what would make it perfect would be – If we had more clinicians, would that 
be perfect? So that there is less waiting, less wait lists, more resources in the 
community, but then I imagine them being filled up just as they are because the need 
is unmeetable. Even if we had a third, if we had two medical providers downstairs 
and we were double screening, that schedule would fill up just as fast and then they’d 
be waiting two weeks anyway because it’s a really high-need thing. If we just 
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screened everyone all the time, then we would be probably catching people that I’m 
not catching.  
 
Kaiser Primary Care Pediatrician:   
 
Well, I guess, some kind of class or an educational thing for parents about marijuana, 
for example. Would I be able to suggest it to some families without revealing that the 
kid’s using or just mention it to everybody? Something like that where the parents 
could go and really hear and teens could hear this information. 
 
Kaiser Primary Care Pediatrician:  
 
Having every teen check have a psychologist that meets with them, it would be well-
received by everyone, if it's the standard of care, which it should be. That makes more 
sense than to pick up the phone when there are issues. Even if they're the mousy one 
who doesn't do anything. They might be a ticking time bomb for something 
completely different that you don't understand – the stress of college, the stress of a 
loved one doing something, trying to help their siblings, you know.  
 
Kaiser Policymaker:  
 
Q:  So, what do you think of the idea of bringing in people from CD or from Child & 
Family Psych to have some sort of a presence, whether it’s groups or having an 
orientation in pediatrics? 
 
A: I think that would be very powerful, because not only does it reduce the stigma, but 
oftentimes it’s just more convenient for the families as well. And, you know, I think if 
you send a patient, either an adult or an adolescent, to a CD program, they’re going to 
access a fairly intensive level of treatment, and oftentimes that’s not necessary. So by 
having groups or programs in primary care, you’re kind of doing almost an extended 
evaluation to really see, okay, what is it that this teen needs in this particular 
circumstance? And if it’s done, you know, very seamlessly integrated with pediatrics, 
nobody really even notices that’s what you’re doing, actually.  
 
 Engaging. Several participants talked about their experiences engaging various 
critical stakeholders – in particular, different levels of leadership and fellow clinicians – in 
change processes.  They described important organizational goals (e.g., in the case of Kaiser, 
“value”) that must be addressed in order to support engagement in implementation, and 
suggested tactics (attempting local versus regional implementation) which could help engage 
support for implementation. 
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Kaiser Primary Care Pediatrician:   
 
So I’ve learned that Kaiser really is going to show me the value, right? If someone 
says, I believe this would help: that’s great, do a program. Show me that it works. It’s 
not even the cost. It really is show me the value, does it really work? If you say, Let’s 
go to 20-minute visits, or Let’s go to 30-minute visits, tell me why. You know? 
 
Case in point: when I was doing access, I was in a meeting with all the access people 
from all of Northern California, and there must have been about 60 people in the 
room, I think they were all pediatricians, actually. I said, How many people in the 
room feel that 15-minute well-care visits for teens are enough? And half the room 
raised their hands, and the other half didn’t. I said, How many people feel that it 
isn’t? And the other half did. So there’s obviously already not agreement.  
 
And I think that’s what it would take to kind of integrate it. And I think even on a 
local level, because trying to change something on a regional level is crazy-hard. But 
trying to do it on a local level would definitely be better. 
 
FQHC Pediatrician:   
We’re really lucky, our medical director is fully onboard with it. I think if she could 
figure out a way to finagle the budget to have it be one-to-one, she would. You know, 
but it’s just not 100 percent up to her. 
 
Kaiser Policymaker:   
 
I would say increasingly we’re trying to move towards: ‘I have a really good model 
that I think really works, and we’re trying to put this out everywhere in the region. 
Let me answer some questions for you to see if you could support implementing this 
at your local medical center.’ That’s a very different conversation than saying, Thou 
shalt implement this model, or something.  
 
 Executing. A few participants described specific, practical, logistical details involved 
in earlier and current implementation efforts, both with SBIRT and other new interventions, 
which could inform adolescent SBIRT implementation efforts in the future. 
FQHC Clinic Consortium Behavioral Health Integration Manager:   
 
The major focus of the training and the technical assistance, if you will, from the 
beginning, was the work of bringing in this behavioral clinician, getting them up to a 
proper skill-level, and working out the workflow with the primary care side. So, the 
warm handoffs come from the PCPs. Where the actual screening happens varies 
among the different clinics.  
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And quite honestly, that's something that, you know, everyone is trying to work out. 
Does the screening for anything, whether it's mental health screening, depression 
screening, anxiety screening, trauma screening – does that happen when a person first 
walks in the door? Do they get the screening form in front of them in the waiting 
room? Is it something that the medical assistant does? Is it something that the PCP 
monitors and then does a warm handoff? 
 
Kaiser Primary Care Pediatrician:   
 
For example, I'm the immunization champion. I send out outreach lists to all the 
Pediatricians of kids who are behind and what they want to do with these kids. These 
are kids under the age of two. And it's routine now. They all get the list back and they 
send it back to me and we just have a whole flow. And the same thing is now 
happening with asthma. It is part of the thing that we know we need to do that's part 
of the right care for our kids. So, I do think having a champion can help. 
 
 Evaluating. Surprisingly, only one participant, from a community-based 
organization, discussed the importance of explicitly including evaluation mechanisms in 
implementation efforts. 
FQHC Clinic Consortium Behavioral Health Integration Manager:   
 
So, in the end, there’s a really rigorous, continuous learning cycle, which goes on for 
about six months. There's a measurement piece to that.  
 
 Leadership. Organizational leaders were cited as critical to implementation success 
by a number of respondents.  Leadership support at all organizational levels – local, facility-
level and particularly executive – was seen as greatly increasing the chances that an 
implementation effort would succeed.  In some cases the implication was that leadership 
approval – of resources or simply of the concept of an intervention – was required. Leaders 
imprimaturs were also seen as likely to convince providers of the importance of adopting a 
new intervention or activity into their practice.   
Kaiser Primary Care Pediatrician:  
 
 I think it absolutely does help to have something from above. I think pediatrics is not 
really as recognized that we're here, but when you have something that comes from 
above – from the Associate Executive Director, or even the Physician-in-Chief to 
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recognize that this is what Pediatrics is doing. You know, ‘This is what they're doing. 
This needs to be recognized.’ Then, ‘Whoa!’ We all, like, open our eyes. ‘Oh, hold on 
a second. This is something we're doing that's important we should keep doing,’ you 
know. 
 
Kaiser Child & Family Psychiatry Clinician:   
 
I’d start with leadership. You target your audience. Starting with the Associate 
Executive Director, you know, maybe a captive audience to say, let us show you the 
harm this is causing. About we have opportunities to grow, we have opportunities to 
integrate, and we have opportunities to put us ahead of everybody. Because once you 
get the leadership, you know, involved, then the second thing is we do a huge 
conference, you know, to bring the experts to – to start a movement. What I find with 
Kaiser is that once you start a movement, it moves a little bit. 
 
 Training. Many of the interview participants discussed training primary care 
providers for SBIRT (and other behavioral health interventions), and described both those 
training approaches that they had found helpful in the past, and others that had been less 
effective.  Interestingly, Kaiser policymakers tended to downplay the complexity of training 
large numbers of providers in a new intervention. 
Kaiser Policymaker:  
So that’s what you can take advantage of, to say, Look, we want to teach you how to 
do it more efficiently with evidence-based questions. We understand this can be 
uncomfortable. Here’s, you know, the three best questions to ask. I mean, I think 
that’s part of the pitch to them, right? 
 
Kaiser Policymaker:   
 
If we can demonstrate a reduction in risky use, I think that almost is enough of an 
argument, because it’s easy enough to say, Okay, we’re teaching them about safe 
patterns of use versus unsafe patterns of use, which, down the road, as they become 
adults – because they haven’t had a chance to develop the health effects of using too 
much doesn’t mean that we shouldn’t try to intervene as early as possible.  
 
I think the other thing you say is that you’re already screening for these things. If we 
can show you a very quick intervention around these things, you know, we save you 
the anxiety of screening and not having anything to do, you know. 
 
I think also just the organization sponsoring these kinds of educational programs and 
discussions is really powerful. If I’m in a medical center and my PIC says, I want all 
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the pediatricians to go to this one-hour grand round on screening for substance use 
disorders, that’s extremely powerful, because the PIC is saying, This is important to 
me, and I think you all need to go, and, in fact, I’m going to require you to go, or 
something like that. 
 
Kaiser Child & Family Psychiatry Clinician:  
 
We should do Grand Rounds every year of how marijuana, alcohol, caffeine, how all 
of that affects the brain and what’s out there, what are kids doing. 
 
I think once a physician or PCP understands the impact, negative impact – some 
permanent impact – on the brain that these children, I think that they would be much 
more serious about it, you know? Like what we did with smoking. This is much 
worse than smoking. 
 
FQHC Clinic Consortium Behavioral Health Integration Manager:   
 
As part of the initiative, there's an arm of it that is training and technical assistance. 
We've made a purposeful training agenda to bring up the skill level of our behavioral 
health clinicians on different advanced base practices, SBIRT being one of them. 
Over the last three years or so, we've done a variety of different types of trainings 
with – we have expert trainers who are external to our organization.  
 
There were five specific evidence-based practice models that were chosen at the very 
beginning. And the focus was, "Let's do evidence-based training on depression, on 
anxiety, on sleep disorders, on trauma" – and what was our other area?  
 
We did five trainings focused on those areas, and that was our original training 
agenda two-and-a-half years ago. That was the original collaboration partnership with 
UCLA and Humphrey. All of the trainers were chosen for, you know, their expertise 
on delivering an evidence-based, therapeutic model.  
 
We do this over an eight to ten week period for eight to ten sessions, I should say, not 
weeks. And then, every session, you check in about where the person’s at and then 
develop essentially. We try not to do a one-off training, so it's not just one day, you 
get all your skills, and you're an expert, right? There's an understanding that you have 
to practice these skills. You have to go back and work with the client and see what 
went well, what didn't go well, where you still having challenges, where you're 
getting stuck. So then they come back for further training. They have what we call a 
follow-up training period –  
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Kaiser Primary Care Pediatrician:   
 
I think having things sent to us through emails is always good because you can refer 
back to it, but also, in person at the department meetings is the best thing. Joint 
meetings between behavioral medicine providers and pediatric providers have been 
really great. But I think everybody is very pressed for time, so that’s difficult, too. 
We get so many emails, like, ‘Oh, how can I change it?  Big, huge upgrade. Watch all 
these videos and figure out how to do it.’ Everybody knows that coaching for some 
works and learning together works and reinforcing learning works, but there’s not 
that much opportunity for any innovative things. That’s what’s kind of hard. 
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CHAPTER 8: DISCUSSION  
This is the first study, to my knowledge, to explore the barriers and facilitators to 
implementing pediatric primary care-based SBIRT for adolescents. It fills a gap in the 
literature by examining the perspectives of pediatric primary care providers, specialty mental 
health and chemical dependency clinicians, pediatrics staff, and policymakers on SBIRT 
implementation in pediatric primary care, in the context of a healthcare system in which 
different models of adolescent SBIRT delivery were recently tested.  It also includes 
interviews with key informants outside of the KPNC system, in order to provide perspective 
on which factors are unique to a large, integrated healthcare delivery system, and which 
factors are also found in publicly funded systems.  While several studies have examined such 
factors as they effect the implementation of SBIRT for adults,
236-238
 fewer have examined 
them in relation to adolescent SBIRT.
239
. While many of the same things found to impact 
SBIRT implementation in previous studies conducted in adult settings were reflected in the 
responses of participants in this study, some issues unique to the pediatric population and the 
health system also emerged. Below I discuss some of the more salient barriers and facilitators 
to SBIRT implementation discussed by participants – some more easily remediable than 
others – and suggest possible approaches which are included in the Plan for Change which 
follows. Because many of the barriers and potential facilitators identified through the 
interviews were similar across settings, while the focus of the Plan for Change is SBIRT 
implementation within Kaiser Permanente Northern California, many of its features are 
applicable to systems outside of Kaiser. 
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Outer Setting 
Patient and family needs. Patient and family needs, particularly linguistic needs, and 
the high prevalence of co-occurring substance use and mental health symptoms, were 
mentioned by a number of participants.  Many noted the high co-occurrence of mental health 
symptoms and substance use among their adolescent patients, and how this co-occurrence 
can exacerbate each condition and complicate intervention approaches. Given the constraints 
of limited appointment times and competing priorities, pediatricians may be forced to focus 
on one type of symptom or another (but not both) during the course of a typical well-visit. 
This is supported the finding from the parent RCT that patients in the pediatrician-only arm 
were less likely than patients in the embedded BHC arm to receive brief interventions for 
both substance use and mental health symptoms, even when both kinds of symptoms were 
endorsed.
152
  The co-occurrence of mental health problems and substance use could also 
provide pediatricians an entrée to conversations about the possibility of behavioral health 
treatment with patients and families, who may be more amenable to going to the somewhat 
less stigmatized setting of mental health treatment than that of substance abuse treatment.  
Mental health clinicians I interviewed made clear, however, that in spite of the presence of 
“No Wrong Door” policies in place, and region-wide efforts to ensure that both Psychiatry 
and Chemical Dependency programs across the organization are “Dual Diagnosis Capable,” 
i.e., having the skills, personnel, resources and capacity to assess and treat co-occurring 
mental health and substance use disorders,
240-242
  Kaiser’s Child & Family Psychiatry 
department does not typically see patients with frank substance use problems for long, and 
will refer them on to Chemical Dependency treatment as soon as possible. For this reason, 
and because many less-severe patients are unlikely to initiate treatment in either Psychiatry 
or Chemical Dependency, an embedded BHC, trained in the identification and treatment of 
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mild-to-moderate substance use and mental health problems and working as part of an 
interdisciplinary pediatric primary care team, offers an appealing and potentially cost-
effective approach to adolescent behavioral health and may reach far more patients than the 
system as it is currently organized. 
Reflective of California’s demographic profile, Kaiser Permanente has a very diverse 
member population, and it is working hard to increase the linguistic capacity of its behavioral 
health programs in order to meet the needs of its members, through the use of mechanisms 
such as its interpreter services. However, given the very high prevalence of a few core 
languages in certain facilities, efforts should be accelerated to recruit behavioral health 
clinicians who are also fluent speakers of the most prevalent languages (e.g., Spanish, 
Mandarin and Cantonese, and Tagalog) and train them in integrated pediatric behavioral 
health.  
Efforts to increase language capacity among pediatric primary care staff are farther 
along, and many families in which parents speak limited English are empaneled with 
pediatricians who speak their language. Given the recognition of the importance of culturally 
and linguistically appropriate behavioral health services (e.g., linguistically appropriate 
behavioral health care is a cornerstone of the recent “Excellence in Mental Health Act” of 
2014
243
), it would seem incumbent upon health systems like Kaiser Permanente to target bi-
lingual pediatricians in particular for training in behavioral health screening, assessment and 
brief intervention techniques such as SBIRT 
Confidentiality. The issue of confidentiality plays a unique role in the delivery of 
SBIRT in pediatric primary care.  The guarantee of confidentiality is one of the bedrocks 
upon which adolescent medicine rest, and which increases access to care to vulnerable 
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populations
244,245
 and makes possible precisely the kind of conversations between 
pediatricians and patients during which the disclosure of risky behaviors, including substance 
use, is more likely to occur.
246
 At the same time, it frequently acts as a barrier to effective 
substance use prevention and intervention, at least in the minds of many pediatricians. The 
pediatricians I spoke to interpret the limits of the California adolescent confidentiality law 
differently, and navigate those limits and their role accordingly.  These different 
interpretations of the law and confusion about clinical implications contribute to a 
widespread skittishness among many (though not all) generalist pediatricians about 
addressing risky substance use in primary care, which we hear reflected in many of the 
participants’ thoughts on the different approaches to SBIRT and the referral process. 
 The providers’ confusion over the limits of adolescent health services confidentiality 
is well-founded.  The law and policies are nothing if not confusing, and involve a number of 
(sometimes contradictory) intersecting federal and state laws and regulations, including 
privacy regulations under the Health Insurance Portability and Accountability Act of 1996 
(HIPAA). Under HIPAA, the protected health information and privacy of adolescent patients 
is generally protected if they are acting as individuals and if parents have “assented to an 
agreement of confidentiality between the health care provider and the minor, which occurs 
most often when an adolescent is seen by a physician who knows the family.” In such a case, 
“the parent is not the personal representative of the minor and does not automatically have 
the right of access to health information specific to the situation, unless the minor requests 
that the parent act as the personal representative and have access.”247  Under California state 
law, adolescents aged 12 or older can receive care for a number of “sensitive” services (birth 
control, pregnancy prevention, diagnosis and treatment, abortion, STI and other contagious 
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and reportable disease diagnosis and treatment, HIV testing, sexual assault care, alcohol and 
drug counseling by federally assisted treatment programs, alcohol and drug counseling by 
non-federally assisted treatment programs, and outpatient mental health treatment) without 
parental consent. State regulations enacted to implement a  recent state law specifying that 
children 12 and older can consent to mental health and substance abuse treatment without 
parental consent specify the following, seemingly contradictory statements:    
Parent Access/Confidentiality Obligation 
If the minor consents or could have consented to care, the 
provider only may share the minor’s medical information with 
parents or guardian with the signed authorization of the minor. 
Cal. Health & Saf. Code §§ 123110(a), 123115(a); Cal. Civ. Code 
§ 56.10(b)(7), 56.11(c); 45 C.F.R 164.502(g)(3); 45 C.F.R. 
164.508(a).
248
 
 
and 
 
Discretion to Inform Parents without Minor’s Authorization 
The health care provider is required to involve a parent or 
guardian in the minor’s outpatient treatment unless the health care 
provider decides that such involvement is inappropriate. This 
decision and any attempts to contact parents must be documented 
in the minor’s record. When services are being provided under 
Health and Safety Code § 124260, providers must consult with the 
minor before making the determination concerning parental 
involvement. Involving parents in treatment will necessitate 
sharing certain confidential information; however, having them 
participate does not mean parents have a right to access 
confidential records. Providers should attempt to honor the 
minor’s right to confidentiality to the extent possible while still 
involving parents in treatment. Cal. Fam. Code § 6924; 45 C.F.R. 
164.502(g)(3)(ii); Health & Saf. Code § 124260(c).
248
 
 
 In general, the providers I spoke with tended to embrace a more conservative 
interpretation of confidentiality guidelines, although there was clearly variation among them.  
In order to gain more perspective on this issue, I spoke with  experts in the field of 
confidential adolescent health: Dr. Charles Wibbelsman,
249
 recently retired pediatrician with 
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the Permanente Medical Group, former Chair of the KPNC Adolescent Medicine Specialists 
Committee, Professor of Pediatrics at UCSF, and past president of the California chapter of 
the AAP, and Dr. Sharon Levy,
250
 Director of the Adolescent Substance Abuse Program at 
Boston Children’s Hospital, Assistant Professor of Pediatrics at Harvard Medical School, and 
Chair of the AAP Committee on Substance Abuse. Both acknowledged the critical 
importance of confidentiality, and agreed that it should not be broken except in cases of acute 
safety concerns, but both felt strongly that this potential barrier is one that can be addressed 
using clinical skills and tools (e.g., scripts, educational materials, etc.) that can be easily 
learned and developed.  
Dr. Wibbelsman emphasized the importance of leveraging the strong pediatrician-
patient relationship to convince patients to reduce or stop their use and lower risk, include 
their parents in the conversation about their substance use, or if they would not agree to 
include their parents, to agree to an initial assessment conversation with an adolescent 
specialist at the chemical dependency treatment program.
249
 Dr. Levy feels that often far too 
much is made of confidentiality and that it is used as an excuse for not addressing substance 
use with adolescent patients, and that the reticence with which this critical health issue is 
approached by many pediatricians is indicative of the stigma still surrounding substance use. 
For example, while it is widely accepted that experimentation with substances is a 
developmentally-appropriate, if undesirable, phase of adolescence, acknowledgement and 
frank discussions of substance use, among parents, providers and teens is still a very 
sensitive, if not outright taboo, topic, and rarely occur.  In many cases however, particularly 
with regular use, parents are already more aware of their children’s use than many teens 
realize (though not always, and often not of the full extent of use or related consequences), 
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and pediatricians can very often guide patients toward discussing their use with their parents, 
particularly if that conversation also includes a discussion of strategies or interventions to 
reduce use and health and other risks and consequences. Dr. Levy stated that she usually 
broaches the possibility of this kind of conversation with questions like: “What would your 
mom say if we talked to her about your weed smoking and talked about ways to help you cut 
back?” and that often teens come to understand how relieved their parents are likely to be to 
be able to discuss something that has been causing anxiety and tension in their relationship 
with their child, and agree to engage in the conversation.  
In cases where use is less serious and parents are not yet aware, or if patients refuse to 
disclose to their parents (the types of situations frequently raised in the participant 
interviews), the brief interventions used in SBIRT, delivered by the pediatrician or an 
embedded behavioral health clinician, are appropriate and precisely the circumstances for 
which SBIRT was developed.   
Such fears may be unfounded. Dr. Levy reported that in her experience, parents are so 
used to multidisciplinary teams being used in clinics that only once in 16 years of working in 
an adolescent health clinic has she come across a parent who questioned or resisted having 
their child speak to a behavioral health clinician. This is consistent with our experience in the 
parent RCT; during the entire two years of the trial, we did not encounter any parent 
complaints or hesitancy about having their teen speak with a behavioral health clinicians; in 
most cases parents were enthusiastic about having such a service available to their child.  Dr. 
Levy’s matter-of-fact “script” for this scenario: “As part of the well-check today we’re also 
going to be talking about behavioral health with a specialist here” is echoed by one of the key 
informant pediatricians who was also very comfortable navigating this conversation and 
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normalizing the use of a behavioral specialist: “So, I’m going to do a physical on you today. 
I’m really fortunate at this time. I’ve partnered up with Dr. XYZ, who does the mental health 
kind of check-in with teenagers.” This approach of normalizing a behavioral health 
assessment as a standard part of the adolescent well visit is a key component of the Plan for 
Change below. 
Growing awareness of the role of behavioral health and stigma.  The interviews 
reflected the striking cultural and clinical ambivalence about behavioral health in general, 
and substance abuse and treatment in particular.  There is clearly both a growing recognition 
of the significant role that behavioral health plays in health and well-being, and an 
accompanying, gradual acceptance of behavioral health treatment, and the persistence of 
considerable stigma, among patients, their families and providers. Many participants readily 
acknowledged the very high prevalence of behavioral health problems among their patients, 
the complex relationship between those problems and physical health , and that these 
concerns are particularly salient for adolescents. Yet it was clear that, particularly in the 
Kaiser system, physical health and other preventive activities tend to trump behavioral health 
screening and intervention. This prioritization is manifested in myriad ways: the 
unsystematic assessment of substance use risk that we found in the parent RCT, and the fact 
that pediatricians reported that they generally do not follow-up with families or behavioral 
health colleagues on the results of referrals to behavioral health when they most certainly 
would do so in the case of another specialty (e.g., dermatology, orthopedics, radiology). 
Participants were very clear that stigma continues to affect the identification of 
problems, by making patients or their families hesitant to disclose concerns to pediatricians 
and other providers, and that it inhibits families’ willingness to initiate and engage in 
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specialty treatment, particularly specialty substance abuse treatment. However,  providers in 
both settings reported that patient and family reluctance could be broken down by being 
introduced to an embedded BHC by a trusted primary care provider. Providing a spectrum of 
behavioral health offerings – from pediatricians trained in early identification and brief 
intervention, to behavioral specialists, to classes and support groups – in pediatric primary 
care could go far toward lessening the barrier of stigma and increasing access to care. 
Marijuana policy.  While policy advocacy is not the focus of the Plan for Change 
below, the issue of marijuana policy, and its impact on the health and well-being of 
adolescents, and pediatric primary care practices with regard to marijuana use, bear 
mentioning. This is of growing concern as California seems to be moving toward full 
legalization of cannabis in the next few years. The San Francisco Bay Area is already awash 
in marijuana, and participants in both settings reported that many patients view marijuana as 
“natural” and its use as benign, and that many parents share this view. This view is consistent 
with the continuing decline found among U.S. adolescents in their perception of the 
harmfulness of marijuana use in recent Monitoring the Future surveys.
19
 For many adults, 
marijuana probably is less harmful than many other substances, certainly than alcohol, but 
this is not the case for adolescents, and the public’s (including teens’, parents’ and many 
providers’) misunderstanding of the risks of adolescent marijuana use continues to 
complicate clinical identification and intervention efforts. However, there does seem to be a 
growing awareness among providers, spurred on by recent scientific discoveries, of the 
deleterious and potentially irreversible effects of marijuana on the adolescent brain, offering 
an opportunity to motivate pediatricians and other clinicians to step up prevention and early 
intervention efforts such as SBIRT. California clinicians, health systems and policymakers 
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also need to carefully study the experiences of other states and territories which have already 
legalized marijuana (Colorado, Washington, Oregon, Alaska, the District of Columbia) in 
terms of youth use and health problems, and plan clinical and system responses accordingly 
Inner Setting 
Time and competing priorities. Factors intrinsic to the Inner Setting, i.e., system 
and clinic level factors, were the most commonly mentioned, and as in many studies of adult 
settings,
238,251
 time pressures and competing priorities, endemic in modern primary care 
settings, were identified by many as the biggest obstacles to SBIRT implementation.  The 
impact of time pressure on primary care pediatricians cannot be overstated: most of the 
pediatricians I spoke with talked about being inundated by what they needed to accomplish 
within the very limited visit length (15 minutes), and several were frankly overwhelmed. 
They recited the litany of tasks they were required to complete, many tied to published 
guidelines and performance measures, and some which they felt had little value. Providers 
are forced to prioritize the activities they perform, and frequently, because of the perception 
of behavioral health as less crucial than other health problems discussed above or, because 
patients may not immediately endorse behavioral health problems, they are overlooked or 
short-changed. It is beyond the scope of this Plan for Change to advocate for an increase in 
visit length for adolescent well visits in Kaiser, but it is certainly something worth 
considering. Short of that, using other clinicians and staff, in a team approach to care, may 
offer a way to effectively “stretch” doctors’ schedules while not reducing the number of 
patients who can be seen during the course of a day. While certainly subject to the same time 
pressures and demands of Kaiser providers, those in the FQHCs seemed to have more time 
flexibility than in Kaiser, providing perhaps more opportunity for implementing one or both 
models of SBIRT. 
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Screening and assessment instruments and the electronic health record. Most of 
the clinicians, across settings and departments/disciplines, reported little if any use of 
standardized instruments for assessing substance use problems.  They often relied on home-
grown tools and questions they have come to feel comfortable with, or instruments developed 
for adult and inappropriate for use with teens, which they learned in medical school (e.g., the 
CAGE).  In some cases these were combined with tools their clinic had in place, usually 
embedded in larger screening instruments. While a few pediatricians who had become 
familiar with the CRAFFT tool through the training they received in the parent RCT 
discussed its ease of use, most clinicians did not use brief evidence-based tools, even when 
they were easily available to them in the EHR, along with clinical tools such as the ability to 
track patients’ substance use over time. It is well established that clinical impressions of 
substance use are frequently inaccurate, and that structured, evidence-based screening 
instruments offer a quick, easy and far more accurate way to identify adolescent substance 
use problems.
252
 Any attempt to implement more effective substance use prevention and 
early intervention must focus on training providers on the value, effectiveness and use of 
evidence-based, EHR-embedded screening and assessment instruments and clinical decision-
support tools, such as brief intervention and referral algorithms and scripts.  
Workflow and warm handoff. The effects on clinic workflow of the adoption of 
either model of SBIRT – either physicians taking on the components and increasing the time 
spent with patients, or introducing the introduction of a behavioral health clinician into the 
clinic – should not be underestimated.  With the embedded behavioral health clinician model, 
while studies suggest that having the specialist come directly into the exam room is ideal, this 
also has implications for space and clinic flow. While the “warm hand-off” was praised for 
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its effectiveness in engaging patients, and generally described as working well, some 
participants had valid concerns about logistics, and even the most enthusiastic participants 
reported some hiccups, mostly related to exam room availability and how to handle the hand-
off when the behavioral health clinician was busy with another patient. Thus implementation 
of either model must carefully consider potential logistical obstacles, and do everything 
possible to operationalize SBIRT in the least disruptive, most seamless way. 
Workforce.  Workforce considerations inform most of the discussions about barriers 
and facilitators of either modality of SBIRT.  Adopting the embedded BHC model 
necessarily involves the use of an interdisciplinary primary care team, whether formally or 
informally, and raises questions of who the “Behavioral Health Clinician” is and what 
training and credentials they must have: Must they be a licensed behavioral clinician, such as 
a Clinical Psychologist, Licensed Clinical Social Worker or Marriage and Family Therapist?  
Could they be a nurse? Could they be a Clinical Health Educator, who is not be trained in 
psychotherapy, but may be quite well-trained in the motivational interviewing and 
enhancement techniques central to SBIRT?  What about para-professionals, who are 
increasingly being used to great effect in many primary care and community health settings? 
Medical Assistants, who in many cases speak the home language of many patients and 
families, could be a possibility for performing some or all of the components of SBIRT; 
Medical Assistants trained to work at the top of their scope of work are engaged in similar 
activities in innovative pilot programs such as the “Ambulatory ICU” at Stanford University 
Hospital, where they are conducting assessments of patients’ social determinants of health 
and providing case management services in order to address the high utilization and costs of 
“super utilizers.” 253 However, such alternative workforce approaches, which could prove 
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more effective and efficient than current models, must be considered very delicately in the 
context of a very sensitive labor-management environment in Kaiser in which roles, and 
professional and bargaining unit scopes of work, have been painstakingly hammered out and 
are carefully guarded. Non-Kaiser policymakers I spoke with seemed open to considering 
different types of professionals, and were already experimenting with creative combinations 
of licensed and non-licensed personnel, to deliver various aspects of SBIRT. Acceptance of 
different types of professionals and para-professionals is thus likely to differ across other 
settings, where professional roles vary based on cultural and organizational norms and state 
laws. 
Networks, linkages and communications between departments and 
organizations. Sub-optimal linkages, both inter- and extra-organizationally, between 
pediatric primary care and the other disciplines and departments and organizations which 
also impact adolescent behavioral health clearly act as powerful barriers in both settings 
studied. The lack of well-organized systems of communication and well-established 
functional relationships was quite striking, particularly within Kaiser, an ostensibly 
“integrated” system. There were few regular, formalized communication channels that 
actually worked well between Pediatrics and specialty behavioral health, either Child & 
Family Psychiatry or especially Chemical Dependency treatment.  For example, chemical 
dependency providers rarely looped back to a patient’s pediatrician to discuss treatment 
progress, in spite of having the tools – information release forms – available to allow that 
conversation.  Similarly, pediatricians reported that they rarely followed up on their referrals 
to treatment (although most believed that they could not obtain any information because of 
the privacy firewalls in place around substance abuse treatment). There were few 
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opportunities for interdisciplinary meetings, in-services or training, and most providers 
seemed resigned to this weak linkage as simply status quo. Much of the engagement between 
departments that did occur seemed to depend on the individual interest, motivation or 
dynamism of individual clinicians and relationships.  Across the disciplines/departments, 
providers did not really understand the procedures or services of the other settings, and 
seemed to make little effort to learn about them.  Even between the specialty behavioral 
health departments – Child & Family Psychiatry and Chemical Dependency –  there were 
significant gaps in knowledge about services offered and treatment/program philosophies.  
Many pediatricians had very little idea of what occurs in either department, or what happens 
to the patients they refer for services. Few participants talked of trying to bridge these gaps or 
strengthen linkages.  
Similar gaps were reported by the community-based providers, and were often 
exacerbated by the lack of capacity in the community behavioral health system, whether it 
was linguistic or dual diagnosis or simply availability.  
Solutions for these weak linkages seem relatively straightforward, and many are 
proposed in the Plan for Change: convening regular inter-departmental (or inter-
organizational, in the case of an implementation plan in a public setting) meetings where 
programs, services, procedures and emerging issues are discussed; creating opportunities for 
interdisciplinary trainings on topics of mutual interest (e.g., SBIRT); and creating clear 
information flow mechanisms between departments and removing obstacles to 
communication, such as establishing a default protocol whereby all patients (except those 
who refuse outright, of which there are very few) sign releases of information at chemical 
dependency treatment intake and their therapist automatically communicates relevant 
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treatment outcome information back to each patient’s pediatrician. Counteracting the deeper 
divisions and entrenched attitudes which have led to these weak linkages will require not 
only the pragmatic steps above, and ongoing troubleshooting and technical assistance, but 
also a careful and continuous nurturing of the relationships between departments.  The Plan 
for Change calls for the use of an “Implementation Facilitator” for both of these types of 
activities. It goes without saying that healthcare is an intrinsically personnel-driven industry, 
the result, largely, of transactions between humans – clinicians, staff and patients and their 
families – and relationships are critical to its smooth functioning.  Nevertheless, the strong 
linkages required for effective care coordination should not have to rely on personal 
relationships between clinicians in different departments or organizations, or the enthusiasm 
of individual clinicians alone, particularly not in a highly systematic and theoretically 
integrated healthcare system like Kaiser. It is also especially incumbent upon specialty 
behavioral health departments/programs, particularly chemical dependency to take initiative 
and proactively reach out to pediatric primary care, to make them aware of the substance 
abuse treatment program offerings and procedures. 
 Leadership Engagement. Many participants discussed the important role of 
leadership in the adoption and implementation of new interventions, and it was clear that 
leadership creates environments that are conducive to innovation, or not, in large and small 
ways. Leadership activities which enable implementation include non-material elements such 
as endorsement of projects consistent with organizational vision, which can, in turn, 
influence others’ reception of said initiative, as well as approving the use of tangible 
resources, such as funding, space and staff; as Aarons says about aligning leadership to make 
institutions conducive to implementation, in both “word and deed.”254 A pediatrician in an 
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FQHC made it clear that her clinic’s administrator was a supporter of the embedded-BHC 
model, and  advocated for the staffing and resources necessary to support it. It was clear that 
in a large, highly rationalized and systematic organization like Kaiser, the imprimatur of 
different levels of leaders – both executive level and local Physicians-in-Chief – is crucial for 
mustering resources and approvals, and catches the attention of clinicians.  
Characteristics of the Individuals Involved 
Provider knowledge, skills and self-efficacy.  Providers’ ability to either conduct 
SBIRT themselves, or to screen patients sufficiently to identify those in need of further 
assessment and effectively conduct a handoff to a behavioral specialist, relies on their 
knowledge, skills and confidence.  Many participants felt that they lacked knowledge, skill 
and self-efficacy, and physicians reported only minimal behavioral health content during 
their medical training.  Both approaches to SBIRT delivery will entail developing a deeper 
understanding of adolescent behavioral health risks, and acquiring concrete practical skills, 
such as motivational interviewing techniques and fluency with scripts for dealing with a 
variety of circumstances. This will require a multi-pronged process of training and 
dissemination, as well as a “marketing” campaign to address the stigma and attitudes that 
underlie pediatrician reticence to deal with substance use and other behavioral health 
concerns – a “hearts and minds” campaign to normalize SBIRT as an integral part of 
adolescent healthcare within Kaiser Permanente.  While this is a tall order, it is achievable.  
While many pediatricians currently lack the knowledge and self-efficacy to provide their 
patients top-quality, integrated behavioral healthcare,  as more than one participant said: 
“everybody here wants to do the right thing,” and given the chance and sufficient support, 
most are interested in acquiring new competencies. Provider training, role-play and technical 
assistance and support are thus key components of the Plan for Change.  
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Characteristics of the Intervention 
Evidence strength and quality. Several participants indicated that evidence of the 
effectiveness of any intervention was important in determining implementability.  Evidence 
provided something to “hang your hat on” or support your decision to adopt a certain 
practice, but pointed out  that many common practices, including many prescribed by 
performance measures or clinical guidelines, were not evidence-based or connected to health 
outcomes.  Several also noted that evidence alone, regardless of strength, was typically not 
enough to insure implementation, and that a variety of other factors – executive 
championship, support from local leaders, effective marketing, and “value”  - were also 
necessary..  
The evidence on the effectiveness of SBIRT for teens is small – especially when 
delivered in pediatric primary care – but growing.4,5,67-69,71,81  There is also mounting 
evidence of the effectiveness of integrated behavioral health approaches in general for 
improving child and adolescent health.
255
 As the evidence for SBIRT’s effectiveness, and 
potentially its cost-effectiveness, accumulates, it should contribute to Kaiser’s willingness to 
adopt SBIRT.  Other evidence which may help to support SBIRT implementation is the 
growing literature on adolescent brain development and the effects of substance use, which 
seems to be particularly compelling to pediatricians. The implementation findings from the 
parent RCT already seem to have caught the attention of pediatricians in Kaiser, and several 
have contacted me to discuss how to implement elements of one or both models of SBIRT in 
their clinics, and as patient outcome findings emerge, SBIRT may gain even more 
momentum.   
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Cost. Several participants mentioned the importance of cost data in influencing the 
adoption of innovations. Cost studies are sorely needed, not only to demonstrate the cost-
effectiveness of each model, but also to examine potential cost offsets.  However, the kind of 
cost savings which have been so important in establishing the value of adult alcohol SBIRT 
in reducing the prevalence of expensive chronic health conditions and thus utilization and 
costs,
256,257
 are more difficult to demonstrate in adolescents, who typically have yet to 
develop such costly substance use-related health conditions (except for accidents).  
Moreover, health systems have not, historically, had much of a financial interest in 
preventing problems that take many years to develop, because adolescents often left health 
plans once they turned 18, unless they remained covered by their parents’ insurance while in 
college. Under the ACA however, adolescents are more likely to stay insured at least until 
age 26 through the Medicaid expansion and the health insurance exchanges, making their 
ongoing health and well-being of greater interest to health systems.   
Perhaps even more crucial are studies which examine the costs of integrated 
behavioral health models using embedded behavioral health clinicians, in terms of the net 
productivity and efficiency of primary care providers.  
Relative advantage of PCP model. As discussed earlier, a physician-delivered 
model of SBIRT has a number of strengths and offers an appealing approach to SBIRT.  It 
draws upon the unique power of the physician-patient relationship, and studies suggest that 
guidance from physicians regarding substance use can be very effective.
67,258,259
  There are a 
number of practical logistical considerations which also make this model appealing. 
Depending on the pediatrician’s level of comfort with a hand-off to another clinician, or 
clinic space constraints, simply delivering a brief intervention themselves may offer a more 
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streamlined workflow. Pediatrician-delivered SBIRT also addresses some of the participants’ 
concerns about confidentiality: if patients are unwilling to disclose their substance use to 
their parents and are unwilling to consider treatment initiation, a brief intervention delivered 
in the privacy of the exam room may offer the best (and only) treatment option available. 
Resources also play a key role in determining the model of SBIRT which will be possible, as 
many Pediatrics clinics currently do not have embedded behavioral health clinicians, and 
thus, this model may be the only option for many at this time. 
A big question, however,  is whether pediatrician-delivered SBIRT can realistically 
be implemented. Although the past few years have seen efforts to incorporate more substance 
abuse screening, assessment and treatment content into medical training programs, most 
pediatricians still do not receive much training in this area. Even relatively brief physician 
training can certainly improve SBIRT implementation rates, as we were able to demonstrate 
in the parent RCT; patients of pediatricians in the pediatrician-only arm were 10 times more 
likely to receive a brief intervention than patients from the usual care arm.
152
  A number of 
recent evaluations of attempts to incorporate SBIRT training into pediatric residency 
curricula suggest that various methods, including in-person and on-line training can improve 
physician knowledge, skills and self-efficacy, as well as self-report SBIRT delivery.
260-264
  
Moreover, there are emerging, evidence-based, computerized clinician SBIRT training and 
skills assessment applications which show great promise for training clinicians, and which 
could be particularly helpful for skills maintenance or “boosters.” 
(https://resources.kognito.com/sbirt/SBI_with_Adolescents_Overview.pdf) 
But can high-quality, physician-delivered SBIRT be implemented, effectively, in the 
time Kaiser that pediatricians are allotted for adolescent well visits? It is unclear whether 
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they can realistically incorporate and sustain SBIRT delivery into their tightly scheduled 
workflows as they are currently organized.  Pediatrics may be able to learn from experiments 
in Adult Medicine. Informed by research conducted by our research group,
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 alcohol SBIRT 
was implemented in Adult Medicine in KPNC in June of 2013, and since that time, over 4 
million alcohol screenings have been conducted, and over 218,000 brief interventions. The 
success of that large-scale SBIRT implementation effort within Kaiser, and that of the 
Veteran’s Administration,162 suggest that large-scale implementation is possible, but will 
require a carefully designed implementation strategy and significant leadership support, and 
will need to take into account the factors unique to the pediatric setting, such as 
confidentiality, in order to succeed. It may be that adopting pediatrician-delivered SBIRT 
could be an interim step on the way to a more fully fleshed-out integrated behavioral health 
model. 
Relative advantage of embedded BHC model. Based on participant responses, the 
concept of having an embedded behavioral health specialist available to help teens with 
substance use and other behavioral health problems is very appealing, to pediatricians and 
behavioral health providers alike. A number of Kaiser pediatricians thought that this was the 
best approach to SBIRT, because it would free up their time to provide the medical care they 
are trained to do by handing off potentially lengthy patient conversations to clinicians who 
are specially trained to deal with behavioral health. Doctors who had been in the embedded-
BHC arm of the trial praised the model for how well it had worked in their practice and how 
well it had been received by patients and parents alike.  Physicians in FQHCs that had 
adopted the model lauded its value, with one pediatrician saying that working in concert with 
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the BHC made it possible for her to do her job: “There’s no possible way we could work here 
without it.” 
Many would argue that an interdisciplinary model of integrated behavioral health 
which includes primary care-based, BHC-delivered SBIRT is simply better quality care.  
Team-based care seems especially appropriate for Pediatrics, which is intrinsically 
preventive.  Integrated behavioral health models using embedded behavioral health clinicians 
harken back to origins of Patient-Centered Medical Home model in Pediatrics, and have been 
called for in the “Joint Principles for Integrating Behavioral Health Care into the Patient-
Centered Medical Home” recently developed and endorsed by the American Academy of 
Family Physicians, the American Academy of Family Physicians Foundation, the American 
Board of Family Medicine, the Association of Departments of Family Medicine, the 
Association of Family Medicine Residency Directors, the North American Primary Care 
Research Group, the Society of Teachers of Family Medicine, the American Academy of 
Pediatrics, the American Osteopathic Association, the Collaborative Family Healthcare 
Association, the American Psychological Association, and the National Association of Social 
Workers
265-271:  “Physical integration of a behavioral health professional into the PCMH is a 
particularly attractive strategy for improving both access and coordination, making possible 
warm handoffs at the moment patients or families are ready. This reduces stigma, improves 
adherence, and augments access to support groups, parenting programs, and other 
neighborhood services.”266  
Whether Kaiser leaders are willing to support an embedded-BHC model of SBIRT is 
unclear. Support involves considerable faith that the up-front investment of resources such as  
space and behavioral clinician salaries will prove cost-effective. More than ever, healthcare 
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systems base decisions about adopting practices on their estimates effect on the bottom line.  
Innovations with limited evidence of cost benefit, particularly if not seen as responding to 
“life and death” problems, may not be supported by leadership. Kaiser has attempted (and 
effectively abandoned) embedded BHC models of care in the past, albeit not in Pediatrics. 
The Kaiser behavioral health policymakers interviewed for this study were notably lukewarm 
about embracing such a system, even as they acknowledged its potential for improving 
access and quality of care. The embedded-BHC model may find more support among 
Pediatrics leaders, particularly if it can be demonstrated that it can improve physician 
efficiency and clinic workflow. A centerpiece of the Plan for Change is generating both 
executive and local leadership support for SBIRT implementation within Kaiser. The FQHC 
and other public setting participants seemed more enthusiastic about implementing 
embedded-BHC approaches, and all were either beginning the implementation process or had 
already adopted some version of the embedded model.  None of the public-sector participants 
I spoke to had attempted to implement a model which relied on physicians delivering all 
aspects of SBIRT. 
Implementation Process 
      The Plan for Change takes into account the responses from participants to questions 
about how new innovations are disseminated and adopted in their organizations, and what 
implementation practices they have observed which were successful, and which were less so. 
Kaiser policymakers downplayed the complexity of a large-scale implementation of SBIRT 
and suggested that simple physician training in the use of screening instruments would go a 
long way toward achieving implementation. The Kaiser clinicians often had not been 
involved in the planning and execution of new practice implementation and were more likely 
to have been on the receiving end of implementation efforts. Some spoke about the constant 
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stream of information about new practices: so much that it was hard to keep track of what 
new initiative was beginning, and how and when. With the exception of the leadership 
support discussed above, the only other implementation strategy Kaiser clinicians mentioned 
as successful was the “champion” system used throughout Kaiser. Most facilities have 
numerous clinical champions, each tasked with being a subject expert and resource for their 
colleagues, frequently also monitoring and encouraging colleagues’ performance. The Teen 
SBIRT Initiative Plan for Change incorporates both these important implementation 
components.  
 One of the interviewees, whose job it was to implement adult SBIRT throughout a 
consortium of FQHCs across the county, had clearly considered the process of 
implementation thoughtfully, from the planning stage, through engagement, execution, 
reflection and including evaluation. She described in great detail a thoroughly laid-out plan 
that she and colleagues had developed for implementing SBIRT and other integrated 
behavioral health programs, including extensive (and intensive) training, practice and 
feedback regimens, technical assistance, and a carefully crafted evaluation plan. The program 
they had developed, in the comparatively low-resourced context of a publicly-financed 
community health center system was quite impressive, and could serve as a model for a 
system with far more resources like Kaiser Permanente. 
 In some ways, Kaiser Permanente would seem to offer an ideal setting in which to 
attempt large-scale implementation of one or both models of pediatric primary care-based 
SBIRT. It is an integrated healthcare delivery system, and as such has many of the structural 
elements described as necessary for integrated behavioral health in the PCMH Joint 
Principles Statement, including joint medical records and shared revenue streams, along with 
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a mature, robust EHR into which evidence-based tools can be incorporated. It has used such 
aspects of its system to great effect in improving population health in some areas, such as 
blood pressure control and heart attack incidence. However, while it appears very integrated 
from the outside, behavioral healthcare in Kaiser remains fragmented in numerous important 
ways. For the most part, pediatric primary care remains separate from behavioral health, and 
potent barriers – both structural and attitudinal – continue to limit communication between 
Pediatrics, Child & Family Psychiatry and Chemical Dependency, inhibiting coordination 
and quality of care for adolescents with behavioral health problems. In many ways, 
community-based organizations seem to do a better job at integrating behavioral health and 
meeting the psychosocial needs of adolescent primary care patients than an “integrated” 
delivery system like Kaiser. It is unclear why publicly funded primary care systems seem to 
be further along in integrating behavioral health than a system like Kaiser. The social and 
behavioral health needs of public populations may be more acute than those of Kaiser 
members, and therefore more clearly apparent. Public funding and healthcare reform 
regulations may include a combination of mandates and incentives designed to facilitate 
integration which don’t affect private health plans like Kaiser, or it could be that the social 
mission of community health centers are more closely aligned with the patient-centeredness 
of integrated behavioral health. While there is some evidence in the literature that public 
institutions are less open to the adoption and implementation of new evidence-based 
interventions,
254
 the people I spoke with suggested that public settings have better 
implementation or innovation climates,
82,272
 are more willing to adopt SBIRT generally, and 
seem particularly open to models which use embedded behavioral specialists and other 
personnel to perform one or more components, in order to maximize provider efficiency and 
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impact. Recently, however, Kaiser has begun to make attempts to address behavioral health 
in adult medicine, such as the aforementioned adult alcohol SBIRT initiative and the 
initiation of depression screening, in compliance with HEDIS performance measures.  The 
Teen SBIRT Initiative Plan for Change described below builds on these earlier integration 
efforts in adult medicine and expands integration into Pediatrics through a comprehensive, 
multi-pronged strategy for adolescent SBIRT implementation across the KPNC region. 
While many of the activities of the Plan for Change are discussed in relation to the 
Kaiser setting, most (though not all) can be relatively easily adapted to other settings, 
including the emphasis on provider training, the use of evidence-based instrument, the use of 
performance feedback and marketing strategies, activities to strengthen linkages between 
departments or organizations, and a comprehensive evaluation plan. Moreover, many of the 
activities described in the Plan can be applied not only to the implementation of SBIRT, but 
to behavioral health integration efforts more broadly. It should be noted however, that the 
context for this study – Kaiser Permanente – is a closed, integrated healthcare system with a 
capitated payment structure, and as such, is relatively unique. The inclusion of participants 
from public health systems helped somewhat to provide a broader frame of reference for 
gauging whether the barriers and facilitators identified in by the participants in Kaiser were 
unique to that system, or generalizable to other types of systems. While there were some 
dissimilarities between Kaiser and the public settings in the study, particularly having to do 
with the public clinics’ seemingly greater openness towards adoption of integrated behavioral 
health strategies like SBIRT, overall there were more similarities than differences. This 
similarity may stem from the fact that these systems both have at least some access to 
behavioral health services, whether provided within the system or through formal, 
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established relationships between entities, as is often the case between public programs. Both 
of these types of systems also have payment structures which ostensibly incentivize the 
delivery of preventive services such as SBIRT as a way of keeping covered members 
healthier and controlling cost and utilization, including more costly specialty behavioral 
health services.  
Whether these findings, as well as the foci and activities outlined in the Plan for 
Change strategy described below, are generalizable to other types of systems, is less clear.  
While healthcare payment structures are slowly moving toward risk- and value-based 
payments, including capitated payment mechanisms such as Kaiser Permanente’s, fee-for-
service remains the predominant model of payment structure in the U.S.
273,274
 Most 
adolescents in this country receive care in healthcare systems which do not have integrated or 
easily accessible behavioral health resources (and are often not responsible for the costs of 
behavioral health services, if they are contracted out to behavioral health firms), and which 
have no financial incentives – no “skin in the game” – for providing services for which there 
is no clear cost offset. Such systems may face even greater challenges to SBIRT 
implementation than the kinds of systems examined here, and the implementation strategy 
outlined below may not, or may only begin to, address those challenges. For example, it 
could be much more challenging to establish a multi-disciplinary Teen SBIRT Community of 
Practice, the cornerstone of the Plan for Change, as a private for-profit or not-for-profit 
health system with “carved-out” behavioral health benefits. It would require significant 
coalition- and relationship-building effort when such a health system likely has even more 
tenuous ties to community behavioral healthcare providers than either of the systems 
described here, and it will be considerably more work, with less clear immediate benefits for 
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members. It may require working within existing collaborations with public systems or 
adolescent or behavioral health affinity groups, to involve such health systems in coalition 
with others pursuing SBIRT implementation. Other possible incentives might come as the 
result of the adoption of performance measures; NCQA is beginning to consider the adoption 
of adult SBIRT measures in its HEDIS guidelines, and although clearly a long way down the 
line, adoption of adolescent SBIRT HEDIS measures would also do much to propel less 
inclined systems toward implementation. At the same time, open healthcare systems, in 
contrast to Kaiser’s closed system, might offer less change-averse contexts, where cultural 
and clinical norms are less predominant, and innovations more likely to be adopted. Future 
studies should examine the challenges to and opportunities for SBIRT implementation across 
diverse types of healthcare systems. 
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CHAPTER 9: PLAN FOR CHANGE 
Teen SBIRT Initiative 
This Plan for Change, the Adolescent SBIRT initiative, will employ a multi-pronged 
approach to the creation of a plan for the region-wide implementation of systematic, 
evidence-based screening, brief intervention and referral to treatment as needed, for 
adolescents in KPNC with behavioral health risks.  This implementation plan is informed by 
the extant adolescent substance use prevention and treatment, SBI/RT and implementation 
literatures.  It uses the framework provided by the Consolidated Framework for 
Implementation Research to guide the direction of its efforts.  It also incorporates 
implementation findings from the parent adolescent SBIRT RCT. Most directly, the activities 
described below respond to the barriers, facilitators and issues raised during the course of 
Key Informant interviews conducted for this study.  
The CFIR model, described briefly in Chapter 2, was chosen to conceptually frame 
this dissertation for a number of reasons. The CFIR model incorporates and synthesizes 
concepts and constructs from across the dissemination and implementation science literature, 
organizing them under the broad domains of Outer Setting, Inner Setting, Characteristics of 
the Intervention, Characteristics of the Individuals Involved, and Implementation process.  
The CFIR is extensive and comprehensive, and includes many constructs, yet is flexible, in 
that it was explicitly developed so that users could choose those constructs relevant to their 
particular intervention, organization and context.  The CFIR was developed through a careful 
review of the existing implementation science literature, using at its foundation Trisha 
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Greenhaglh’s seminal 2004 systematic review of the literature on diffusion of innovations 
within services organizations.
275
 Greenhalgh et al.’s review drew on literatures from a wide 
range of disciplines, from evidence-based medicine, to rural/agricultural sociology to 
marketing and communications, and was itself deeply informed by the early work of 
implementation science pioneers such as Everett Rogers.
276
 It culminated in the development 
of a unified model for thinking about the diffusion of innovations within organizations.  In 
turn, Damschroder and colleagues built on Greenhalgh’s model, adding new studies from the 
rapidly emerging dissemination and implementation literature which were not captured in 
Greenhalgh’s review, and combining them into a “meta-theoretical” taxonomy which fills the 
conceptual gaps left in most models by including the most salient constructs from each, and 
combining those which were clearly redundant. The CFIR is not a process theory, in that it 
does not indicate relationships or mechanisms itself between constructs, but instead:  
“…specifies a list of constructs within general domains that are believed to influence 
(positively or negatively, as specified) implementation, but does not specify the 
interactions between those constructs. The CFIR does provide a pragmatic 
organization of constructs upon which theories hypothesizing specific mechanisms of 
change and interaction can be developed and tested empirically.” 
 
Moreover, the CFIR implementation model was not developed for a specific purpose, such as 
implementation planning or evaluation, as many such models are.   
For these reasons, the CFIR provided what I felt was an ideal conceptual framework 
for this dissertation.  Because it is not limited to a specific purpose, in the way, for example, 
that the RE-AIM model described below was specifically designed for implementation 
evaluation,
277
 it can be used for research, planning, implementation itself and evaluation. 
Thus it was appropriate for shaping the development of the Key Informant interview guides 
and interviews, and for creating the thematic coding structure used for analyzing the 
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interview data, and for informing the resulting Plan for Change strategy, and as such, 
provided a unified theoretical underpinning and enhanced conceptual continuity across the 
enterprise. Because the CFIR does not specify directionality among constructs, it is entirely 
consistent with the fundamentally inductive methodology of qualitative research, which 
allows data to emerge and shape explanations and theory,
278
 and with the agnostic approach I 
have taken in this dissertation toward data collection, analysis and application, allowing 
themes from participants’ perspectives on SBIRT implementation barriers and facilitators to 
emerge on their own, with a minimum of preconception.  
Because it is not, as noted above, a process model itself, the CFIR is complementary 
to such models and as such, could easily be used in conjunction with one or another of them.  
For example, the RE-AIM framework, which is at this point one of the better-known models 
in the dissemination and implementation literature, is now widely used for evaluating the 
impact of public health innovations and the translation of evidence-based practices to real-
world contexts. RE-AIM was developed explicitly for evaluation however, and is an elegant, 
straightforward model for measuring an intervention’s effects on the Reach (proportion of the 
target population participating in an intervention), Efficacy (success if implemented 
faithfully), Adoption (proportion of settings which adopt intervention), Implementation 
(extent to which an intervention is implemented as intended in the real world), and 
Maintenance (the extent to which the intervention is sustained over time). Because RE-AIM 
necessarily assumes at least initial implementation of an intervention, it would not be 
appropriate for use alone in this study which aimed to identify factors which will likely act as 
barriers and facilitators to SBIRT implementation, in order to counteract and exploit them, 
respectively. However, RE-AIM could easily be incorporated into the evaluation activities of 
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the Plan for Change below, in conjunction with the CFIR, particularly as it relates to 
measuring sustainability. 
Another implementation framework which was considered but ultimately rejected in 
favor of the CFIR is the PRISM (Practical, Robust Implementation and Sustainability 
Model).
279
 More comprehensive and nuanced than RE-AIM, the PRISM mirrors many of the 
constructs of the CFIR which emerged as important, from the Key Informant data.  In 
particular, like the CFIR, the PRISM explicitly recognizes and assigns great importance to 
the role of clinicians, staff and other individuals and their perceptions and attitudes, in the 
process of implementation, which was clearly very salient in this study of SBIRT 
implementation, given the outsized role of pediatricians and other pediatric clinicians in 
delivering SBIRT. It also takes into account the needs and desires of clients/patients on a 
much deeper level than does RE-AIM. Moreover, PRISM focuses careful attention on the 
role of coordination across departments or specialties – the lack of which emerged as a key 
barrier from the SBIRT Key Informant interviews, and relatedly, organizational structure and 
capacity. The scope of the constructs it includes and the nuance and depth with which they 
and their impact are characterized would make PRISM an excellent choice if this dissertation 
was strictly concerned with development of the Plan for Change. Nevertheless, the PRISM is 
a process model, designed explicitly for planning and executing implementation, and as such, 
I felt it did not lend itself as well to the data collection and analysis components of this 
dissertation as the CFIR, and because Damschroder included the PRISM in developing the 
CFIR, the Plan for Change thus benefits not only from PRISM constructs but those of others 
as well. 
 139 
Over a three year period, the initiative will engage in a variety of activities designed 
to lay the groundwork for an enduring coalition and infrastructure for addressing the public 
health impact of adolescent substance use problems among adolescent members of KPNC, 
including a sustainability plan.  The Plan for Change will work toward supporting both 
modalities of delivering SBIRT examined in this study – pediatrician delivered SBIRT and 
embedding a behavioral health clinician in pediatric primary care.  The short-term goal is to 
establish a robust program of pediatric primary care-based SBIRT using pediatricians as the 
administering clinicians (and embedded behavioral health clinicians in the minority of KPNC 
facilities that have them).  A longer-term goal is to advocate for the increased use of the 
embedded behavioral health clinician model across KPNC, though engagement with 
leadership, strategic communications and development of the evidence base for such models. 
Major initiative foci:  
1. Creation of a multi-disciplinary Community of Practice (“Teen SBIRT CoP”) focused 
on adolescent SBIRT implementation and the adoption of other behavioral health 
prevention and early intervention activities for adolescents in KPNC, 
2. Finalization of evidence-based SBIRT instruments for KPNC with stakeholder input 
and development of a suite of evidence-based clinical protocols for delivering Teen 
SBIRT, 
3. Identification of Teen SBIRT Pediatrics and Child & Family Psychiatry and 
Chemical Dependency Treatment Health Champions, 
4. Identification of a KPNC Executive Sponsor for Teen SBIRT implementation, 
5. Training of pediatric primary care providers (PCPs) and staff, and Child & Family 
Psychiatry and Chemical Dependency Treatment health clinicians and staff, 
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6. Formalizing KPNC adolescent behavioral health response infrastructure, 
7. Establish a regular performance feedback structure to spur clinical quality 
improvement, 
8. Development of Communications & Marketing plans (for health system leadership, 
Pediatrics leaders, Child & Family Psychiatry and Chemical Dependency treatment 
leaders, clinicians, medical assistants, parents and patients), including creation of Teen 
SBIRT provider-, staff-, parent- and patient-facing materials and materials for 
dissemination of initiative activities to larger community, 
9. Creation of a Sustainability plan which includes as a top priority the increased use of 
embedded behavioral health clinicians in pediatric primary care, 
10. Evaluation of short-, mid- and long-term Teen SBIRT Initiative outcomes, 
11. Provide national scientific and policy leadership on Teen SBIRT and Integrated 
Adolescent Behavioral Health. 
Leadership approach for the Teen SBIRT Initiative team. The leadership approach 
that will guide the Teen SBIRT Initiative team’s efforts draws from a number of theoretical 
traditions, and is explicitly informed by the work of theorists such as Alice Eagly, Margaret 
Wheatley, Bill George, Fred Walumbwa and Bruce Avolio,
280-286
 using an ethics-driven, 
intentionally participatory
287
 and collaborative approach.  It will be guided by the principles 
of Authentic Leadership, an intrinsically multi-dimensional approach which takes into 
account multiple domains of leadership rather than focusing solely on a single aspect of 
leadership (e.g., only a leader’s innate traits or the specific situational context), and which 
underscores the important role of both intrapersonal and interpersonal factors.  Authentic 
Leadership also includes an explicit ethical component, such that leaders’ actions are 
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purposeful, value-centered, and driven by personal conviction and internalized moral 
perspective.
284
 This approach is well-suited to the Teen SBIRT Initiative as its overarching 
objective is to prevent and/or alleviate suffering and improve the health and well-being of 
adolescents.  Apropos to the nature of many of the initiative’s core activities, Authentic 
Leadership emphasizes the importance of interpersonal dynamics, with a focus on the 
reciprocal relationship between leaders and others; authenticity emerges from the nature and 
quality of interactions between leaders and other stakeholders, and relationships are 
characterized by transparency.
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  The Teen SBIRT initiative will involve constant and 
ongoing collaboration with a wide variety of stakeholders – clinicians of various types, health 
system leaders, patients, researchers – and relies on maintaining the trust and goodwill of 
stakeholders in order to encourage adoption, implementation and sustainability of Teen 
SBIRT.  
Below I describe the specific foci and activities of the initiative.  Each of the foci 
proposed in the Plan for Change responds to themes which emerged from the Key Informant 
interviews, many of which correspond directly to CFIR constructs, or to sub-themes 
identified through coding and analysis. Table 7 describes each CFIR domain and interview 
theme and the Plan for Change focus wherein it is addressed.  Table 8 describes each Plan for 
Change focus in specific detail, and indicates (prior to the description of specific activities) 
the particular overarching CFIR domain(s) and CFIR constructs, and implementation 
barriers, facilitators or issues raised during the Key Informant interviews to which the 
activities respond.   
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Table 7. CFIR Domains/Interview Themes and corresponding Plan for Change 
Activities 
 Plan for Change Focus 
CFIR Domains and Interview 
Themes 
1 2 3 4 5 6 7 8 9 10 11 
OUTER SETTING                                                                        
External Policies and Incentives            
Confidentiality  x   x x     x 
Cultural Attitudes and Mores about 
Substance Use 
       x   x 
Growing Awareness of the Role of 
Behavioral Health 
 x  x    x   x 
Stigma        x    
Marijuana Policy & Legislation        x   x 
Performance Measures    x   x x x x  
Insurance coverage, co-pays, co-
insurance 
           
Billing/Financing            
            
Patient and Family Needs    x  x  x    
Comorbidity  x x   x      
Parental Attitudes            
Linguistic  x          
Patient Behavior            
Family Behavior            
Clinical Acuity  x          
Logistics/Distance            
SES            
Gender            
Health Care Reform, ACA            
            
INNER SETTING            
Structural Characteristics            
Time, Appointment Length  x    x  x    
Screening, Assessment Instruments  x   x      x 
Competing Priorities  x    x x x    
EHR  x  x   x   x x 
Workflow  x    x x x    
Workforce  x     x  x   
Protocols            
Warm Handoff  x          
Leadership Engagement   x x  x x  x  x 
            
Networks and Communications  x x x  x      
Referral Process   x   x      
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 Plan for Change Focus 
Linkages between Departments  x x x  x      
Information back to Pediatricians 
about resolution of referral 
     x      
Consultation with Colleagues            
Infrastructure       x x x   
            
Community Resources            
Implementation Climate       x  x   
            
CHARACTERISTICS OF THE 
INTERVENTION                     Total 
           
Relative Advantage of BHC 
Model 
        x  x 
Evidence Strength and Quality x x  x   x x x  x 
Information Technology  x  x  x  x x  x 
Cost        x x x x 
Relative Advantage of PCP 
Model 
      x    x 
Impact of Trial         x   
            
CHARACTERTISTICS OF THE 
INDIVIDUALS INVOLVED   Total  
           
Provider Knowledge and Skills x x x x  x x x x   
Provider Attitudes (Toward 
Substance Use) 
   x        
Provider Self-Efficacy x x  x  x  x    
Provider Perception of Role vis a 
vis Behavioral Health 
x   x        
Medical Training    x        
            
IMPLEMENTATION PROCESS                                             
Total 
           
Planning x x x x  x   x   
Executing x x x    x  x   
Training x x   x x x x    
Engaging x x x x x x  x x   
Reflecting x x    x   x x x 
Evaluating       x  x x x 
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Table 8. Teen SBIRT Initiative Foci 
 Focus #1: Teen SBIRT Community of Practice 
CFIR Domains: Inner Setting, Characteristics of Individuals Involved, Characteristics of 
Intervention, Implementation Process 
Specific Interview Themes Addressed: Evidence strength and quality, provider self-
efficacy, provider knowledge and skills, provider perception of role vis a vis behavioral 
health, planning, engaging, executing, reflecting, and training 
Activities:  
 Identify relevant KPNC stakeholders in Pediatrics and Adolescent Medicine 
physicians/other pediatric PCPs, Child & Family Psychiatry and Chemical 
Dependency program clinicians at each KPNC facility, 
 Contact identified stakeholders directly by phone and email to solicit their 
participation, 
 Request representation (and related administrative time to participate) from each 
facility, from facility-level leadership, 
 Market Teen SBIRT CoP at relevant interest and workgroup meetings (e.g., Pediatric 
Chiefs, Adolescent Medicine Specialists, KP Inter-regional Pediatric Behavioral 
Health Workgroup), to raise awareness of adolescent substance use problems, co-
occurrence and health implications and to recruit participation, 
 Assemble a Teen SBIRT stakeholder strategy group, with representation from 
pediatric primary care, Child & Family Psychiatry, adolescent Chemical Dependency 
treatment, regional leadership, research,  
 Create a Teen SBIRT Facilitator position to staff and support Teen SBIRT CoP and to 
provide technical assistance to clinical staff during implementation, 
 Convene an annual in-person meeting and quarterly, webinar-format Collaborative 
Teen SBIRT CoP meetings, 
 Communicate regularly with Teen SBIRT CoP members to disseminate information 
and nurture and maintain a sense of shared purpose and enthusiasm 
Creation of the Community of Practice responds to a number of themes from the 
interviews, across the CFIR domains, and lays the groundwork for the rest of the 
activities of the initiative. Much of the early leadership work of the Teen SBIRT 
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Initiative will involve relationship building, and nurturing individuals’ and groups 
natural tendency to self-organize.
286
 To that end, we will work to maximize the 
influence and effectiveness of the Teen SBIRT Initiative and the Teen SBIRT CoP by 
fostering healthy, supportive and respectful relationships and communication between 
the CoP members, across disciplines.
286
 
 Focus #2: Evidence-based SBIRT instruments and protocols 
CFIR Domains: Outer Setting, Inner Setting, Characteristics of Intervention, 
Implementation Process 
Specific Interview Themes Addressed: Patient needs (acuity, linguistic, cultural, 
comorbidities), growing awareness of the role of behavioral health, time, screening and 
assessment instruments, competing priorities, workflow, workforce, warm handoff, networks 
and communications, linkages between departments, evidence strength and quality, provider 
self-efficacy, provider knowledge and skills, EHR, IT, planning, engaging, executing, 
reflecting, and training 
Activities: 
 Conduct an updated scan of state-of-the-art of Teen SBIRT screening and assessment 
instruments, interventions and practices, 
 Assemble a set of core standardized Teen SBIRT screening and assessment measures, 
suitable for use in pediatric primary care, 
 Develop a clinical workflow for responding to Teen SBIRT screening, based on Teen 
SBIRT RCT workflow but incorporating Key Informant Interview data, 
 Carefully review State of California Adolescent Confidential Health Services laws 
and regulation and develop commonsense interpretation of confidentiality constraints, 
 Obtain consensus on instruments and workflow, first from CoP, then from other 
relevant KPNC pediatric groups, including the Adolescent Medicine Specialists, 
Pediatric Chiefs, Child & Adolescent Psychiatry Performance Excellence Group and 
Adolescent Chemical Dependency Coordinating Committee, 
 Teen SBIRT Project Strategy Group members and Teen SBIRT Implementation 
Facilitator will work with KP HealthConnect (EHR) Information Technology team to 
get screening and assessment tools and clinical decision support tools incorporated 
into the EHR, 
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 Teen SBIRT Project Strategy Group members and Teen SBIRT Implementation 
Facilitator will provide technical support to the Teen SBIRT CoP and clinicians 
throughout the organization throughout the implementation and maintenance period 
An important early activity of the Teen SBIRT Initiative will be to review and agree 
upon an evidence-based, feasible set of core Teen SBIRT screening and assessment measures 
and intervention and referral protocols, through consensus of the Teen SBIRT CoP and 
informed by our current KP-based research, the research literature, expert consultation and 
best practices, which obviously responds most directly to the construct of evidence strength 
and quality, but cuts across a number of other constructs and themes as well. Our approach 
for this activity will use implementation science techniques to transfer “gold standard,” 
evidence-based instruments and interventions whose efficacy and effectiveness have been 
tested in experimental trials such as the parent Teen SBIRT RCT, and adapt them if 
necessary to the KPNC pediatric primary care setting with clinician input, in a manner which 
will maximize the external validity of our approach for future scaling up and spread. This 
approach takes into account factors such as strength of the evidence, scalability of the 
intervention, characteristics of the patients receiving and providers delivering the 
interventions, and the organizational and environmental contexts for the intervention.
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 Focus #3: Teen SBIRT Clinical Champions 
CFIR Domains: Outer Setting, Inner Setting, Characteristics of Individuals Involved, 
Implementation Process 
Specific Interview Themes Addressed: Patient comorbidities, networks and 
communications, linkages between departments, leadership engagement, provider knowledge 
and skills,  referral process, planning, engaging, executing 
Activities: 
 Meet with Pediatrics Chiefs, Child & Family Psychiatry Chiefs, Adolescent CD 
Program Directors, Facility Physicians-in-Chief to communicate Teen SBIRT 
Initiative Activitys, describe workflow logistics and solicit support, 
 Identify Teen SBIRT clinician champions in each facility, in Pediatrics, Child & 
Family Psychiatry and Chemical Dependency, 
 Establish a Teen SBIRT Clinical Champion information dissemination protocol, 
based on current KPNC clinical champion best practices 
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Focus #4: Leadership Support  
CFIR Domains: Outer Setting, Inner Setting, Characteristics of Individuals Involved, 
Characteristics of Intervention, Implementation Process 
Specific Interview Themes Addressed: Patient needs, growing awareness of the role of 
behavioral health, performance measures, ACA, networks and communications, linkages 
between departments, leadership engagement, evidence strength and quality, EHR & IT, 
planning and engaging 
Activities: 
 Meet with Pediatrics Chiefs, Child & Family Psychiatry Chiefs, Adolescent CD 
Program Directors, Facility Physicians-in-Chief to communicate Teen SBIRT 
Initiative objectives, describe workflow logistics and solicit support, 
 Identify leadership champions of Teen SBIRT Initiative, 
 Teen SBIRT Strategy Team, with support and assistance from leadership champions, 
seek executive sponsorship at Associate Executive Director level 
     The involvement and engagement of leaders from all levels of an organization can 
increase its openness to innovation as well as providing critical resource support. In 
healthcare settings, particularly large systems such as Kaiser Permanente and county 
health systems, system-level leaders frequently determine organizational priorities and 
funding capacity at the local level, which in turn can determine clinics’ ability to consider 
implementation of new practices.
254
 Moreover, leadership support, both in terms of vision 
and material support, can often effectively enable or prevent the sustainability of newly 
adopted practices.
110
 Plan for Change activities thus focus on fostering leadership support 
at all organizational levels. 
 Focus #5: Training  
CFIR Domains: Inner Setting, Characteristics of Individuals Involved, Characteristics of 
Intervention, Implementation Process 
Specific Interview Themes Addressed: Evidence strength and quality, screening and 
assessment instruments, provider self-efficacy, provider knowledge and skills, medical 
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training, provider attitudes toward substance abuse, provider perceptions of role vis a vis 
behavioral health,  EHR,  engaging, and training 
Activities:  
 Develop pediatric primary care provider, pediatric primary care staff, and behavioral 
health clinician training programs and materials on Teen SBIRT screening, 
assessment, brief intervention and referral workflows, 
 Develop sample scripts for sensitive discussions with specific emphasis on 
confidentiality issues, 
 Conduct trainings across region: 
o 2 pediatrician lunchtime trainings which include clinician roll-play, w CMEs, 
per Pediatrics department 
o 1 Pediatrics department staff (e.g., Medical Assistants, Reception) lunchtime 
training per department 
o 1 Child & Family Psychiatry training per facility, with CEUs 
o 1 Chemical Dependency program training per facility, with CEUs 
 Offer technical assistance, training webinars and provider telephonic provider 
coaching on Teen SBIRT identification and brief intervention 
Efforts with clinicians will be informed by adult learning theory, leadership models 
which emphasize relationship and coalition building, and implementation science 
frameworks such as the CFRI which stress the importance of inter-organizational networks 
and an ecological orientation.
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 Focus #6: Infrastructure 
CFIR Domains: Outer Setting, Inner Setting, Characteristics of Individuals Involved,  
Implementation Process 
Specific Interview Themes Addressed: Patient needs, comorbidity, time, competing 
priorities, workflow, networks and communications, linkages between departments, 
leadership engagement, referral process, information back to pediatricians about resolution of 
referral, provider self-efficacy, provider knowledge and skills, IT, planning, engaging, 
reflecting, and training 
Activities: 
 Facilitation of inter-departmental/inter-disciplinary (pediatrics, psychiatry, chemical 
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dependency) relationships between clinical champions at each facility, 
 “Matchmaking” introduction emails sent to clinical champions at each facility, 
 Support for regular meetings and information sharing between champions, 
 Encourage free flow of relevant information between departments through 
establishment of consistent practice of obtaining consent-to-release information to 
pediatricians for patients entering specialty behavioral health treatment,  
 Establish protocol for consistent follow-up information from specialty behavioral 
health clinicians back to referring pediatrician 
 Focus #7: Performance Feedback 
CFIR Domains: Inner Setting, Characteristics of Individuals Involved,  Implementation 
Process 
Specific Interview Themes Addressed: Performance measures, EHR, competing priorities, 
workforce, workflow, infrastructure, implementation climate, leadership engagement, IT, 
relative advantage of different modalities of SBIRT, provider knowledge and skills, 
executing, evaluating, training 
Activities: 
 Create facility-, provider- and medical assistant-level performance feedback report 
templates, 
 Identify target audiences for performance feedback reports, e.g., Pediatric Chiefs, 
medical assistant managers, relevant executive leaders, 
 Establish process and schedule for dissemination of performance feedback data, 
 Encourage use of feedback reports for performance improvement efforts, through a 
combination of encouragement, incentives, and competition, using un-blinded 
performance reporting once Initiative is established 
 Focus #8:  Communications & Marketing  
CFIR Domains: Outer Setting, Inner Setting, Characteristics of Individuals Involved, 
Characteristics of Intervention, Implementation Process 
Specific Interview Themes Addressed: Patients and families, marijuana policy, stigma, 
growing awareness of the role of behavioral health, cultural attitudes about substance use, 
performance measures, time, competing priorities, workflow, infrastructure, leadership 
engagement, evidence strength and quality, cost, IT, provider self-efficacy and knowledge 
and skills, engaging, leadership, training 
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Activities: 
 Create and curate an Teen SBIRT CoP Wiki on-line, as a repository for Teen SBIRT 
screening and intervention materials and community forum, 
 Develop email lists for easy communications, 
 Develop and disseminate a brief, monthly Teen SBIRT Initiative email newsletter, 
with news from the field, clinical tips and integrated adolescent behavioral health 
advocacy tools, 
 Create a marketing plan targeted at KPNC clinical leaders, policymakers and 
executive leadership focused on positioning Teen SBIRT screening and intervention 
as an approach which will set Kaiser Permanente apart from other healthcare systems 
as a leader in adolescent  behavioral health,
290
 
o E.g., the physician-focused marketing approach will be positioned as 
providing “tools” for the pediatrician’s “toolbox” and offering means (skills 
development, clinical tools, etc.) which can help to improve practice management, 
meet quality and performance measurement goal for preventive services, and 
address adolescent risk behaviors that many physicians find frustrating to treat.  
The marketing messages directed at physicians will also emphasize SBIRT’s 
potential to help reduce patient office visits,   
 Creation of a KPNC region-wide marketing campaign focused on children, 
adolescents and the deleterious impact of alcohol and drug use, problems and 
comorbidity, to raise awareness of adolescent substance use as a critical public health 
issue 
 
 Focus #9: Sustainability 
CFIR Domains: Outer Setting, Inner Setting, Characteristics of Intervention, 
Implementation Process 
Specific Interview Themes Addressed: Performance measures, workforce, infrastructure, 
implementation climate, evidence strength and quality, cost, IT, impact of trial, leadership 
engagement, relative advantage of BHC model, provider knowledge and skills, planning, 
engaging, executing, reflecting, leadership and evaluating 
Activities: 
  Short-term: 
 The Teen SBIRT Initiative Strategy Group will create a plan for sustainability which will 
include eventual situation of Teen SBIRT Initiative functions in an appropriate 
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operational “home,” e.g., as a function of a sub-committee of the Adolescent Medicine 
Committee, or Regional Health Education, or Pediatrics, 
 A first activity of the sustainability plan will be to obtain funding to support .25 - .5 FTE 
of Teen SBIRT Implementation Facilitator role and .10 data analyst role, 
  Longer-term: 
 Development of a business plan and organizational advocacy strategy to gain leadership 
support and marshal organizational resources for a spectrum of pediatric primary care-
based behavioral health services for adolescents, including particularly the adoption of a 
model of universal embedded behavioral health clinicians;  
o this effort will involve use of both existing and new cost-effectiveness/cost-offset 
research to support resource allocation, as well as clear communication to 
executive leadership of the value such a model will add to Kaiser Permanente’s 
organizational product and profile as a leader in preventive health. 
          Achieving this objective will require engaging in advocacy activities aimed at 
incorporating Teen SBIRT screening and intervention into the regional standards of care and 
workflows, and ultimately securing funding for ongoing service delivery, including the 
increased use of embedded behavioral health clinicians across the region.  It will be informed 
by those components of implementation science frameworks which provide guidance on best 
practices for facilitating the institutionalization and maintenance of public health 
interventions.
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 We will use sustainability measures (“the extent to which (it) becomes 
routine and part of the everyday culture and norms of the organization”) from the RE-AIM to 
measure maintenance of the implementation.
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 Focus #10: Evaluation 
CFIR Domains: Outer Setting, Inner Setting, Implementation Process 
Specific Interview Themes Addressed: Performance measures, EHR, IT, reflecting, 
evaluating  
Activities: 
Creation of an evaluation plan for the initiative, incorporating measures which allow for 
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both short- and long-term evaluation. Our evaluation plan will draw heavily from the 
practical evaluation framework developed by the CDC,
237
 in which stakeholder perspectives 
are kept at the forefront and the focus is on feasibility and usability of findings, including the 
following steps:  
o Conducting a systematic analysis of stakeholders, formally describing their 
interests in the project to be, as well as how we envision them using the results 
of the evaluation.
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o Engaging stakeholders from within and external to the project and the Teen 
SBIRT CoP to help guide the evaluation from the beginning 
o Describing The Program 
o Focusing The Evaluation 
o Gathering Credible Evidence 
o Justifying Conclusions 
o Ensuring Use of Evaluation Findings and Share Lessons Learned 
o Creating a detailed logic model describing the initiative’s inputs, activities, 
outputs, short-, intermediate- and long-term outcomes, and develop a program 
theory to describe the theoretical model for the initiative 
o Developing short- and medium-term measures for clinical performance 
measurement and outcomes monitoring, for the specific initiative activities, 
o Developing longer-term measures for evaluating the overall health impact of 
the initiative, 
o Using operational data, documentation processes and analytics effort to the 
extent possible to maximize efficiency, and adapting and supplementing 
existing operation data as necessary for evaluation,
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o Dissemination of interim and final evaluation data will be made to the 
stakeholder evaluation committee, and the larger Teen SBIRT CoP and 
community healthcare provider partners.
177
 
Performance Feedback Data 
 Initiative staff will work with operational metrics and analytics departments (e.g., 
Quality and Operations Support department) to establish data reporting relationships, 
in order to obtain a stable source and flow of monthly Teen SBIRT Initiative 
performance data, for the performance feedback activities described in Activity #7, 
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 Creation of standardized performance measure reports (figures and graphics) for 
monthly dissemination to executive and facility-level leaders and clinicians, 
 Teen SBIRT Strategy staff will be tasked with monitoring documentation and data 
collection, in order to ensure the availability of consistent data points, and will 
troubleshoot and provide technical assistance as necessary 
 Focus #11: Scientific and Policy Leadership on Teen SBIRT  
CFIR Domains: Outer setting, Characteristics of the intervention 
Specific Interview Themes Addressed: Growing awareness of the role of behavioral health, 
cultural attitudes and mores about substance use, marijuana policy and legislation, EHR, 
screening and assessment instruments, evidence strength and quality, relative advantage of 
different models of SBIRT, cost, IT, reflecting, evaluating, leadership 
Activities: 
 Continuing to pursue extramural funding to conduct research on SBIRT and other 
integrated pediatric behavioral health approaches, 
 Continuing to contribute to the peer-reviewed scientific literature on this topic, 
 Continuing to disseminate research and evaluation finding through a variety of 
mechanisms, such national and international conferences and meetings, advisory 
boards and social media, 
 Conducting frequent literature searches to stay abreast on developments in this and 
related fields, 
 Contributing to the national and international scientific dialogues about adolescent 
SBI/RT, and to policy conversations about best practices for adolescent substance use 
problem prevention and early intervention 
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APPENDIX A: COMPLETE LIST OF CFIR CONSTRUCTS 
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APPENDIX B: KEY INFORMANT INTERVIEW GUIDES 
Teen SBIRT Interview Guide – Kaiser Clinical Staff 
 
 
Study ID:  ___________________________ 
 
 
Job Title:  ___________________________ 
 
 
Date of Interview: ___________________________ 
 
 
Treatment Arm: ___________________________ 
 
 
We'd like to invite you to participate in an interview to get a better understanding of 
your thoughts and experiences about addressing alcohol and drug use and other behavioral 
health problems in pediatrics.  The interview will include both structured and open-ended 
questions. We will ask about preventive services in your clinic, alcohol and drug screening 
practices and policies in your clinic, and training you may have had for alcohol and drug 
screening and treatment or referral. We will not ask questions about any specific patients. 
The interview will last approximately 40 minutes.  
Your participation is voluntary and you may refuse to answer or skip any of the 
questions. Participation, refusal, or withdrawal from this study will not affect your 
employment status at Kaiser Permanente. Study staff will not disclose your 
study participation (or non-participation) to other clinicians, health plan administrators, or 
anyone else, unless compelled by law. All information obtained from you will be kept strictly 
confidential. The information you provide will be combined with the information from other 
participants and will only be presented as group results. Any reports or publications about 
the study will not identify you or any other study participant. You will not be asked for any 
personal information and we will not record your name as part of the interview. 
We do not expect that you will get any personal benefit from being in this study, but 
participating in a research study is often rewarding. In addition, your feedback 
combined with the feedback from other participants will help us improve the delivery of and 
access to health care for our members and do so in a way that works best for Kaiser 
Permanente providers and staff. 
With your permission, I would like to record our interview. Tapes and transcriptions 
will be destroyed at the end of the research study.  May I record the interview?” 
   Are there any questions that you have about the research study or the interview? 
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For All Clinicians 
 
I’m going to start out with some questions about how you generally handle your patients’ 
behavioral health concerns. 
 
Can you walk me, step by step, through what happens if you feel like one of your 
patients is at risk for alcohol or drug problems, or mental health problems? 
 
[Prompt: e.g., if a patient screens positive for alcohol or drug use, or emotional 
problems, on the Teen Well Check Questionnaire?]  
 
 
How do you communicate to them that you are concerned about a behavioral health 
issue? 
 
How does the conversation usually go?     
 
[Probes:  How do the patients usually respond? Do you mention anything about alcohol 
or drugs? 
 
 
 
How do you involve parents in discussions about behavioral health problems?   
 
 
How do parents/guardians usually respond? 
 
 
At what point would you break confidentiality, if you were concerned about the teen’s 
wellbeing but they didn’t want to tell their parents? 
 
Based on your experience, how would you compare teens’ confidentiality concerns 
about substance use versus mood and anxiety problems versus contraception and 
sexual health?  
 
 
 
What is your sense of the strength of the evidence for SBIRT for teens?   
 
Can you talk about how much the evidence about an intervention matters to you, in 
terms of using it, or if other factors, like it being included in the EHR, are more 
important? 
 
 
 
 
What do you see as the biggest barriers to implementing alcohol and drug Screening, 
Brief Intervention and Referral to Treatment (SBIRT) in pediatrics? 
 
 
What would facilitate its implementation?  
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Ideally, if you could imagine or design a program to address substance use and similar 
issues with your teen patients, what would that look like? 
 
What sort of organizational resources would need to be brought to bear to make that 
happen? 
 
[Probes:  Space?  Staff?  Training? Executive sponsorship?] 
 
If behavioral health became a bigger priority, would something else take a back seat? 
 
 
Who do you think is the best person or role to screen for at-risk alcohol or drug problems 
in Pediatric Primary Care settings?  
 
MA 
Primary Care Provider  
Nurse 
BMS 
CHE/HEALTH EDUCATOR 
Other: _____________________ 
 
Probes: Why?  For example, efficiency, qualifications? If not an MA, why not an MA? 
 
Who do you think is the best person or role to give a brief intervention for at-risk alcohol 
or drug problems in Primary Care settings?  
 
E.g.:  
MA 
Primary Care Provider  
Nurse 
BMS 
CHE/HEALTH EDUCATOR 
Other: _____________________ 
 
Probes: Why?  For example, efficiency, qualifications? 
 
 
Only for Pediatricians in the PCP arm of the study (who were trained to deliver 
SBIRT) 
 
Since the Teen SBIRT study, on a scale of 1 to 10, where 1 means not at all prepared, 
and 10 means completely prepared 
 
To what extent you feel prepared to conduct brief interventions for at-risk 
drinking?   
 
To refer to treatment?   
Is there anything (either about the training or otherwise) that could have increased 
widespread use of the Teen SBIRT intervention? 
What, if anything, facilitated its use or could help do so?  
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What is your sense of how beneficial the SBIRT procedures have been for patients, as 
they were implemented?   
 
 
 
Only for those in the BHC arm of the study (who were trained to refer teens to the 
BHC) 
 
How do you think that the Behavioral Health Clinician meeting with teens in your exam 
room might impact you referring to the Teen Healthy Lifestyle Check-Up? 
 
How did it impact your workflow? 
 
In what ways does the Behavioral Health Clinician meeting in the exam room make it 
easier or harder to engage the teen? 
 
[Probes: 
 
To maintain privacy for the teen? 
 
To coordinate other services the teen will receive in the appointment 
(vaccinations, sexual health check-ins, etc.)? 
 
To reduce stigma experienced by teens and/or their parents? 
 
Did you ever decide not refer a patient to the Teen Healthy Lifestyle Check-Up 
because you did not want to risk a parent becoming aware of substance use? If 
so, please explain your concerns.  
 
Also for emotional health concerns? 
 
 
Is there anything (either about the training or otherwise) that could have increased 
widespread use of the Teen Healthy Lifestyle Check-Up? 
 
What might be potential barriers to using the Teen Healthy Lifestyle Check-Up? 
 
What was the impact of the Teen Healthy Lifestyle Check-Up upon patient care? 
 
What was the impact of the Teen Healthy Lifestyle Check-Up upon your 
workflow/workload? 
 
Can you describe the most appropriate type of patient to refer to the Teen Healthy 
Lifestyle Check-up? 
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For All Clinicians 
 
Do you feel that you have enough information about how to refer directly to the 
Behavioral Health services if you wanted to?  If not, what sort of information would you 
like to know about the programs or the referral process? 
Can you tell me about any barriers you have encountered trying to refer patients to 
Chemical Dependency or Child & Family Psychiatry? 
 
 
What could make that process work more smoothly? 
 
 
What type of a patient do you typically refer to Chemical Dependency treatment? 
 
 
What type of patient do you typically refer to the Child & Family Psychiatry department? 
 
After a referral to the Chemical Dependency Program or Child & Family Psychiatry, do 
you generally get feedback from the program or patient about whether they accessed 
treatment?  
 
 
Anything else you’d like to comment on, about the Teen Healthy Lifestyle Check-Up, or 
about the screening and treatment of behavioral health problems for teens in pediatrics? 
 
 
What kinds of questions or concerns or feedback have patients or their parents had 
about any of the SBIRT activities? 
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Teen SBIRT Interview Guide – Kaiser Policymakers 
 
 
Study ID:  ___________________________ 
 
 
Job Title:  ___________________________ 
 
 
Date of Interview: ___________________________ 
 
 
Treatment Arm: ___________________________ 
 
 
We'd like to invite you to participate in an interview to get a better understanding of 
your thoughts and experiences about addressing alcohol and drug use and other behavioral 
health problems in pediatrics.  The interview will include both structured and open-ended 
questions. We will ask about preventive services in your clinic, alcohol and drug screening 
practices and policies in your clinic, and training you may have had for alcohol and drug 
screening and treatment or referral. We will not ask questions about any specific patients. 
The interview will last approximately 40 minutes.  
Your participation is voluntary and you may refuse to answer or skip any of the 
questions. Participation, refusal, or withdrawal from this study will not affect your 
employment status at Kaiser Permanente. Study staff will not disclose your 
study participation (or non-participation) to other clinicians, health plan administrators, or 
anyone else, unless compelled by law. All information obtained from you will be kept strictly 
confidential. The information you provide will be combined with the information from other 
participants and will only be presented as group results. Any reports or publications about 
the study will not identify you or any other study participant. You will not be asked for any 
personal information and we will not record your name as part of the interview. 
We do not expect that you will get any personal benefit from being in this study, but 
participating in a research study is often rewarding. In addition, your feedback 
combined with the feedback from other participants will help us improve the delivery of and 
access to health care for our members and do so in a way that works best for Kaiser 
Permanente providers and staff. 
With your permission, I would like to record our interview. Tapes and transcriptions 
will be destroyed at the end of the research study.  May I record the interview?” 
   Are there any questions that you have about the research study or the interview? 
 
I’m going to start out with some questions about how adolescent behavioral health is 
handled in primary care in your system. 
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Most important 
1. Can you tell me how adolescent behavioral health issues are addressed in pediatric 
primary care in your organization? 
2. Is there standardized screening for alcohol and drug use, mental health symptoms? 
3. What do you see as the biggest barriers to implementing alcohol and drug integrated 
behavioral health care in pediatrics? 
4. What would facilitate its implementation?  
5. Ideally, if you could imagine or design a model of care to address substance use and 
mental health issues with adolescents, what would that look like? 
6. What sort of organizational resources would need to be brought to bear to make that 
happen? 
[Probes:  Space?  Staff?  Training? Executive sponsorship?] 
 
7. If behavioral health became a bigger priority, would something else take a back seat? 
8. Are clinicians in your practice/system trained in brief interventions for behavioral health 
issues? 
 
Important, as time permits 
9. How is it communicated to adolescents if there is a concern about a behavioral health 
issue? 
10. How are parents be involved in discussions about behavioral health problems?   
 
11. Who do you think is the best person or role to screen for at-risk alcohol or drug problems 
in Pediatric Primary Care settings?  
 
MA 
Primary Care Provider  
Nurse 
BMS 
CHE/HEALTH EDUCATOR 
Other: _____________________ 
 
Probes: Why?  For example, efficiency, qualifications? If not an MA, why not an MA? 
 
12. Who do you think is the best person or role to give a brief intervention for at-risk alcohol 
or drug problems in Primary Care settings?  
 
E.g.:  
MA 
Primary Care Provider  
Nurse 
BMS 
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CHE/HEALTH EDUCATOR 
Other: _____________________ 
 
Probes: Why?  For example, efficiency, qualifications? 
 
 
13. To what extent do you think the clinicians in your system (or clinic) are feel prepared to 
conduct brief interventions for adolescent drinking or drug use?   
 
 
14. What is your sense of how beneficial Brief Interventions for alcohol and drug use are for 
teens?    
 
 
15. Can you tell me about any barriers you are aware of, to referring adolescents to 
specialty substance abuse or mental health treatment? 
 
 
16. What could make that process work more smoothly? 
 
 
17. What kind of patients typically get referred to substance abuse treatment? 
 
 
18. What type of patients typically get referred to mental health treatment?   
 
19. Is there a flow of information between primary care and specialty care settings, e.g., do 
primary care providers generally get feedback from the program or patient about 
whether they accessed specialty behavioral health treatment?  
 
 
20. Anything else you’d like to comment on, about the screening and treatment of behavioral 
health problems for teens in pediatrics? 
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Teen SBIRT Interview Guide – NON-KP 
 
 
Study ID:  ___________________________ 
 
 
Job Title:  ___________________________ 
 
 
Date of Interview: ___________________________ 
 
 
Treatment Arm: ___________________________ 
 
 
We'd like to invite you to participate in an interview to get a better understanding of 
your thoughts and experiences about addressing alcohol and drug use and other behavioral 
health problems.  The interview will include both structured and open-ended questions. We 
will ask about preventive services, alcohol and drug screening practices and policies, and 
training for alcohol and drug screening and treatment or referral. We will not ask questions 
about any specific patients. The interview will last approximately 40 minutes.  
Your participation is voluntary and you may refuse to answer or skip any of the 
questions. Study staff will not disclose your study participation (or non-participation) to other 
clinicians, administrators, or anyone else, unless compelled by law. All information obtained 
from you will be kept strictly confidential. The information you provide will be combined with 
the information from other participants and will only be presented as group results. Any 
reports or publications about the study will not identify you or any other study participant. 
You will not be asked for any personal information and we will not record your name as part 
of the interview. 
We do not expect that you will get any personal benefit from being in this study, but 
participating in a research study is often rewarding. In addition, your feedback 
combined with the feedback from other participants will help us improve the delivery of and 
access to health care for our members and do so in a way that works best for Kaiser 
Permanente providers and staff. 
With your permission, I would like to record our interview. Tapes and transcriptions 
will be destroyed at the end of the research study.  May I record the interview?” 
   Are there any questions that you have about the research study or the interview? 
 
I’m going to start out with some questions about how adolescent behavioral health is 
handled in primary care in your system. 
21. Can you tell what you know about me how adolescent behavioral health issues are 
addressed in pediatric primary care in your system? 
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22. Is there standardized screening for alcohol and drug use, mental health symptoms? 
23. What do you see as the biggest barriers to implementing alcohol and drug integrated 
behavioral health care in pediatrics? 
24. What would facilitate its implementation?  
25. Ideally, if you could imagine or design a model of care to address substance use and 
mental health issues with adolescents, what would that look like? 
26. What sort of organizational resources would need to be brought to bear to make that 
happen? 
 
[Probes:  Space?  Staff?  Training? Executive sponsorship?] 
 
27. If behavioral health became a bigger priority, would something else take a back seat? 
28. Are clinicians in your practice/system trained in brief interventions for behavioral health 
issues? 
 
29. How is it communicated to adolescents if there is a concern about a behavioral health 
issue? 
30. How are parents involved in discussions about behavioral health problems?   
 
31. Who do you think is the best person or role to screen for at-risk alcohol or drug problems 
in Pediatric Primary Care settings?  
 
MA 
Primary Care Provider  
Nurse 
BMS 
CHE/HEALTH EDUCATOR 
Other: _____________________ 
 
Probes: Why?  For example, efficiency, qualifications? If not an MA, why not an MA? 
 
32. Who do you think is the best person or role to give a brief intervention for at-risk alcohol 
or drug problems in Primary Care settings?  
 
E.g.:  
MA 
Primary Care Provider  
Nurse 
BMS 
CHE/HEALTH EDUCATOR 
Other: _____________________ 
 
Probes: Why?  For example, efficiency, qualifications? 
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33. To what extent do you think the clinicians in your system (or clinic) feel prepared to 
conduct brief interventions for adolescent drinking or drug use?   
 
 
34. What is your sense of how beneficial Brief Interventions for alcohol and drug use are for 
teens?    
 
 
35. Can you tell me about any barriers you are aware of, to referring adolescents to 
specialty substance abuse or mental health treatment? 
 
 
36. What could make that process work more smoothly? 
 
 
37. What kind of patients typically get referred to substance abuse treatment in your 
system? 
 
 
38. What type of patients typically get referred to mental health treatment in your system?   
 
39. Is there a flow of information between primary care and specialty care settings, e.g., do 
primary care providers generally get feedback from the program or patient about 
whether they accessed specialty behavioral health treatment, and vice versa – do 
specialty treatment setting get information from pediatric primary care?  
 
40. Anything else you’d like to comment on, about the screening and treatment of behavioral 
health problems for teens? 
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APPENDIX C: SYSTEMATIC LITERATURE REVIEW RESULTS 
Type of study Intervention/ 
Program 
Description 
Sample/N/ 
Comparison 
group(s) 
Provider 
type 
Outcome(s) data 
sources 
Evidence of: efficacy, 
effectiveness, feasibility 
Quality of evidence & 
Limitations 
Efficacy/Effectiveness 
Boekeloo BO, Jerry J, Lee-Ougo WI, et al. Randomized trial of brief office-based interventions to reduce adolescent alcohol use. Archives of 
pediatrics & adolescent medicine. Jul 2004;158(7):635-642. 
RCT 
 
  
5 pediatric 
primary care 
group practices 
belonging to a 
managed care 
health plan. 
 
3 study arms: 
Group I - 
Usual Care; 
Group 2 - 
Usual Care + 
15 minute 
audio-taped 
“priming” for 
visit, which 
involved a 
simulated teen 
office visit, 
including 
Providers 
discussing 
alcohol and 
alcohol risk 
behaviors and 
consequences, 
self-assessment 
of alcohol and 
drug use; 
Group 3 - 
Eligibility: 12-17, 
first sibling in 
family recruited, 
had to have had 
appointment 
scheduled for 7 
business days, 
well-visit, fluent 
in English. 
n = unclear (either 
447 as indicated 
by diagram, or 
444 indicated in 
text) 
 
   
Physicians Baseline interviewer-
administered 
interviews; exit 
interview post-exam, 
to measure beliefs 
about alcohol; 6 and 
12-month 
interviewer-
administered 
telephone follow-up 
interviews. 
 
Follow-up measures 
included both alcohol 
use (any, binge/5+, 
drinking before sex); 
being around friends 
while they were 
drinking in past 30 
days; instances of 
refusing alcohol when 
offered by friends; 
beliefs about alcohol; 
self-efficacy about 
alcohol-refusal, 
negative alcohol 
outcome 
expectations; 
perceived alcohol 
tolerance; intention to 
At exit interview, both 
intervention groups 
reported perceiving lower 
amounts of alcohol as 
necessary to impair 
thinking that did those in 
the usual care group.  
Significantly higher 
percentages of both 
intervention groups 
reported intent to drink 
alcohol in the next 3 
months. 
 
At 6 months, Group 3 was 
significantly more likely to 
report having refused 
alcohol offered by friends 
(p<.01).  
 
A higher proportion of 
Group 2 participants 
reported drinking in past 30 
days and the past 3 months, 
at 12 months, than those in 
the Usual Care group (both 
p<.05).  
 
Both intervention groups 
were significantly more 
Low 
The intervention group 
participants actually had 
significantly worse alcohol 
use outcomes at 6 and 12 
months. 
 
The authors argue that these 
counter-intuitive findings 
could be due to the 
intervention groups 
increased forthrightness 
resulting from “priming” 
effects of psychosocial 
messages about the 
importance of honest and 
open discussion of alcohol 
use between providers and 
patients.   
 
However, the teens in the 
two intervention groups 
were significantly more 
likely to have drunk in the 3 
months prior to baseline, 
perhaps suggesting a higher 
propensity to drink alcohol 
in general.  The authors 
controlled for past 3 month 
alcohol use in the analyses. 
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Type of study Intervention/ 
Program 
Description 
Sample/N/ 
Comparison 
group(s) 
Provider 
type 
Outcome(s) data 
sources 
Evidence of: efficacy, 
effectiveness, feasibility 
Quality of evidence & 
Limitations 
Everything in 
group 2 + 
actual 
providers given 
patients’ 
answers to self-
assessment and 
guide to 
interpreting 
self-assessment 
of risk 
behaviors.  
 
Participants in 
both 
intervention 
arms also 
listened to the 
same audio 
recording over 
the phone at 
the 6 month 
follow-up, as a 
booster.  
 
 
drink. likely to report binge 
drinking at both 6 and 12 
months, compared to the 
Usual Care group: Group 2 
teens were almost 3 ½ 
times as likely to report 
binge drinking at 6 months 
(p <.05) and 3 times more 
likely at 12 months (p<.01); 
Group 3 teens were almost 
5 times as likely to report 
binge drinking at 6 months 
(p<.01) and almost 3 times 
as likely at 12 months 
(p<.05). 
 
The groups differed in the 
percentage of African 
Americans in each group 
(83%, 83% and 71.5%, 
respectively in Groups 1, 2 
and 3), and the percent who 
drank alcohol in the past 3 
months (18, 29, and 30%, 
respectively). 
Randomization procedures 
are described as 
computerized 
randomization, stratified by 
provider as well at 
participant age and gender.  
While it is difficult to 
determine how 
randomization might have 
been flawed, the 
implications of Groups 2 and 
3 being potentially more 
severe or “at risk” become 
more apparent in light of the 
results. Risk of selection bias 
is potentially quite high. 
 
Follow-up rates were high 
(92% at 12 months), and 
almost identical across 
groups.  Risk of attrition bias 
is therefore low. 
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Type of study Intervention/ 
Program 
Description 
Sample/N/ 
Comparison 
group(s) 
Provider 
type 
Outcome(s) data 
sources 
Evidence of: efficacy, 
effectiveness, feasibility 
Quality of evidence & 
Limitations 
De Micheli D, Fisberg M, Formigoni ML. [Study on the effectiveness of brief intervention for alcohol and other drug use directed to adolescents in a 
primary health care unit]. Rev Assoc Med Bras. Jul-Sep 2004;50(3):305-313. 
RCT 20 min, single-
session MI 
intervention for 
current AOD 
users, or 2-3 
minute preventive 
AOD 
psychoeducation 
for non-users, 
delivered  in Teen 
primary care 
clinic 
Among users: 
MI group – n=28, 
Controls – n=31 
 
Among non-users: 
Ed group – n=20 
Controls – n=20 
 
Total N = 99 
 
Physician Past month AOD 
quantity and 
frequency, 
dependence 
symptoms (craving, 
tolerance, 
withdrawal), AOD-
associated risk taking 
and problems 
They found significant 
improvements from the BI 
among current users, and 
significantly lower rates of 
increase in alcohol 
consumption among the 
non-users.  
 
Among current users, those 
in the intervention group 
reported significantly 
greater reductions in the use 
of marijuana, inhalants, 
ecstasy, alcohol and 
tobacco, compared to those 
in the control group.   
 
Among non-users, while 
use of alcohol and tobacco 
increased in both groups, 
the increase in both 
frequency and intensity was 
lower in the preventive 
intervention group.  
Marijuana use increased in 
the control group but not 
the intervention group. 
 
Moderate 
D'Amico EJ, Miles JN, Stern SA, Meredith LS. Brief motivational interviewing for teens at risk of substance use consequences: a randomized pilot 
study in a primary care clinic. J Subst Abuse Treat. Jul 2008;35(1):53-61. 
Randomized 
pilot: 2 groups 
– brief MI and 
15-20 minute 
MI 
intervention 
MI group – N=23, 
usual care – N=24 
Associate 
degree and 
MA-level 
Peer influence 
(including perception 
of % of students in 
Those in the intervention 
group were less likely to 
report intention to use 
Low 
 
Considerable study refusal, 
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Type of study Intervention/ 
Program 
Description 
Sample/N/ 
Comparison 
group(s) 
Provider 
type 
Outcome(s) data 
sources 
Evidence of: efficacy, 
effectiveness, feasibility 
Quality of evidence & 
Limitations 
usual care. delivered in 
primary care 
clinic. 
 
Also examined 
effect of 
booster phone 
call. 
case 
managers 
school who drank or 
used marijuana, how 
often they spent time 
around people who 
drank or used 
marijuana, friends’ 
consumption of 
AOD); intentions to 
use alcohol or 
marijuana in next 6 
months; alcohol and 
marijuana 
consumption (days 
per month, # times 
used per day, # drinks 
per day, and # of days 
of 3+ drinks); alcohol 
or marijuana-related 
consequences; social 
desirability. 
marijuana in the next 6 
months, reported a lower 
perceived prevalence of 
marijuana use at school, 
reported fewer friends who 
used marijuana, and 
reported using marijuana 
few times on the days they 
used, compared to the usual 
care group.  
 
No significant effects found 
as result of booster call. 
drop-out and follow-up 
attrition along the way.  
Confusing flowchart of 
recruitment.  3% of original 
sampling frame/ 28% of 
eligible actually received 
intervention. Evidence of 
non-random follow-up 
attrition: those who did not 
follow-up had significantly 
more drinking days and 
more binge drinking days at 
baseline than those who did 
follow-up. 
 
 
 
 
 
Ozer EM, Adams SH, Orrell-Valente JK, et al. Does delivering preventive services in primary care reduce adolescent risky behavior? J Adolesc 
Health. Nov 2011;49(5):476-482. 
Observational 
 
Ozer, 2011 
3 general 
pediatrics 
clinics in large, 
managed care 
health plan. 
 
Two part 
intervention: 
screening and 
brief advice 
and referral on 
a variety of 
risk behaviors 
(N=904)  
14 year olds 
received 
intervention, 15 
year olds assessed 
at well-visit. 
 
Comparison group 
consisted of 
California Health 
Interview Study 
(CHIS) 
adolescents, 711-
Pediatric 
PCPs + 
Health 
Educators 
“ever used alcohol” 
“ever used drugs” 
 
Measured at 14 years 
and 15 years, at teen 
well-visits, compared 
to 14 and 15 year olds 
in CHIS survey 
dataset. 
There was no evidence of 
an effect on self-report 
alcohol or drug use, 
compared to the 
comparison group. 
Low 
Of the original ~ 1,546 
adolescents contacted for 
recruitment, only 904, or 
58% ultimately ended up 
participating.  The authors 
provide no information on 
differences between those 
invited to participate and the 
final sample.  There is 
considerable risk of selection 
bias given the low 
participation rate, although it 
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Type of study Intervention/ 
Program 
Description 
Sample/N/ 
Comparison 
group(s) 
Provider 
type 
Outcome(s) data 
sources 
Evidence of: efficacy, 
effectiveness, feasibility 
Quality of evidence & 
Limitations 
by pediatrician, 
followed by 
reinforcement 
session by 
health educator 
on same topics, 
aimed at 
increasing 
teen’s self-
efficacy. 
 
 
14 year olds, 699-
15 year olds). 
is impossible to determine, 
given the lack of information 
on refusers. 
 
83% follow-up rate – 
moderate attrition bias rate. 
 
There is no discussion of the 
characteristics of the 
comparison group, beyond 
basic demographics: gender 
and ethnicity (which seems 
to differ, although no tests of 
significance are reported).   
There is no information on 
SES, health status, or most 
significantly, access to or 
receipt of preventive 
services. 
 
Harris SK, Csemy L, Sherritt L, et al. Computer-facilitated substance use screening and brief advice for teens in primary care: an international 
trial. Pediatrics. Jun 2012;129(6):1072-1082. 
Quasi-
experimental 
trial, 
asynchronous, 
sites served as 
own UC 
controls 
 
 
Primary Care 
 
2 countries, 19 
primary care 
clinics (U.S. = 
9 and Czech 
Republic = 10),  
 
 
Computer-
facilitated 
AOD 
screening, 
U.S. N=2096, 
Czech N=589 
 
Sites served as 
their own 
historical controls 
 
U.S. intervention 
N = 1068, control 
N = 1028 
 
Czech 
intervention N = 
Physicians Past 90 day alcohol, 
cannabis, hard drug 
Q/F, perceived use by 
peers, siblings and 
parents.  
 
Rates of use, 
initiation among those 
reporting no use in 
past year, cessation in 
those reporting use in 
past year. 
Implementation: 
Brief advice rates x2 in US 
and x4 in Czech, compared 
to UC. 
 
More patients rated 
provider advice as excellent 
or very good, said they 
were very satisfied with the 
visit, and reported being 
very likely to follow 
provider’s advice in the 
intervention condition 
Moderate-High 
Historical, self-as-control 
poses threat to internal 
validity if there were 
significant secular or 
environmental trends.  The 
authors say they asked 
participants how often they 
had heard information about 
alcohol or drugs in the news 
or from friends of family to 
control for secular trends.  
Potentially inadequate way 
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Type of study Intervention/ 
Program 
Description 
Sample/N/ 
Comparison 
group(s) 
Provider 
type 
Outcome(s) data 
sources 
Evidence of: efficacy, 
effectiveness, feasibility 
Quality of evidence & 
Limitations 
pediatrician-
delivered brief 
advice. 
297, control N = 
292  
compared to UC. 
 
US: intervention teens 
reported lower past 90 day 
alcohol use, and higher 
alcohol cessation rates at 3-
month follow-up, compared 
to UC.  Intervention teens 
reported lower alcohol 
initiation and higher 
cessation rates at 12-month 
follow-up. 
 
Czech: at 3-month follow-
up, intervention teens 
reported lower cannabis 
initiation rates than 
controls.  At 12-month 
follow-up, intervention 
teens reported lower past 12 
month cannabis use rates, 
as well as lower cannabis 
initiation and higher 
cannabis cessation rates, 
compared to controls. 
to control. 
 
Low risk of selection bias 
with regard to BLQ 
completion rate in US 
(86.5%), and in Czech 
(100%). 
Louis-Jacques J, Knight JR, Sherritt L, Van Hook S, Harris SK. Do Risky Friends Change the Efficacy of a Primary Care Brief Intervention for 
Adolescent Alcohol Use? J Adolesc Health. Nov 8 2013. 
Secondary 
analysis of 
quasi-
experimental 
trial, using US 
sample from 
Harris study. 
 
Primary Care 
 
9 pediatric 
primary care 
clinics.  
 
 
Computer-
Sites served as 
their own 
historical controls 
 
Intervention N = 
1068, control N = 
1028 
 
Physicians Alcohol use initiation 
and cessation. 
Research question 
examined whether efficacy 
of intervention is moderated 
by peer risk, i.e., having 
friends who use, urge or 
suffer consequences related 
to AOD use. 
 
Moderate-High  
 
Findings suggest that 
intervention effects may be 
moderated by relationships 
with peers who engage in 
AOD use or behaviors, and 
that intervention may be 
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Type of study Intervention/ 
Program 
Description 
Sample/N/ 
Comparison 
group(s) 
Provider 
type 
Outcome(s) data 
sources 
Evidence of: efficacy, 
effectiveness, feasibility 
Quality of evidence & 
Limitations 
Louis-Jacques, 
2014 
facilitated, 
pediatrician-
delivered brief 
advice. 
At the 3-month follow-up, 
those in the intervention 
group were significantly 
more likely to report 
quitting alcohol, compared 
to the UC group, only 
among the group reporting 
peer risk at baseline (OR 
1.44). 
 
At 12-month follow-up, 
those in the intervention 
group were significantly 
less likely to report 
initiating alcohol use 
(among non-drinkers), 
compared to the UC group, 
only among the group 
reporting peer risk at 
baseline (OR .69). 
more effective in these 
patients. 
 
Historical, self-as-control 
poses threat to internal 
validity if there were 
significant secular or 
environmental trends.  The 
authors say they asked 
participants how often they 
had heard information about 
alcohol or drugs in the news 
or from friends of family to 
control for secular trends.  
Potentially inadequate way 
to control. 
 
Low risk of selection bias 
with regard to BLQ 
completion rate (86.5%). 
Walton MA, Bohnert K, Resko S, et al. Computer and therapist based brief interventions among cannabis-using adolescents presenting to primary 
care: one year outcomes. Drug and alcohol dependence. Oct 1 2013;132(3):646-653. 
RCT Compared two 
BIs, one 
delivered by a 
therapist 
trained in MI 
(TBI), the 
other 
computer-
delivered 
(CBI), using a 
virtual “buddy” 
to guide 
participants 
Cannabis-using 
adolescent (age 
12-18) primary 
care patients 
(n=328), recruited 
from seven 
federally-qualified 
health centers 
Master’s- 
level 
therapists, 
and 
Computer-
delivered 
intervetion 
Outcomes measured 
included past three 
month cannabis, 
alcohol and other 
drug use, cannabis 
related consequences, 
and driving while 
under the influence 
(DUI) of cannabis. 
Cannabis related 
consequences decreased 
significantly among the 
CBI arm participants at 3 
and 6 months, and among 
the TBI arm participants at 
6 and 12 months, while 
there were no decreases in 
consequences in the control 
group.  Frequency of 
cannabis DUI decreased 
significantly in the TBI 
group at 3 months.  
High 
 They had good recruitment 
rates (90% among those who 
met eligibility criteria). 
Caucasians were 
significantly less likely to 
agree to recruitment. 
Randomization results 
suggested no significant 
differences across the arms. 
They had  very good follow-
up response rates (85%, 85% 
and 84% at 3, 6 and 12 
  
1
7
4
 
Type of study Intervention/ 
Program 
Description 
Sample/N/ 
Comparison 
group(s) 
Provider 
type 
Outcome(s) data 
sources 
Evidence of: efficacy, 
effectiveness, feasibility 
Quality of evidence & 
Limitations 
through 
discussions and 
scenarios about 
cannabis use 
decision-
making in the 
Midwest, were 
randomized to 
one of the 
intervention 
conditions, or 
to an enhanced 
control arm, in 
which they 
received a 
brochure about 
cannabis 
problems and 
resources for 
assistance.  
Cannabis use frequency 
decreased significantly in 
all three groups, with no 
differences between groups. 
Other drug use decreased 
significantly at 3 and 6 
months, for both the 
intervention groups, but not 
for the control group. There 
were no decreases in 
alcohol use in any of the 
groups. In both intervention 
groups, participants 
reported significant 
increases in perception of 
risks of cannabis use and 
self-efficacy about avoiding 
use, and decreases in their 
intention to use cannabis. 
Generalized estimating 
equation models, examining 
the effects of the 
interventions over time, 
found no significant 
differences in effects by 12 
months, except in alcohol 
use in the CBI arm.   
 
months, respectively. 
African Americans were less 
likely than Caucasians to 
drop out of the study. 
Walton, MA, Resko, S,Barry, KL, Chermack, ST, Zucker, RA, Zimmerman, MA, Booth, BM, Blow, FC. A randomized controlled trial testing the 
efficacy of a brief cannabis universal prevention program among adolescents in primary care. Addiction 2014 May;109(5):786-97. 
RCT Compared two 
BIs, one 
delivered by a 
therapist 
trained in MI 
Cannabis-naïve 
adolescent (age 
12-18) primary 
care patients 
(n=714), recruited 
Master’s- 
level 
therapists, 
and 
Computer-
Outcomes measured 
included past three 
month cannabis, 
alcohol and other 
drug use, cannabis 
CBI arm participants had 
significantly lower rates of 
any cannabis use over 12 
months, of frequency of 
cannabis use at 3 and 6 
High 
 Good recruitment rates 
(84% among those who met 
eligibility criteria) and very 
good follow-up response 
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Type of study Intervention/ 
Program 
Description 
Sample/N/ 
Comparison 
group(s) 
Provider 
type 
Outcome(s) data 
sources 
Evidence of: efficacy, 
effectiveness, feasibility 
Quality of evidence & 
Limitations 
(TBI), the 
other 
computer-
delivered 
(CBI), using a 
virtual “buddy” 
to guide 
participants 
through 
discussions and 
scenarios about 
cannabis use 
decision-
making in the 
Midwest, were 
randomized to 
one of the 
intervention 
conditions, or 
to an enhanced 
control arm, in 
which they 
received a 
brochure about 
cannabis 
problems and 
resources for 
assistance. 
 
from seven 
federally-qualified 
health centers 
delivered 
intervention 
related consequences, 
and driving while 
under the influence 
(DUI) of cannabis. 
months, of any other drug 
use at 3  months, compared 
to controls, (all p<.05). 
 
TBI arm participants had 
significantly lower alcohol 
use, and other drug use 
(both p<.05) and 
delinquency at 3 months 
(p<.01), compared to 
controls. 
rates (95%, 96% and 88% 
across the three study arms), 
suggest relatively little 
selection and attrition bias. 
Boys and Caucasians were 
significantly less likely to 
agree to recruitment. 
Randomization results 
suggested few significant 
differences across the arms, 
with the exception of slight 
but statistically significant 
differences in age and 
percentage of sample in 
grades 6-8. 
Systematic Reviews/Meta-Analyses 
Jonas DE, Garbutt JC, Amick HR, et al. Behavioral counseling after screening for alcohol misuse in primary care: a systematic review and meta-
analysis for the U.S. Preventive Services Task Force. Annals of internal medicine. Nov 6 2012;157(9):645-654. 
Systematic 
review and 
meta-analysis 
A systematic 
review and 
meta-analysis 
0 studies 
involving 
adolescents met 
n/a  Determination of 
insufficient evidence 
available to assess efficacy 
 
  
1
7
6
 
Type of study Intervention/ 
Program 
Description 
Sample/N/ 
Comparison 
group(s) 
Provider 
type 
Outcome(s) data 
sources 
Evidence of: efficacy, 
effectiveness, feasibility 
Quality of evidence & 
Limitations 
of the evidence 
for behavioral 
counseling 
conducted after 
screening for 
alcohol misuse 
in primary 
care. 
 
Only trials of 
at least 6-
months’ 
duration that 
enrolled people 
identified with 
alcohol misuse 
in primary care 
settings. 
 
review criteria. or effectiveness for 
adolescents 
Patnode CD, O'Connor E, Rowland M, Burda BU, Perdue LA, Whitlock EP. Primary care behavioral interventions to prevent or reduce illicit drug 
use and nonmedical pharmaceutical use in children and adolescents: a systematic evidence review for the U.S. Preventive Services Task Force. 
Annals of internal medicine. May 6 2014;160(9):612-620. 
Systematic 
review 
A systematic 
review of the 
evidence for 
primary care 
behavioral 
interventions to 
prevent or 
reduce illicit 
drug use and 
nonmedical 
pharmaceutical 
use in children 
and 
6 studies were 
found which met 
criteria for review 
n/a  4 of the 5 trials assessing 
self-reported cannabis use 
found statistically 
significant reductions 
among intervention group 
participants.   
 
One trial found no effect on 
cannabis-related 
consequences or DUI.  
 
3 trials found significant 
positive outcomes in non-
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Type of study Intervention/ 
Program 
Description 
Sample/N/ 
Comparison 
group(s) 
Provider 
type 
Outcome(s) data 
sources 
Evidence of: efficacy, 
effectiveness, feasibility 
Quality of evidence & 
Limitations 
adolescents. 
 
medical prescription drug 
use. 3 trials found no 
reduction in depression 
symptoms at 12 or 24 
months. Determination of 
insufficient evidence 
available to assess efficacy 
or effectiveness for 
adolescents. 
 
Implementation/Feasibility 
Stern SA, Meredith LS, Gholson J, Gore P, D'Amico EJ. Project CHAT: a brief motivational substance abuse intervention for teens in primary 
care. Journal of substance abuse treatment. Mar 2007;32(2):153-165. 
Feasibility 
 
 
Testing 
feasibility of 
brief MI 
delivered in 
pediatric 
primary care 
setting 
(N=8) 12-18 year 
olds identified as 
high risk (had 
experienced 
alcohol or drug 
problems or had 
developed 
patterns of regular 
use). 
MFT, 
Health 
Educator 
Examined feasibility, 
acceptability, via pilot 
testing intervention 
on teens and through 
qualitative interviews 
and groups with clinic 
staff and adolescents. 
 N/A 
Lustig JL, Ozer EM, Adams SH, et al. Improving the delivery of adolescent clinical preventive services through skills-based training. Pediatrics. 
May 2001;107(5):1100-1107. 
Implementation Testing the 
impact of two, 
4-hour PCP 
trainings on the 
delivery of 
clinical 
preventive 
services for 
adolescents. 
Pediatric primary 
care providers 
(n=63) in an 
integrated health 
care delivery 
system. 
PCPs Adolescent patients’ 
reports of the services 
delivered by their 
PCPs. 
According to patient 
reports, following the 
trainings, the percentage of 
adolescents screened 
increased significantly for 
seatbelt use (38% to 56%), 
helmet use (27% to 45%), 
tobacco use (64% to 76%), 
alcohol use (59% to 76%) 
and sexual behavior (42% 
to 58%).  The percentage of 
Weak 
 
Pre-post design, no control 
group, patient report of PCP 
behavior 
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Type of study Intervention/ 
Program 
Description 
Sample/N/ 
Comparison 
group(s) 
Provider 
type 
Outcome(s) data 
sources 
Evidence of: efficacy, 
effectiveness, feasibility 
Quality of evidence & 
Limitations 
adolescents offered brief 
counseling following the 
training increased 
significantly for seatbelt use 
(36% to 51%), helmet use 
(25% to 43%), and sexual 
behavior (42% to 58%). 
There were no significant 
changes in rates of brief 
counseling for tobacco or 
alcohol use. 
Ozer EM, Adams SH, Lustig JL, et al. Can it be done? Implementing adolescent clinical preventive services. Health Serv Res. Dec 2001;36(6 Pt 
2):150-165. 
Implementation Study of 
implementation 
of an 
intervention to 
increase 
delivery of 
adolescent 
preventive 
services in 
primary care. 
Testing the 
impact of a 
training 
curriculum, use 
of screening 
and charting 
tools, access to 
referral 
resources and 
access to the 
services of a 
clinical health 
Pediatric primary 
care providers 
(n=89) in an 
integrated health 
care delivery 
system. 
PCPs Patient reports of 
delivery of preventive 
services (screening, 
counseling, referral) 
at pre-intervention T1 
(n=104 patients), and 
5-months T2 (n=211 
patients) and 18-
months T3 (n=998 
patients) post 
intervention. 
From T1 to T2, patients 
reported being screened a 
higher percentage of the 
time for tobacco (61% to 
95%), alcohol use (59% to 
96%), sexual behavior 
(47% to 82%), seatbelt use 
(36% to 98%), and helmet 
use (33% to 98%).  (all 
p<.000)Increases from T1 
to T3 were similar.  There 
were small but significant 
decreases in screening rates 
from T2 to T3. 
 
Counseling rates increased 
significantly from T1 to T2: 
tobacco (55% to 96%), 
alcohol (46% to 91%),  
sexual behavior (41% to 
76%), seatbelt use (32% to 
99%), and helmet use (28% 
Moderate 
Pre-post design, no control 
group, patient report of PCP 
behavior 
  
1
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Type of study Intervention/ 
Program 
Description 
Sample/N/ 
Comparison 
group(s) 
Provider 
type 
Outcome(s) data 
sources 
Evidence of: efficacy, 
effectiveness, feasibility 
Quality of evidence & 
Limitations 
educator. to 98%) (all p<.000); rate 
changes were similar from 
T1 to T3.  Rates in 
counseling on tobacco, 
alcohol, sexual behavior 
and helmet use did not 
decline significantly from 
T2 to T3. 
 
Haller DM, Meynard A, Lefebvre D, Ukoumunne OC, Narring F, Broers B. Effectiveness of training family physicians to deliver a brief 
intervention to address excessive substance use among young patients: a cluster randomized controlled trial. Cmaj. May 13 2014;186(8):E263-272. 
Cluster 
randomized 
implementation 
trial 
Study of the 
effect of 
physician 
alcohol 
screening 
training, on 
patient 
drinking 
outcomes in 
primary care. 
 
Trainings 
consisted of 
two sessions, 
with a total of 
~5 hours, with 
a mixture of 
didactic 
instruction and 
role-play 
practice.  
Family physicians 
in Switzerland 
(n=33) were 
randomized to 
receive training 
on brief 
interventions for 
excessive 
substance use 
(n=17), or to a 
usual care control 
group (n=16). 
PCPs Self-report of past 30 
day excessive 
substance use (binge 
drinking or ≥1 
cannabis joint/week), 
among patients aged 
15-24, at 3, 6 and 12 
months after index 
consultation. 
Excessive substance use did 
not differ significantly 
between the study arms at 
any time point. 
High 
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